ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
3,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
4,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
5,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
6,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
7,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
8,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
9,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
10,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
11,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
12,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
12,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
13,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
14,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
15,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
15,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
16,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
17,1,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
17,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
18,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
18,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
18,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
19,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
20,1,Enuresis,Psychiatric elimination disorders,Psychiatric disorders NEC,Psych,N
21,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
22,1,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
23,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
23,2,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
24,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
24,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
24,3,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
25,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
25,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
26,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
27,1,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,Y
28,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
29,1,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
30,1,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
30,2,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,Y
31,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
31,2,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
32,1,Migraine,Migraine headaches,Headaches,Nerv,N
33,1,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
33,2,Headache,Headaches NEC,Headaches,Nerv,N
34,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
35,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
35,2,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
36,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
37,1,Enuresis,Psychiatric elimination disorders,Psychiatric disorders NEC,Psych,N
38,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
39,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
39,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
40,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
41,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
42,1,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
43,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
44,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
44,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
45,1,Gastric ulcer perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
46,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
47,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
47,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
48,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
49,1,Cataract congenital,Lens disorders congenital,Eye disorders congenital,Cong,N
50,1,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
51,1,Headache,Headaches NEC,Headaches,Nerv,N
52,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
53,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
53,2,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
54,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
55,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
56,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
56,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
57,1,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,Y
58,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
59,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
60,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
60,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
61,1,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
62,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
63,1,Acquired hydrocele,Scrotal disorders NEC,Penile and scrotal disorders (excl infections and inflammations),Repro,N
63,2,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
64,1,Spina bifida occulta,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
65,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
66,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
66,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
67,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
68,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
69,1,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
70,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
70,2,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
71,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
72,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
72,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
73,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
74,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
75,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
76,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
77,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
78,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
78,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
79,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
80,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
81,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
81,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
81,3,Headache,Headaches NEC,Headaches,Nerv,N
81,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
81,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
82,1,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
82,2,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
83,1,Headache,Headaches NEC,Headaches,Nerv,N
83,2,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
83,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
84,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
85,1,Hypersensitivity vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
86,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
87,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
87,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
88,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
88,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
89,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
90,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
91,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
92,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
93,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
93,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
93,3,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
94,1,Varicella,Herpes viral infections,Viral infectious disorders,Infec,Y
95,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
96,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
96,2,Colonic abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
96,3,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
97,1,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,Y
98,1,Ventricular hypoplasia,Cardiac hypoplasias congenital,Cardiac and vascular disorders congenital,Cong,Y
99,1,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
99,2,Gastric cancer,Gastric neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
99,3,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
100,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
101,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
102,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
102,2,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
102,3,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
102,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
102,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
102,6,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
103,1,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
103,2,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
103,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
103,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
104,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
105,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
106,1,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
107,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
107,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
108,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
109,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
110,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
111,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,Y
112,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
112,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
113,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
114,1,Peptic ulcer perforation,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
114,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
115,1,Peptic ulcer perforation,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
116,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
117,1,Pneumonia herpes viral,Herpes viral infections,Viral infectious disorders,Infec,Y
118,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,Y
119,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
120,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
120,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
121,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
122,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
123,1,Colonic abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
123,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
123,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
124,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
125,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
126,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
126,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
127,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
127,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
128,1,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
128,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
128,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
129,1,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
129,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
130,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
131,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
131,2,Gastric ulcer perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
131,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
132,1,Thyroid gland abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
133,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
134,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
135,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
136,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
136,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
137,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
138,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,Y
139,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
140,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
141,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,Y
142,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
142,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
143,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
143,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
144,1,Adrenal atrophy,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
144,2,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
144,3,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
144,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
145,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
146,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
147,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
148,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
149,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
150,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
151,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
152,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
153,1,Peptic ulcer haemorrhage,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
154,1,Peptic ulcer haemorrhage,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
155,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
156,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
157,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
158,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
159,1,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
160,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
160,2,Patent ductus arteriosus,Persistent foetal circulation disorders,Cardiac and vascular disorders congenital,Cong,N
160,3,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
160,4,Ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
161,1,Megacolon,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
162,1,Hypersensitivity vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
163,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
164,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
165,1,Albuminuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
165,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
166,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
166,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
167,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
168,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
168,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
169,1,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
170,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
170,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
171,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
172,1,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
173,1,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
173,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
173,3,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
174,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
174,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
174,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
175,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
176,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
177,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
177,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
178,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
179,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
180,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
180,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
181,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
182,1,Adrenal haemorrhage,Adrenal gland disorders NEC,Adrenal gland disorders,Endo,Y
183,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
184,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
185,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
186,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
186,2,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
186,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
187,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
188,1,Albuminuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
189,1,Albuminuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
189,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
190,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
191,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
192,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
193,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
194,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
194,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
195,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
196,1,Gastric ulcer perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
197,1,Gastric ulcer perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
198,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
198,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
199,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
199,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
200,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
201,1,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
202,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
203,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
204,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
205,1,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
206,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
207,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
207,2,Headache,Headaches NEC,Headaches,Nerv,N
207,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
208,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
209,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
209,2,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
210,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
211,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
212,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
213,1,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
213,2,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
214,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
215,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
216,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
217,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
218,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
219,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
219,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
219,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
220,1,Retinal degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
220,2,Retinal dystrophy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
221,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
222,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
223,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
224,1,Smear cervix abnormal,Reproductive organ and breast histopathology procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
225,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
225,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
226,1,Cerebral artery thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
227,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
227,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
228,1,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
229,1,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
230,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
230,2,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
230,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
231,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
232,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,Y
233,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
233,2,Atypical pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
233,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
233,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
233,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
233,6,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
233,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
233,8,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
233,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
233,10,Splinter haemorrhages,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
234,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
235,1,Eye infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
236,1,Neuroendocrine carcinoma of the skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,Y
237,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
238,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
239,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
239,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
239,3,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
239,4,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
239,5,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
240,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,Y
241,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
242,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
243,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
244,1,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
244,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
245,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,Y
246,1,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
246,2,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
247,1,Mediastinitis,Infections NEC,Infections - pathogen unspecified,Infec,N
247,2,Oesophageal perforation,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
248,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
248,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
249,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
250,1,Acne,Acnes,Skin appendage conditions,Skin,N
251,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
252,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
253,1,Kyphosis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
253,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
254,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
255,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
255,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
255,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
256,1,Headache,Headaches NEC,Headaches,Nerv,N
256,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
256,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
256,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
257,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
258,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
258,2,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
258,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
258,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
259,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
259,2,Headache,Headaches NEC,Headaches,Nerv,N
259,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
259,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
260,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
261,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
261,2,Mastitis,Breast infections,Infections - pathogen unspecified,Infec,N
262,1,Peptic ulcer haemorrhage,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
263,1,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
264,1,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
265,1,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
266,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
267,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
267,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
268,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
269,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
270,1,Arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
270,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
270,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
271,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
271,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
272,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
272,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
272,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
273,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
274,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
274,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
274,3,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
274,4,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
274,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
274,6,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
274,7,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
274,8,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
274,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
275,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
276,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
276,2,Peak expiratory flow rate decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
277,1,Peptic ulcer perforation,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
278,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
279,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
279,2,Atypical pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
279,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
280,1,Catatonia,Decreased physical activity levels,Changes in physical activity,Psych,N
280,2,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
280,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
281,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
281,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
281,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
282,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
282,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
282,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
282,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
282,5,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
283,1,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
284,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
284,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
284,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
285,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
286,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
287,1,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
288,1,Peptic ulcer perforation,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
289,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
289,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
290,1,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
291,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
292,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
293,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
294,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
295,1,Astrocytoma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,Y
296,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
297,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
298,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
299,1,Psoas abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
299,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
300,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
301,1,Gastric ulcer perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
302,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
303,1,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
303,2,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
304,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
304,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
304,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
304,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
304,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
305,1,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
305,2,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
305,3,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
306,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
306,2,Mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
306,3,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
306,4,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
307,1,Cataract congenital,Lens disorders congenital,Eye disorders congenital,Cong,N
307,2,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
308,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
309,1,Choanal atresia,Pharyngeal disorders congenital,Respiratory disorders congenital,Cong,N
309,2,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
309,3,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
310,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
310,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
311,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
312,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
313,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
314,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
315,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
316,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
317,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
318,1,Perineal pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
319,1,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
320,1,Catarrh,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
320,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
320,3,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
320,4,Headache,Headaches NEC,Headaches,Nerv,N
320,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
321,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
322,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
322,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
323,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
324,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
325,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
325,2,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
326,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
327,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
328,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
329,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
330,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
330,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
331,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
331,2,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
332,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
332,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
333,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
333,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
333,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
334,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
334,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
334,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
334,4,Peripancreatic fluid collection,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
334,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
334,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
335,1,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
336,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
337,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
338,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
338,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
339,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
339,2,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
340,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
341,1,Urinary hesitation,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
342,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
342,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
342,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
342,4,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
343,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
344,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
345,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
346,1,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
346,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
347,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
348,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
349,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
350,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
351,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
352,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
353,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
354,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
354,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
355,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
356,1,Herpes virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
356,2,Myelitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
356,3,Neurogenic bladder,Myoneurogenic bladder disorders,Bladder and bladder neck disorders (excl calculi),Renal,N
356,4,Paraparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
356,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
356,6,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
357,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
358,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
358,2,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
359,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
359,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
360,1,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
361,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
362,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
363,1,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
364,1,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
365,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
366,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
367,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
367,2,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
368,1,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
369,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
370,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
371,1,Peptic ulcer haemorrhage,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
372,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
373,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
374,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
375,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
376,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
377,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
378,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
379,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
379,2,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
380,1,Osteoporotic fracture,Fractures NEC,Fractures,Musc,N
381,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
382,1,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
383,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
383,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
384,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
385,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
386,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
386,2,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
387,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
388,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
388,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
388,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
389,1,Migraine,Migraine headaches,Headaches,Nerv,N
390,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
390,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
391,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
392,1,Ileal ulcer perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
392,2,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,Y
393,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
394,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
395,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
395,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
395,3,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
396,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
396,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
397,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
397,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
397,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
398,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
398,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
398,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
399,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
399,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
399,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
400,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
400,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
401,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
402,1,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
403,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
403,2,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
403,3,Actinomycosis,Actinomycotic infectious disorders,Bacterial infectious disorders,Infec,N
403,4,Arterial rupture,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
403,5,Arteriosclerosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
403,6,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
403,7,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
403,8,Cytomegalovirus test,Virus identification and serology,Microbiology and serology investigations,Inv,N
403,9,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
403,10,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
403,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
403,12,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
403,13,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
404,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
404,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
405,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
406,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
406,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
407,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
407,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
408,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
408,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
409,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
409,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
409,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
409,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
410,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
410,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
411,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,Y
412,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
413,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
414,1,Congenital hydrocephalus,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
414,2,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
415,1,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
416,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
417,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
417,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
417,3,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
418,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
418,2,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
419,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
420,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
421,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
422,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
422,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
422,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
422,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
423,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
424,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
425,1,Adenoma benign,Neoplasms benign site unspecified NEC,Miscellaneous and site unspecified neoplasms benign,Neopl,N
425,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
426,1,Adenoma benign,Neoplasms benign site unspecified NEC,Miscellaneous and site unspecified neoplasms benign,Neopl,N
427,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
428,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
428,2,Carcinoid tumour,Carcinoid tumours,Endocrine neoplasms malignant and unspecified,Neopl,N
428,3,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
428,4,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
429,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
429,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
430,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
430,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
430,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
431,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
431,2,Rectal polyp,Benign neoplasms gastrointestinal (excl oral cavity),Benign neoplasms gastrointestinal,Gastr,N
431,3,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
431,4,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
432,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
432,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
432,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
433,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
433,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
433,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
434,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
435,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
435,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
435,3,Sweat gland tumour,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
436,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
436,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
436,3,Sweat gland tumour,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
437,1,Sweat gland tumour,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
438,1,Sweat gland tumour,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
439,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
439,2,Hair follicle tumour benign,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
439,3,Neoplasm skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
440,1,Hair follicle tumour benign,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
441,1,Myopathy,Myopathies,Muscle disorders,Musc,N
442,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
443,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
444,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
444,2,Polymyalgia rheumatica,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
445,1,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
445,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
445,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
446,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
447,1,Food interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
447,2,Migraine,Migraine headaches,Headaches,Nerv,N
448,1,Oesophageal ulcer haemorrhage,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
449,1,Hypochromic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
450,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
451,1,Spermatogenesis abnormal,Spermatogenesis and semen disorders,Sexual function and fertility disorders,Repro,N
452,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
452,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
452,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
453,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
453,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
453,3,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
453,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
453,5,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
453,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
454,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
454,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
455,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
456,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
456,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
456,3,Hyperkinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
456,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
457,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
458,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
459,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
459,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
459,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
459,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
460,1,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
461,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
462,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
463,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
464,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
464,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
465,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
466,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
466,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
466,3,Left ventricular failure,Left ventricular failures,Heart failures,Card,Y
467,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
467,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
468,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
469,1,Peptic ulcer haemorrhage,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
470,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
470,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
470,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
471,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
472,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
472,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
472,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
472,4,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
472,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
472,6,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
472,7,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
473,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
473,2,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
474,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
475,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
476,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
477,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
478,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
478,2,Hypertonic bladder,Myoneurogenic bladder disorders,Bladder and bladder neck disorders (excl calculi),Renal,N
478,3,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
479,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
480,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
481,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
481,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
482,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
483,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
484,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
484,2,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
485,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
486,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
486,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
486,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
487,1,Pancreatitis necrotising,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
488,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
489,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
489,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
490,1,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
491,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
492,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
493,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
493,2,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
493,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
494,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
494,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
494,3,Fat embolism,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
494,4,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
494,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
494,6,Renal transplant,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
494,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
495,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
495,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
496,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
497,1,Headache,Headaches NEC,Headaches,Nerv,N
498,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
499,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
499,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
500,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
501,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
502,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
503,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
503,2,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
504,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
505,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
505,2,Pathological fracture,Fractures NEC,Fractures,Musc,N
506,1,Agnosia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
506,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
506,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
506,4,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
506,5,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
506,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
506,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
507,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
508,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
508,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
509,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
510,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
511,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
511,2,Gastritis haemorrhagic,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
512,1,Peptic ulcer haemorrhage,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
513,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
514,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
515,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
515,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
515,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
515,4,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
516,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
516,2,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
516,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
516,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
517,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
518,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
518,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
519,1,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
520,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
520,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
521,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
521,2,Headache,Headaches NEC,Headaches,Nerv,N
522,1,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
523,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
524,1,Syndactyly,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
525,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
525,2,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
526,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
526,2,Headache,Headaches NEC,Headaches,Nerv,N
526,3,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
526,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
526,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
526,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
526,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
527,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
527,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
527,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
528,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
529,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
530,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
531,1,Gravitational oedema,Oedema NEC,General system disorders NEC,Genrl,N
531,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
532,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
533,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
534,1,Duodenal perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
534,2,Gastric ulcer perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
535,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
535,2,Inappropriate affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
536,1,Skin fragility,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
536,2,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
536,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
537,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
537,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
538,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
539,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
539,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
540,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
540,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
540,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
540,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
541,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
541,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
542,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
542,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
543,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
544,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
544,2,Joint effusion,Joint related signs and symptoms,Joint disorders,Musc,N
544,3,Mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
545,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
545,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
545,3,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
545,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
546,1,Hyperkinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
547,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
548,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
548,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
548,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
548,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
549,1,Neuroendocrine carcinoma of the skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,Y
550,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
551,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
551,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
551,3,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
551,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
552,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
553,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
553,2,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
553,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
553,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
554,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
554,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
554,3,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
555,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
556,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
557,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
557,2,Blood viscosity increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
557,3,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
557,4,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
557,5,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
558,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
558,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
559,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
559,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
559,3,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
560,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
561,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
561,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
561,3,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
561,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
561,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
562,1,Blood viscosity increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
562,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
562,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
563,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
564,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
565,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
566,1,Corneal perforation,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
566,2,Keratoconus,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
567,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
567,2,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
567,3,Blood viscosity increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
567,4,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
568,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
569,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
570,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
570,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
571,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
571,2,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
572,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
573,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
574,1,Cataract subcapsular,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
575,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
576,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
576,2,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
576,3,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
576,4,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
576,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
576,6,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
576,7,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
577,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
577,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
578,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
579,1,Multiple congenital abnormalities,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
580,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
580,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
580,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
581,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
582,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
583,1,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
584,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
584,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
585,1,Horner's syndrome,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
585,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
585,3,Paresis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
586,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
586,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
587,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
587,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
587,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
588,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
589,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
589,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
589,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
589,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
590,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
591,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
591,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
592,1,Conversion disorder,Somatic symptom disorders,Somatic symptom and related disorders,Psych,N
592,2,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
593,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
593,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
593,3,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
594,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
594,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
595,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
596,1,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
596,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
597,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
597,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
597,3,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
598,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
599,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
599,2,Headache,Headaches NEC,Headaches,Nerv,N
600,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
601,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
601,2,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
601,3,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
601,4,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
601,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
602,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
603,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
603,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
603,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
604,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
604,2,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
605,1,Cataract subcapsular,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
606,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
606,2,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
606,3,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
607,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
607,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
608,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
609,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
609,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
609,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
610,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
611,1,Testicular disorder,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
612,1,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
613,1,Renal aplasia,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
614,1,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,Y
614,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
614,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
615,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
616,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
616,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
616,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
617,1,Anal cancer,Anal canal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
617,2,Anorectal disorder,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
617,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
617,4,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
618,1,Anal cancer,Anal canal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
618,2,Dyspareunia,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
618,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
618,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
618,5,Protein urine,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
618,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
618,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
619,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
620,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
621,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
622,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
622,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
622,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
622,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
623,1,Hypospadias,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
624,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
625,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
626,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
627,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
627,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
628,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
629,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
629,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
630,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
631,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
632,1,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
632,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
632,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
632,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
633,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
634,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
635,1,Headache,Headaches NEC,Headaches,Nerv,N
635,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
635,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
635,4,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
636,1,Cataract subcapsular,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
637,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
638,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
638,2,Neuroendocrine carcinoma of the skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
638,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
638,4,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
639,1,Adenocarcinoma gastric,Gastric neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
639,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
639,3,Osteoporotic fracture,Fractures NEC,Fractures,Musc,N
640,1,Histoplasmosis,Histoplasma infections,Fungal infectious disorders,Infec,N
640,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
641,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
641,2,Virilism,Female gonadal function disorders,Endocrine disorders of gonadal function,Endo,N
642,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
642,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
642,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
642,4,Laryngospasm,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
642,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
642,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
642,7,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
643,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
644,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
645,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
645,2,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
646,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
647,1,Gastric ulcer perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
648,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
649,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
649,2,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
649,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
650,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
650,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
650,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
650,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
651,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
651,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
651,3,Headache,Headaches NEC,Headaches,Nerv,N
651,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
652,1,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
652,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
653,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
654,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
655,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
656,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
656,2,Varicella,Herpes viral infections,Viral infectious disorders,Infec,Y
657,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
658,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
658,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
659,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
660,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
661,1,Asthenopia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
661,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
661,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
661,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
661,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
661,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
662,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
663,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
664,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
664,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
665,1,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
666,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
667,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
667,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
668,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
668,2,Myopathy,Myopathies,Muscle disorders,Musc,N
668,3,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
669,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
669,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
669,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
669,4,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
669,5,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
670,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
671,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
671,2,Gastritis haemorrhagic,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
672,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
673,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
674,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
674,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
674,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
674,4,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
675,1,Muscle injury,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
675,2,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
676,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
676,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
676,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
676,4,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
676,5,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
677,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
677,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
677,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
678,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
678,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
678,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
679,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
679,2,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
679,3,Headache,Headaches NEC,Headaches,Nerv,N
679,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
679,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
679,6,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
679,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
680,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
680,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
681,1,Headache,Headaches NEC,Headaches,Nerv,N
681,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
681,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
681,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
682,1,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
682,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
683,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
683,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
683,3,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
683,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
683,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
683,6,Headache,Headaches NEC,Headaches,Nerv,N
683,7,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
683,8,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
684,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
685,1,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
685,2,Speech disorder developmental,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
686,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
686,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
687,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
687,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
688,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
688,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
689,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
689,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
689,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
689,4,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
689,5,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
689,6,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
690,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
690,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
691,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
692,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
692,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
693,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
693,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
694,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
694,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
694,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
694,4,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
695,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
695,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
696,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
697,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
698,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
698,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
698,3,Headache,Headaches NEC,Headaches,Nerv,N
699,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
700,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
701,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
702,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
703,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
703,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
704,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
705,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
706,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
707,1,Thyrotoxic crisis,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
708,1,Gastric perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
709,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
709,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
709,3,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
709,4,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
709,5,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
710,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
710,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
711,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
711,2,Obliterative bronchiolitis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
712,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
712,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
712,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
713,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
714,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
715,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
715,2,Polymyalgia rheumatica,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
716,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
717,1,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
717,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
717,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
718,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
718,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
719,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
719,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
719,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
719,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
719,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
719,6,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
719,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
720,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
720,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
721,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
722,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
722,2,Peptic ulcer,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
723,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
724,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
725,1,Body mass index increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
725,2,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
725,3,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
725,4,Oligohydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
726,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
726,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
727,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
727,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
727,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
727,4,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
727,5,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
727,6,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
727,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
727,8,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
728,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
729,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
730,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
731,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
731,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
731,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
731,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
732,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
733,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
733,2,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
733,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
733,4,Death,Death and sudden death,Fatal outcomes,Genrl,Y
733,5,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
733,6,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
734,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
735,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
736,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
736,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
736,3,Gastritis erosive,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
736,4,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
736,5,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
736,6,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
737,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
737,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
737,3,Ovarian cyst,Ovarian and fallopian tube cysts and neoplasms,Ovarian and fallopian tube disorders,Repro,N
738,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
738,2,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
738,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
739,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
739,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
739,3,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
740,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
740,2,Myopia,Refractive and accommodative disorders,Vision disorders,Eye,N
741,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
741,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
742,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
742,2,Lipomatosis,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
742,3,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
743,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
744,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
745,1,Peak expiratory flow rate decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
746,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
747,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
747,2,Granuloma skin,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
747,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
747,4,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
747,5,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
748,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
748,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
749,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
749,2,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
750,1,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
750,2,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
751,1,Infective exacerbation of chronic obstructive airways disease,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
752,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
753,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
754,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
755,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
756,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
757,1,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
757,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
758,1,Gastric antral vascular ectasia,Gastrointestinal vascular malformations,Gastrointestinal vascular conditions,Gastr,N
758,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
758,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
759,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
759,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
760,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
761,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
761,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
761,3,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
761,4,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
761,5,Oesophagobronchial fistula,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
761,6,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
761,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
762,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
763,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
763,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
763,3,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
763,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
763,5,Tension headache,Headaches NEC,Headaches,Nerv,N
764,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
764,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
765,1,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
766,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
767,1,Transposition of the great vessels,Great vessel disorders congenital,Cardiac and vascular disorders congenital,Cong,N
768,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
768,2,Infective exacerbation of chronic obstructive airways disease,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
769,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
770,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
771,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
772,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
773,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
774,1,Gastric ulcer perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
775,1,Hepatic fibrosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
776,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
777,1,Anal cancer,Anal canal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
777,2,Anal skin tags,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
777,3,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
777,4,Spleen disorder,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
778,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
778,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
778,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
778,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
778,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
779,1,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
780,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
781,1,Conductive deafness,Hearing losses,Hearing disorders,Ear,N
782,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
783,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
784,1,Eyelid oedema,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
784,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
784,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
785,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
785,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
786,1,Deafness,Hearing losses,Hearing disorders,Ear,N
787,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
788,1,Hypoproteinaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
788,2,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
788,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
788,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
789,1,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
790,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
791,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
792,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
793,1,Beta haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
794,1,Acute abdomen,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
794,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
795,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
795,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
796,1,Deafness,Hearing losses,Hearing disorders,Ear,N
797,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
798,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
799,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
800,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
801,1,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
801,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
802,1,Gastric ulcer perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
803,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
803,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
803,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
804,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
805,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
805,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
805,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
806,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
807,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
807,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
807,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
808,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
808,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
809,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
810,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
811,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
812,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
812,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
813,1,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
813,2,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
814,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
814,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
815,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
816,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
816,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
817,1,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
817,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
818,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
818,2,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
818,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
818,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
818,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
818,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
818,7,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
818,8,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
818,9,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
818,10,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
818,11,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
818,12,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
818,13,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
819,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
819,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
820,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
821,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
822,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
822,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
822,3,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
822,4,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
822,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
822,6,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
823,1,Headache,Headaches NEC,Headaches,Nerv,N
823,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
824,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
824,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
825,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
825,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
825,3,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
825,4,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
826,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
826,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
826,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
827,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
828,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
828,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
828,3,Ureteric obstruction,Ureteric disorders NEC,Ureteric disorders,Renal,N
828,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
829,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
830,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
831,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
831,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
832,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
833,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
833,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
833,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
834,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
834,2,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
834,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
834,4,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
834,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
834,6,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
834,7,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
834,8,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
835,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
835,2,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
835,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
835,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
836,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
837,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
837,2,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
837,3,Gram stain positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
837,4,Peritoneal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
837,5,Peritonitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
837,6,Purulence,Infections NEC,Infections - pathogen unspecified,Infec,N
837,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
837,8,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
838,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
839,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,Y
839,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
840,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
840,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
840,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
841,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
841,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
841,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
842,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
843,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
843,2,Headache,Headaches NEC,Headaches,Nerv,N
844,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
845,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
846,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
847,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
847,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
848,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
848,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
848,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
848,4,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
848,5,Graft complication,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
848,6,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
848,7,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
848,8,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
848,9,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
848,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
848,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
848,12,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
848,13,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
848,14,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
848,15,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
848,16,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
849,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
850,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
850,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
850,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
850,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
850,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
850,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
850,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
850,8,Polymyalgia rheumatica,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
851,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
851,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
851,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
851,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
851,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
851,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
851,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
851,8,Polymyalgia rheumatica,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
852,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
852,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
852,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
852,4,Muscle swelling,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
852,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
853,1,Headache,Headaches NEC,Headaches,Nerv,N
854,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
855,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
855,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
855,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
855,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
855,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
855,6,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
856,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
856,2,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
856,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
856,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
857,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
857,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
857,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
858,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
858,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
858,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
858,4,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
858,5,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
858,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
858,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
859,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
860,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
860,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
860,3,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,Y
861,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
861,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
861,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
862,1,Hyperplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
862,2,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
863,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
863,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
863,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
863,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
863,5,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
863,6,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
864,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
864,2,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
864,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
865,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
865,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
866,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
866,2,Hyperglycaemic hyperosmolar nonketotic syndrome,Diabetic complications neurological,Diabetic complications,Metab,N
867,1,Blepharospasm,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
867,2,Facial spasm,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
868,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
869,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
869,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
869,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
870,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
870,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
870,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
871,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
872,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
873,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
874,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
874,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
874,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
875,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
875,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
876,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
877,1,Endocarditis enterococcal,Enterococcal infections,Bacterial infectious disorders,Infec,N
878,1,Congenital hearing disorder,Hearing disorders congenital,Ear and labyrinthine disorders congenital,Cong,N
879,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
880,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
880,2,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
880,3,Aortic aneurysm rupture,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,Y
880,4,Arteriosclerosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
880,5,Bladder neoplasm surgery,Bladder therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
880,6,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
880,7,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
880,8,Cytomegalovirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
880,9,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
880,10,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
880,11,Large intestine anastomosis,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
880,12,Large intestine polyp,Benign neoplasms gastrointestinal (excl oral cavity),Benign neoplasms gastrointestinal,Gastr,N
880,13,Mass excision,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
880,14,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
880,15,Polypectomy,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
880,16,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
880,17,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
880,18,Red blood cells urine positive,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
880,19,Transitional cell carcinoma,Urinary tract neoplasms malignant NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
880,20,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
881,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
881,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
881,3,Reaction to colouring,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
882,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
883,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
883,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
883,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
883,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
883,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
884,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
884,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
884,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
885,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
885,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
885,3,Peptic ulcer perforation,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
885,4,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
886,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
886,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
887,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
887,2,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
888,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
888,2,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
889,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
889,2,Myopathy,Myopathies,Muscle disorders,Musc,N
890,1,Tendon pain,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
890,2,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
891,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
891,2,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
891,3,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
891,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
891,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
892,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
892,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
892,3,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
892,4,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
893,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
893,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
894,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
895,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
896,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
896,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
896,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
896,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
896,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
896,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
897,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
898,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
899,1,Cranial nerve disorder,Cranial nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
899,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
899,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
899,4,Meningism,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
899,5,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
899,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
900,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
900,2,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
900,3,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
901,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
901,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
901,3,Headache,Headaches NEC,Headaches,Nerv,N
901,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
902,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
902,2,Claustrophobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
902,3,Hydrophobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
902,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
902,5,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
903,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
904,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
904,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
904,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
905,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
905,2,Labyrinthitis,Ear infections,Infections - pathogen unspecified,Infec,N
906,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,Y
906,2,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
906,3,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
906,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
907,1,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
907,2,Ligament disorder,Ligament disorders,"Tendon, ligament and cartilage disorders",Musc,N
907,3,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
907,4,Nerve compression,Mononeuropathies,Peripheral neuropathies,Nerv,N
907,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
907,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
907,7,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
907,8,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
907,9,Systemic inflammatory response syndrome,Inflammations,General system disorders NEC,Genrl,N
908,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
908,2,Neurocysticercosis,Cestode infections,Helminthic disorders,Infec,N
908,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
909,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
909,2,Bowen's disease,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
909,3,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
909,4,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,Y
909,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
909,6,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
909,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
909,8,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
910,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
910,2,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
910,3,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
911,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
911,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
911,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
911,4,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
911,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
911,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
911,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
911,8,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
912,1,Aura,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
912,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
913,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
913,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
913,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
913,4,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
914,1,Arthritis infective,Bone and joint infections,Infections - pathogen unspecified,Infec,N
915,1,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
915,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
916,1,Molluscum contagiosum,Molluscum contagiosum viral infections,Viral infectious disorders,Infec,N
916,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
917,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
917,2,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
917,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
918,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
918,2,T-cell lymphoma,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,Y
919,1,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
919,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
919,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
919,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
919,5,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
920,1,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
921,1,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
922,1,Disorder of orbit,Ocular disorders NEC,Eye disorders NEC,Eye,N
923,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
924,1,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
924,2,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
925,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
926,1,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
927,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
927,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
927,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
927,4,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
928,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
929,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
930,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
930,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
930,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
930,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
931,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
931,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
932,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
932,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
932,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
932,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
932,5,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
933,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
934,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
934,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
934,3,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
935,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
935,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
935,3,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
936,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
937,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
937,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
937,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
937,4,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
938,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
939,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
939,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
939,3,Headache,Headaches NEC,Headaches,Nerv,N
939,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
940,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
940,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
940,3,Headache,Headaches NEC,Headaches,Nerv,N
940,4,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
940,5,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
940,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
941,1,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
942,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
942,2,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
942,3,Peptic ulcer haemorrhage,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
942,4,Pneumonia staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
942,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
943,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
943,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
944,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
944,2,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
945,1,Nasal septum perforation,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
946,1,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
947,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
948,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
948,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
948,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
949,1,Conjunctival oedema,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
949,2,Conjunctival oedema,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
949,3,Exophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
949,4,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
949,5,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
949,6,Parophthalmia,"Orbital infections, inflammations and irritations","Ocular infections, irritations and inflammations",Eye,N
949,7,Parophthalmia,"Orbital infections, inflammations and irritations","Ocular infections, irritations and inflammations",Eye,N
949,8,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
950,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
950,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
951,1,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
952,1,Cranial nerve palsies multiple,Cranial nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
952,2,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
952,3,Sinusitis aspergillus,Aspergillus infections,Fungal infectious disorders,Infec,N
953,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
954,1,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
955,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
955,2,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
955,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
955,4,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
955,5,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
955,6,Respiratory gas exchange disorder,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
955,7,Stenotrophomonas infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
956,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
956,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
956,3,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
957,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
957,2,Helicobacter infection,Helicobacter infections,Bacterial infectious disorders,Infec,N
958,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
958,2,Lipohypertrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
958,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
959,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
959,2,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
959,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
959,4,Debridement,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
959,5,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
959,6,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
959,7,Mediastinitis,Infections NEC,Infections - pathogen unspecified,Infec,N
959,8,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
959,9,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
959,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
959,11,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
959,12,Tracheostomy,Tracheal therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
960,1,Erosive oesophagitis,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
960,2,Pneumopericardium,Pericardial disorders NEC,Pericardial disorders,Card,N
961,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
961,2,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
961,3,Increased bronchial secretion,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
961,4,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
961,5,Lung transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
961,6,Spirometry abnormal,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
961,7,Tracheobronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
962,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
962,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
962,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
962,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
962,5,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
962,6,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
962,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
963,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
964,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
965,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
965,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
965,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
966,1,Headache,Headaches NEC,Headaches,Nerv,N
967,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
968,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
968,2,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
968,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
969,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
969,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
969,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
969,4,Tendon injury,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
970,1,Morning sickness,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
970,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
971,1,Multiple fractures,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
971,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
971,3,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
972,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
972,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
972,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
972,4,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
972,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
972,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
972,7,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
972,8,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
972,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
972,10,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
972,11,Headache,Headaches NEC,Headaches,Nerv,N
972,12,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
972,13,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
972,14,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
972,15,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
972,16,Muscle injury,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
972,17,Myalgia,Muscle pains,Muscle disorders,Musc,N
972,18,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
972,19,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
972,20,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
972,21,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
972,22,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
972,23,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
973,1,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
973,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
974,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
974,2,Hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,N
974,3,Hepatitis B DNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
974,4,Hepatitis B e antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
974,5,Hepatitis B surface antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
975,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
975,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
975,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
976,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
977,1,Cataract subcapsular,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
977,2,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
977,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
978,1,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
979,1,Sensation of foreign body,Feelings and sensations NEC,General system disorders NEC,Genrl,N
979,2,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
980,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
980,2,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
980,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
980,4,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
981,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
981,2,Corneal deposits,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
982,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
982,2,Blood phosphorus increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
982,3,Corneal deposits,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
983,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
983,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
983,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
983,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
983,5,Oral mucosal eruption,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
983,6,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
983,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
983,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
984,1,Monoparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
984,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
985,1,Adjustment disorder with depressed mood,Adjustment disorders,Adjustment disorders (incl subtypes),Psych,N
985,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
985,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
985,4,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
985,5,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
986,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
987,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
987,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
987,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
987,4,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
987,5,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
987,6,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
987,7,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
987,8,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
987,9,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
987,10,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
987,11,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
987,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
987,13,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
988,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
988,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
989,1,Headache,Headaches NEC,Headaches,Nerv,N
989,2,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
990,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
990,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
990,3,Superficial spreading melanoma stage unspecified,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
991,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
991,2,Lentigo maligna,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
991,3,Skin neoplasm excision,Skin lesion excisions,Skin and subcutaneous tissue therapeutic procedures,Surg,N
992,1,Lentigo maligna,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
992,2,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,Y
993,1,Lentigo maligna,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
993,2,Skin neoplasm excision,Skin lesion excisions,Skin and subcutaneous tissue therapeutic procedures,Surg,N
993,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
994,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
995,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
995,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
995,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
995,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
996,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
997,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
997,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
998,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
998,2,Oligohydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
999,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
999,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
999,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
999,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
999,5,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
999,6,Inguinal mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
999,7,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
999,8,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
999,9,Mass excision,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
999,10,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
999,11,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
999,12,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
999,13,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
999,14,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
999,15,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
999,16,Skin oedema,Skin vascular conditions NEC,Skin vascular abnormalities,Skin,N
1000,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
1000,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1000,3,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1001,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1001,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1001,3,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1002,1,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,Y
1002,2,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1003,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1003,2,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,Y
1003,3,Nodular melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1003,4,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1004,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1004,2,Superficial spreading melanoma stage unspecified,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1005,1,Keratopathy,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1006,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1006,2,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1006,3,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1006,4,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1006,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1007,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1007,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1008,1,Akinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1008,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1008,3,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1008,4,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
1008,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1008,6,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1008,7,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1008,8,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1008,9,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1008,10,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1008,11,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
1008,12,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1008,13,Peripartum cardiomyopathy,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
1008,14,Sinus rhythm,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1008,15,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1008,16,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1008,17,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
1008,18,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1009,1,Beta haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
1009,2,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1009,3,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1009,4,Intervertebral discitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1009,5,Psoas abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
1009,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1010,1,Barrett's oesophagus,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
1010,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1010,3,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1010,4,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1010,5,Helicobacter test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
1010,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1011,1,Ophthalmic herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1012,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1012,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1012,3,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1012,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1013,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1013,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1013,3,Headache,Headaches NEC,Headaches,Nerv,N
1013,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1013,5,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1013,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1014,1,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1014,2,Visual field defect,Visual field disorders,Vision disorders,Eye,N
1015,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1015,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1016,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1016,2,Light chain analysis abnormal,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1016,3,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1016,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1016,5,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1017,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1017,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1017,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1017,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1017,5,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1018,1,Gingival ulceration,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1018,2,Hyperaesthesia teeth,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
1019,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1019,2,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1020,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1021,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1022,1,Allodynia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1022,2,Headache,Headaches NEC,Headaches,Nerv,N
1022,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1022,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1023,1,Delayed puberty,Endocrine abnormalities of puberty,Endocrine disorders of gonadal function,Endo,N
1023,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1023,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1023,4,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1023,5,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1023,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1023,7,Short stature,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1023,8,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
1024,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1024,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1024,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1024,4,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1024,5,Headache,Headaches NEC,Headaches,Nerv,N
1024,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1024,7,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1024,8,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1024,9,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1024,10,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1024,11,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1024,12,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1024,13,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1025,1,Infertility female,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
1026,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1026,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1026,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1026,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1026,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1026,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1026,7,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1026,8,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1026,9,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1026,10,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1026,11,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1026,12,Weight fluctuation,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1027,1,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
1027,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1027,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1028,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1028,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1028,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1028,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1028,5,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
1029,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1029,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1029,3,Eyelid disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1029,4,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1029,5,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1029,6,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1029,7,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1029,8,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1029,9,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1029,10,Osteolysis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1029,11,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1029,12,Tonsillectomy,Tonsillar therapeutic procedures,Head and neck therapeutic procedures,Surg,N
1029,13,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1029,14,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1030,1,Anal ulcer,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1030,2,Anastomotic ulcer,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1030,3,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1030,4,Small intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
1031,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1031,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1031,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1031,4,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1031,5,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1031,6,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
1031,7,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1031,8,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1031,9,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1031,10,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1031,11,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1031,12,Myalgia,Muscle pains,Muscle disorders,Musc,N
1031,13,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
1031,14,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1031,15,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1032,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1032,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1033,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1034,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1034,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1035,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1036,1,Neutropenic colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
1037,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1037,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1038,1,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1038,2,Cardiac valve disease,Cardiac valve disorders NEC,Cardiac valve disorders,Card,N
1038,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1039,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1039,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1040,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1041,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1041,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1041,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1041,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1042,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,Y
1043,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1044,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1045,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1046,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1046,2,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1046,3,Cytomegalovirus hepatitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1046,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1047,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1047,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1047,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1047,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1047,5,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1047,6,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1047,7,Impaired driving ability,Disability issues,Lifestyle issues,SocCi,N
1047,8,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1047,9,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1047,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1047,11,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1048,1,Abdominal rigidity,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1048,2,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1048,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1048,4,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
1048,5,Gallbladder rupture,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
1048,6,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1048,7,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1049,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1050,1,Lipohypertrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
1051,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1051,2,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1051,3,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,Y
1051,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1051,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1051,6,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1051,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1052,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1052,2,Lactose intolerance,Sugar intolerance (excl glucose intolerance),Food intolerance syndromes,Metab,N
1052,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1053,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1053,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1053,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1053,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1053,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1053,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1053,7,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1053,8,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1054,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1054,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1054,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1055,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1056,1,Necrotising retinitis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
1057,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1057,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1057,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1057,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1058,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1058,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1059,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1059,2,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1059,3,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
1059,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1059,5,Retinitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
1060,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1061,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1061,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1061,3,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1061,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1062,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1062,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1063,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1063,2,Hyperplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
1064,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1064,2,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1065,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1066,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1066,2,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1066,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1067,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1067,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1067,3,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1067,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1067,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1067,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1068,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1068,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1068,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1068,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1068,5,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1068,6,Dyssomnia,Dyssomnias,Sleep disorders and disturbances,Psych,N
1068,7,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1068,8,Headache,Headaches NEC,Headaches,Nerv,N
1068,9,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1068,10,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1068,11,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1068,12,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1068,13,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1068,14,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1068,15,Obsessive-compulsive disorder,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
1068,16,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1068,17,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1068,18,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1068,19,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1068,20,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1069,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1070,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1070,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1070,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1071,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1071,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1071,3,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1071,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1071,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1072,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1073,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
1073,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1073,3,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1073,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1073,5,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1074,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1075,1,Toxic skin eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1076,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1076,2,Antisocial behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1076,3,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1077,1,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
1078,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1079,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1080,1,Beta haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
1080,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1080,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1081,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1082,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1082,2,Negative thoughts,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1083,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1083,2,Localised oedema,Oedema NEC,General system disorders NEC,Genrl,N
1083,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1084,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1085,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1085,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
1086,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1086,2,Headache,Headaches NEC,Headaches,Nerv,N
1086,3,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1087,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1087,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1087,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1087,4,CD19 lymphocytes decreased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
1087,5,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1087,6,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1087,7,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1087,8,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1087,9,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1087,10,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1087,11,Past-pointing,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1087,12,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1087,13,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1087,14,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
1087,15,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1087,16,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1088,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1088,2,Pernicious anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
1089,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1089,2,Bone marrow oedema syndrome,Haematological disorders,Haematological disorders NEC,Blood,N
1090,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1090,2,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1090,3,Costovertebral angle tenderness,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1090,4,Myoglobinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1090,5,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
1090,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1091,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1091,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1091,3,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1091,4,Myoglobinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1091,5,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1091,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1091,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1091,8,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
1092,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1093,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1094,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1094,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1095,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1095,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1095,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1095,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1095,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1095,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1095,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1095,8,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1095,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1096,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1096,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1096,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1096,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1096,5,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1096,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1096,7,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1096,8,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
1096,9,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1096,10,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1097,1,Chest X-ray abnormal,Respiratory tract and thoracic imaging procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
1097,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1097,3,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
1097,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1097,5,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
1097,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1097,7,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1097,8,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1097,9,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1097,10,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1098,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1099,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1099,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1099,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1099,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1099,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1099,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1099,7,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1100,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1101,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1101,2,Tendon disorder,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
1102,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1102,2,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
1103,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1103,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1103,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1104,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1104,2,Headache,Headaches NEC,Headaches,Nerv,N
1104,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1104,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1105,1,Epigastric discomfort,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1105,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1106,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1106,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1107,1,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1107,2,Haemoglobin abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1108,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1109,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
1110,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1111,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1112,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1112,2,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1112,3,Extremity contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1112,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1112,5,Joint contracture,Joint related disorders NEC,Joint disorders,Musc,N
1112,6,Lichenification,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
1112,7,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
1112,8,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
1112,9,Skin hypopigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
1112,10,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1113,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1113,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1114,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1115,1,B-cell lymphoma stage I,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
1115,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1115,3,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
1115,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1115,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1115,6,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1115,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1116,1,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1117,1,Corneal deposits,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1117,2,Corneal epithelium defect,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1117,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1118,1,Corneal deposits,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1119,1,Corneal deposits,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1120,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1120,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1121,1,Acute myelomonocytic leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
1122,1,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
1122,2,Headache,Headaches NEC,Headaches,Nerv,N
1122,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1122,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1123,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1123,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1123,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1123,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1124,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1124,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1124,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1125,1,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
1125,2,Enterovesical fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
1126,1,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1126,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1126,3,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1126,4,Pernicious anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
1127,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1127,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1127,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1127,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1127,5,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1127,6,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
1127,7,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1128,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1128,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1128,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1128,4,Peptic ulcer perforation,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
1129,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1129,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1129,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1129,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1130,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
1131,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1131,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1131,3,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1131,4,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1132,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1133,1,Diplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1133,2,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1133,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1134,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1134,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1134,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1134,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1135,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1135,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1135,3,Kidney enlargement,Renal structural abnormalities and trauma,Renal disorders (excl nephropathies),Renal,N
1135,4,Obstruction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1135,5,Ureteric stenosis,Ureteric disorders NEC,Ureteric disorders,Renal,N
1136,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1136,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1136,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1136,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1136,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1137,1,Lumbar vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1137,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1138,1,Anorectal disorder,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
1138,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1138,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1138,4,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1138,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1139,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1139,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1139,3,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1140,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1140,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1140,3,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1140,4,Laryngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1140,5,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1140,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1141,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1141,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1141,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1141,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1141,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1141,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1141,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1142,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1142,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1142,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1142,4,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1142,5,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1142,6,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1142,7,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1142,8,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1142,9,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1142,10,Tracheal obstruction,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
1143,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1143,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
1143,3,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1143,4,Cardiac valve vegetation,Cardiac infections,Infections - pathogen unspecified,Infec,N
1143,5,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
1143,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1143,7,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1143,8,Fungal endocarditis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1143,9,Fungal sepsis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1143,10,Intestinal infarction,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
1143,11,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1143,12,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
1143,13,Mycotic endophthalmitis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1143,14,Septic embolus,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1143,15,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1144,1,Abscess fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
1144,2,Acute pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1144,3,Aortic valve incompetence,Aortic valvular disorders,Cardiac valve disorders,Card,N
1144,4,Aortic valve replacement,Cardiac valve therapeutic procedures,Cardiac therapeutic procedures,Surg,N
1144,5,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
1144,6,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1144,7,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1144,8,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1144,9,Cardiac valve vegetation,Cardiac infections,Infections - pathogen unspecified,Infec,N
1144,10,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1144,11,Forced expiratory volume decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
1144,12,Fungal endocarditis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1144,13,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1144,14,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1144,15,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1144,16,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1144,17,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1144,18,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1144,19,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1144,20,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1145,1,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
1146,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1146,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1146,3,Dilatation ventricular,Myocardial disorders NEC,Myocardial disorders,Card,N
1146,4,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1146,5,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1146,6,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1146,7,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
1146,8,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1146,9,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
1147,1,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1148,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1148,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1148,3,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1148,4,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1148,5,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1148,6,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1148,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1149,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1149,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1150,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1150,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1150,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1150,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1151,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1152,1,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1153,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1153,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1153,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1153,4,Headache,Headaches NEC,Headaches,Nerv,N
1153,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1153,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1153,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1153,8,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1153,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1154,1,Systemic lupus erythematosus rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1155,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1155,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1155,3,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1155,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1155,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1155,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1155,7,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1155,8,Testicular swelling,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
1155,9,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1156,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1156,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1156,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1156,4,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,Y
1156,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1156,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1156,7,Traumatic lung injury,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
1157,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1157,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1157,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1157,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1157,5,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1157,6,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1158,1,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1158,2,Salmonellosis,Salmonella infections,Bacterial infectious disorders,Infec,N
1159,1,Anti-erythropoietin antibody negative,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
1159,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1159,3,Granulomatosis with polyangiitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1159,4,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
1159,5,Iron deficiency,Iron deficiencies,Iron and trace metal metabolism disorders,Metab,N
1159,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1160,1,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1161,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1161,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1162,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1163,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1164,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
1164,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1165,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1165,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1166,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
1166,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1167,1,Acanthosis nigricans,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
1167,2,Central obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1167,3,Chorioretinitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1167,4,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1167,5,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1168,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1169,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1169,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1169,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1169,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1170,1,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1171,1,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
1172,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1172,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1172,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1172,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1172,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1172,6,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1172,7,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1172,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1172,9,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1172,10,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1172,11,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1172,12,Vitreous disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1172,13,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1172,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1173,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1174,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1174,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1174,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1174,4,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1175,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1175,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1176,1,Beta haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
1176,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1176,3,Choroidal haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1176,4,Corneal transplant,Corneal and scleral therapeutic procedures,Eye therapeutic procedures,Surg,N
1176,5,Eye infection staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1176,6,Keratitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1176,7,Pneumonia streptococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
1176,8,Stem cell transplant,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
1177,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1177,2,Eye infection staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1178,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1178,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1178,3,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1178,4,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1178,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1178,6,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
1178,7,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1178,8,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1178,9,Immunodeficiency common variable,Primary immunodeficiency syndromes,Immunodeficiency syndromes,Immun,N
1178,10,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1178,11,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1178,12,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1178,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1179,1,Toxic cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
1180,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1180,2,Hepatosplenic T-cell lymphoma,Adult T-cell lymphomas/leukaemias,Lymphomas non-Hodgkin's T-cell,Neopl,Y
1181,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1181,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1182,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1182,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
1182,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1182,4,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1182,5,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1182,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1183,1,Adenoviral hepatitis,Adenoviral infections,Viral infectious disorders,Infec,Y
1184,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1185,1,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1186,1,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1186,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1187,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1187,2,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
1188,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1189,1,Corneal perforation,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1189,2,Eye infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1189,3,Keratitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1190,1,Corneal perforation,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1190,2,Eye infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1190,3,Keratitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1191,1,Eye infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1191,2,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
1192,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1192,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1192,3,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
1192,4,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1192,5,Epstein-Barr virus antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1193,1,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1193,2,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1194,1,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1194,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1194,3,Campylobacter infection,Campylobacter infections,Bacterial infectious disorders,Infec,N
1194,4,Complications of transplant surgery,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1194,5,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1194,6,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1194,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1194,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1194,9,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1194,10,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1194,11,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1194,12,Renal cyst,Renal neoplasms,Renal disorders (excl nephropathies),Renal,N
1194,13,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1194,14,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1195,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1195,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1195,3,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
1195,4,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1196,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1197,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
1198,1,Bladder transitional cell carcinoma,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1198,2,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1198,3,Polyomavirus-associated nephropathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1198,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1199,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1200,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1201,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1202,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1203,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1204,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1205,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1206,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1207,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1208,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1209,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1210,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1211,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1212,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1213,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1214,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1215,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1216,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1217,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1218,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1219,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1220,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1221,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1222,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1223,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1224,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1225,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1226,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1227,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1228,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1229,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1230,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1231,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1231,2,Hepatic enzyme abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1231,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1231,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1231,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1231,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1232,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1232,2,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1232,3,Haemodialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
1232,4,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1232,5,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
1233,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
1234,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
1234,2,Antinuclear antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
1234,3,Aspiration bone marrow abnormal,Bone marrow and immune tissue histopathology procedures,Haematology investigations (incl blood groups),Inv,N
1234,4,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
1234,5,Microangiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1234,6,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
1234,7,Myelofibrosis,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1234,8,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1234,9,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1234,10,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1234,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1234,12,Red blood cell abnormality,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
1234,13,Rheumatoid factor positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
1234,14,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1235,1,Idiosyncratic drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1235,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1236,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1237,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1237,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1237,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1238,1,Bacterial disease carrier,Infectious disorders carrier,Ancillary infectious topics,Infec,N
1238,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1238,3,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1238,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1238,5,Peritonitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1238,6,Red blood cell schistocytes present,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1238,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1238,8,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1239,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1240,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1241,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1242,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1243,1,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1243,2,Lupus nephritis,Nephritis NEC,Nephropathies,Renal,N
1243,3,Obliterative bronchiolitis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1243,4,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1244,1,Cataract subcapsular,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1244,2,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1245,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1245,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1246,1,Base excess abnormal,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1246,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1246,3,Haemoglobin urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1246,4,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1246,5,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1246,6,Myoglobin urine present,Musculoskeletal and soft tissue tests NEC,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
1246,7,Propofol infusion syndrome,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1247,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1247,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1247,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1248,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1248,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1248,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1249,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1250,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1251,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1251,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1251,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1251,4,Head titubation,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1251,5,Headache,Headaches NEC,Headaches,Nerv,N
1251,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1251,7,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1251,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1251,9,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1252,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1253,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1253,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1254,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1254,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1255,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1255,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1255,3,Infectious mononucleosis,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1255,4,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
1255,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1255,6,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1256,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1257,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1258,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1258,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1258,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1259,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1259,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1259,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1259,4,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1259,5,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1259,6,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1259,7,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1259,8,Carbohydrate antigen 19-9 increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
1259,9,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1259,10,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1259,11,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
1259,12,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
1259,13,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1259,14,Hepatitis A,Hepatitis virus infections,Viral infectious disorders,Infec,N
1259,15,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1259,16,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1259,17,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
1259,18,Infectious mononucleosis,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1259,19,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1259,20,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1259,21,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1259,22,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1259,23,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1259,24,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1259,25,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1259,26,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1259,27,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1260,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1260,2,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1261,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1261,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1261,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1262,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1263,1,Mycobacterium marinum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1263,2,Osteomyelitis acute,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1264,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1264,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1265,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1266,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
1266,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1267,1,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1267,2,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
1267,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1268,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1269,1,Corneal neovascularisation,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
1269,2,Corneal oedema,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
1270,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1271,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1271,2,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1271,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1272,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1273,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1273,2,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1274,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1275,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1276,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1276,2,Blood immunoglobulin E increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1276,3,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1276,4,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1276,5,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1276,6,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1276,7,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1276,8,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1276,9,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1276,10,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1276,11,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1276,12,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
1276,13,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
1276,14,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1276,15,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1276,16,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1276,17,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1276,18,Myopathy,Myopathies,Muscle disorders,Musc,N
1276,19,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1276,20,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1276,21,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1276,22,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1276,23,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1276,24,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1276,25,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1276,26,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1276,27,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1276,28,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1277,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1277,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1277,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1277,4,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1278,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1278,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1278,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1278,4,Meningitis listeria,Listeria infections,Bacterial infectious disorders,Infec,N
1278,5,Mental status changes,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1278,6,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1278,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
1278,8,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1278,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1278,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1279,1,Orchitis,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
1280,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1280,2,Beta haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
1280,3,Body tinea,Tinea infections,Fungal infectious disorders,Infec,N
1280,4,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1280,5,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1280,6,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
1280,7,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1280,8,Malassezia infection,Tinea infections,Fungal infectious disorders,Infec,N
1280,9,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1280,10,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1280,11,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1280,12,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1280,13,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1281,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,Y
1282,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1283,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1283,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1284,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1285,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1285,2,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1285,3,Cystitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
1285,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1285,5,Human polyomavirus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1285,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1285,7,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1285,8,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1285,9,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1285,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1285,11,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1286,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1287,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1287,2,Myopathy toxic,Myopathies,Muscle disorders,Musc,N
1287,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1287,4,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
1288,1,Deafness,Hearing losses,Hearing disorders,Ear,N
1288,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1289,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1289,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1289,3,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1289,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1290,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1290,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1290,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1290,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1291,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1291,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1292,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1292,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1292,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1292,4,Superior sagittal sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1293,1,Cholecystitis infective,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
1293,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1293,3,Encapsulating peritoneal sclerosis,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
1293,4,Hepatic haematoma,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
1293,5,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1293,6,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1294,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1295,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1295,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1295,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1295,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
1296,1,Blindness cortical,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1296,2,Superior sagittal sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1297,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1298,1,Abdominal sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1298,2,Acute abdomen,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1299,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1300,1,Cholecystitis infective,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
1300,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1300,3,Gallbladder rupture,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
1300,4,Haemobilia,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1301,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1301,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1302,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1302,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1302,3,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1302,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1302,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1302,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1302,7,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
1302,8,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1302,9,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
1302,10,Mononeuropathy multiplex,Mononeuropathies,Peripheral neuropathies,Nerv,N
1302,11,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1302,12,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
1302,13,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1302,14,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1302,15,Myalgia,Muscle pains,Muscle disorders,Musc,N
1302,16,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1302,17,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1302,18,Oestrogen deficiency,Endocrine abnormalities of gonadal function NEC,Endocrine disorders of gonadal function,Endo,N
1302,19,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1302,20,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1302,21,Postmenopause,Age related issues,Age related factors,SocCi,N
1302,22,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
1302,23,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1302,24,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1302,25,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1302,26,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1302,27,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1302,28,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1303,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1304,1,Cytomegalovirus enterocolitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1304,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1304,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1305,1,Abnormal faeces,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1305,2,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1305,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1305,4,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1306,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1306,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1306,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1307,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
1307,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1308,1,Conjunctival hyperaemia,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1308,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1308,3,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
1308,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1308,5,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1308,6,Gingival erythema,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1308,7,Lip haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
1308,8,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1308,9,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1308,10,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1308,11,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1308,12,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1309,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
1309,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1309,3,Burkitt's lymphoma stage III,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1309,4,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1309,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1309,6,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1310,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1310,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1310,3,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1310,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1311,1,Acinetobacter infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1311,2,Biliary dilatation,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
1311,3,Cholecystectomy,Biliary tract and gallbladder therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
1311,4,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1311,5,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
1311,6,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1311,7,Hepatic cyst,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1311,8,Infected cyst,Infections NEC,Infections - pathogen unspecified,Infec,N
1311,9,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1311,10,Liver operation,Hepatic therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
1311,11,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1311,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1311,13,Purulence,Infections NEC,Infections - pathogen unspecified,Infec,N
1311,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1311,15,Renal cyst,Renal neoplasms,Renal disorders (excl nephropathies),Renal,N
1311,16,Umbilical hernia repair,Hernia repairs,Gastrointestinal therapeutic procedures,Surg,N
1311,17,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1312,1,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1312,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1313,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1314,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1314,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1314,3,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1314,4,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1314,5,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1314,6,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1314,7,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1314,8,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1315,1,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1316,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1316,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1316,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1316,4,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1316,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
1317,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
1317,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1317,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1317,4,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
1317,5,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1317,6,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1317,7,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1317,8,Tic,Tic disorders,Changes in physical activity,Psych,N
1318,1,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1319,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1319,2,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1319,3,Device related bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1319,4,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1319,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1319,6,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1319,7,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
1319,8,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
1319,9,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1319,10,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1319,11,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1319,12,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1319,13,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1319,14,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1319,15,Tic,Tic disorders,Changes in physical activity,Psych,N
1320,1,Bladder fibrosis,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
1320,2,Catheterisation venous,Venous therapeutic procedures,Vascular therapeutic procedures,Surg,N
1320,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1320,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1320,5,Micturition disorder,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1320,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1320,7,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1321,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1322,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1323,1,Burkitt's leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
1323,2,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1324,1,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
1325,1,Metamorphopsia,Visual disorders NEC,Vision disorders,Eye,N
1326,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1327,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1327,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1328,1,Acute graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1328,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1328,3,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
1328,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1328,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1328,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1329,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1329,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1329,3,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,Y
1329,4,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1329,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1329,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1330,1,Acute graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1330,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1330,3,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
1330,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1330,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1331,1,Duodenal ulcer repair,Small intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
1332,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1332,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1332,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1332,4,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1332,5,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1332,6,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1332,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1332,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1332,9,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1332,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1333,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1333,2,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
1333,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1333,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1333,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1334,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1334,2,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
1334,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1334,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1334,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1335,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
1335,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1335,3,Cutaneous leishmaniasis,Leishmania infections,Protozoal infectious disorders,Infec,N
1335,4,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1335,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1335,6,Lymphocytic infiltration,Leukocytoses NEC,White blood cell disorders,Blood,N
1335,7,Neurodermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1335,8,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
1335,9,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1335,10,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1335,11,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1336,1,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1336,2,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1337,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1337,2,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
1337,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1338,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1338,2,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
1338,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1338,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1338,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1339,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1340,1,Leishmaniasis,Leishmania infections,Protozoal infectious disorders,Infec,N
1341,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1341,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1341,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1341,4,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
1341,5,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1342,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1342,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1343,1,Abnormal faeces,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1343,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1343,3,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1343,4,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1343,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1343,6,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1343,7,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1343,8,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
1343,9,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1343,10,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1343,11,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1343,12,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1343,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1344,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1344,2,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
1344,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1344,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1345,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1345,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1345,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1345,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1345,5,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
1345,6,Enterovirus infection,Enteroviral infections NEC,Viral infectious disorders,Infec,N
1345,7,Extensor plantar response,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1345,8,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1345,9,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1345,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1345,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1346,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1347,1,Myopathy,Myopathies,Muscle disorders,Musc,N
1348,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1348,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1349,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1349,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1349,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1350,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1350,2,Mechanical ventilation,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
1350,3,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
1350,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1350,5,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1350,6,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1351,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1351,2,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
1351,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1351,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1352,1,Pelvic kidney,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
1352,2,Single functional kidney,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1353,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1353,2,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1353,3,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1353,4,Headache,Headaches NEC,Headaches,Nerv,N
1353,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1354,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1354,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1355,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1356,1,Agitated depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1356,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1356,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1356,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1356,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1356,6,Impaired driving ability,Disability issues,Lifestyle issues,SocCi,N
1356,7,Inappropriate affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
1356,8,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1356,9,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1356,10,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1356,11,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1356,12,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1357,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1357,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1358,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1358,2,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1359,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1360,1,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1360,2,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1360,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1360,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1361,1,Debridement,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1361,2,Neoplasm skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1361,3,Oesophageal squamous cell carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1361,4,Oesophagectomy,Oesophageal therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
1361,5,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1361,6,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1361,7,Skin lesion removal,Skin lesion excisions,Skin and subcutaneous tissue therapeutic procedures,Surg,N
1361,8,Sweat gland tumour,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1361,9,Sweat gland tumour,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1362,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1363,1,Cytoreductive surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1363,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1363,3,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1364,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1364,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1365,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1366,1,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
1367,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1368,1,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
1368,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1368,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1368,4,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1368,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1368,6,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
1368,7,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1368,8,Osteoporotic fracture,Fractures NEC,Fractures,Musc,N
1368,9,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1368,10,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1368,11,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1368,12,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1369,1,Myoglobinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1370,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1370,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1370,3,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1370,4,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
1370,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1371,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1371,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1371,3,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
1371,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
1372,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1372,2,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1373,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
1374,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1374,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1375,1,Blood insulin increased,"Gastrointestinal, pancreatic and APUD hormone analyses",Endocrine investigations (incl sex hormones),Inv,N
1375,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1376,1,Oedema mouth,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1376,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1377,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1377,2,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
1377,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1378,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1379,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1379,2,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1379,3,Apoptosis,Cell metabolism disorders NEC,Metabolism disorders NEC,Metab,N
1379,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1379,5,Parvovirus B19 infection,Parvoviral infections,Viral infectious disorders,Infec,N
1379,6,Reticulocytopenia,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
1379,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1380,1,Chorea,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
1380,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1380,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1380,4,Hyperglycaemic hyperosmolar nonketotic syndrome,Diabetic complications neurological,Diabetic complications,Metab,N
1381,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1381,2,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1381,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1381,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1382,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1382,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1382,3,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1382,4,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1382,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1382,6,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1383,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1383,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1384,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
1385,1,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1385,2,Chapped lips,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
1385,3,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1385,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1386,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
1387,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1388,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1388,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1388,3,Superficial spreading melanoma stage unspecified,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1389,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1389,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1390,1,Myopathy,Myopathies,Muscle disorders,Musc,N
1391,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1391,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1391,3,Antiphospholipid syndrome,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,Y
1391,4,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1391,5,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1391,6,Endocarditis noninfective,Endocarditis NEC,Endocardial disorders,Card,N
1391,7,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1391,8,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1391,9,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1391,10,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1391,11,Peritonitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1391,12,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1391,13,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1391,14,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1391,15,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1391,16,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1392,1,Atrophy of globe,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
1392,2,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1392,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1392,4,Mycotic endophthalmitis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1392,5,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1393,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1394,1,Atrophy of globe,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
1394,2,Eye infection fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
1395,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1395,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1395,3,Headache,Headaches NEC,Headaches,Nerv,N
1395,4,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1395,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1395,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1395,7,Muscle strain,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1395,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1395,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1395,10,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
1395,11,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1396,1,Colour blindness,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
1396,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1396,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1396,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1397,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1397,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1397,3,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1397,4,Urine output increased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1397,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1398,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1398,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1398,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1398,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1398,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1399,1,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
1400,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1400,2,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1401,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1401,2,Ketoacidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1401,3,Kussmaul respiration,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1401,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1401,5,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1401,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1402,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1402,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1402,3,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
1402,4,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1403,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1403,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1403,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1404,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1405,1,Infertility female,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
1406,1,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1406,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1406,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1406,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1406,5,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1406,6,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1406,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1406,8,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1406,9,Eschar,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1406,10,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1406,11,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1406,12,Mycobacterium avium complex infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1406,13,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1406,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1406,15,Radiculopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
1406,16,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1407,1,Atypical pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1407,2,Encephalitis enteroviral,Enteroviral infections NEC,Viral infectious disorders,Infec,Y
1407,3,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1407,4,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1407,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1407,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1408,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1408,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1408,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1409,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1410,1,Central serous chorioretinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1411,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1411,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1411,3,Intervertebral disc space narrowing,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1411,4,Intervertebral discitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1411,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1411,6,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1411,7,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1411,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1411,9,Spinal cord infection,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1411,10,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1411,11,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1411,12,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1412,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1413,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1413,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1414,1,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,Y
1415,1,Stress fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
1416,1,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1416,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1416,3,Stress fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
1417,1,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1418,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1418,2,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
1418,3,Neck mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1418,4,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1418,5,Pituitary-dependent Cushing's syndrome,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
1418,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1418,7,Varicose vein ruptured,Varicose veins NEC,Venous varices,Vasc,N
1419,1,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
1419,2,Epstein-Barr virus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1419,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1419,4,Intestinal ulcer,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1419,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1419,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1420,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1420,2,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1421,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1422,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1422,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1422,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1422,4,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1422,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1422,6,Hemianopia,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
1422,7,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1422,8,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1422,9,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1422,10,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1422,11,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1422,12,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1423,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1424,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1424,2,Palindromic rheumatism,Arthropathies NEC,Joint disorders,Musc,N
1425,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1426,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1426,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1427,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1427,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1427,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1428,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
1429,1,Biliary fibrosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
1429,2,Chronic hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
1429,3,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1429,4,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,Y
1429,5,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1429,6,Liver transplant,Hepatic therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
1429,7,Tumour invasion,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1430,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1430,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1430,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1430,4,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1430,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1430,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1430,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1430,8,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1430,9,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1430,10,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1430,11,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1430,12,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1430,13,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1430,14,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1431,1,Burkholderia cepacia complex sepsis,Burkholderia infections,Bacterial infectious disorders,Infec,Y
1432,1,Burkholderia cepacia complex sepsis,Burkholderia infections,Bacterial infectious disorders,Infec,Y
1433,1,Burkholderia cepacia complex sepsis,Burkholderia infections,Bacterial infectious disorders,Infec,Y
1434,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1435,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1435,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1436,1,Cleft lip and palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
1436,2,Teratogenicity,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
1437,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
1438,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1438,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1439,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1439,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1440,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1441,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1441,2,Eczema infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1441,3,Eczema weeping,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1441,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1441,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1441,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1441,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1442,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1443,1,CSF pressure increased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
1443,2,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1443,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1443,4,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1443,5,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1443,6,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1443,7,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1443,8,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
1443,9,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1443,10,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1444,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1444,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1445,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1445,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1445,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1445,4,Ileal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
1445,5,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1445,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1445,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1446,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1446,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1446,3,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1446,4,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1446,5,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1446,6,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1446,7,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1446,8,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1446,9,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1446,10,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1446,11,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1446,12,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1446,13,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1447,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1447,2,Chorioretinopathy,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1448,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1449,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1450,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1450,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1450,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1450,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1451,1,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1451,2,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1452,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1452,2,Granuloma,Inflammations,General system disorders NEC,Genrl,N
1452,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1452,4,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1452,5,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1452,6,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1452,7,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1453,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1454,1,Hyphaema,Eye injuries NEC,Injuries NEC,Inj&P,N
1455,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1456,1,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
1457,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1458,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1459,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1459,2,Angina unstable,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1459,3,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1460,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1460,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1460,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1461,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
1461,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1462,1,Chronic inflammatory demyelinating polyradiculoneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
1462,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1463,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1463,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1463,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1463,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1464,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1464,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1464,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1464,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1464,5,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1464,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1464,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1464,8,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1464,9,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1465,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
1465,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1466,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1467,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1468,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1468,2,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1469,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1469,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1470,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1471,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1471,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1471,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1471,4,Clonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1471,5,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1471,6,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1471,7,Epidural lipomatosis,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
1471,8,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1471,9,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1471,10,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1471,11,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1471,12,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1471,13,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1471,14,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1471,15,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1471,16,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
1471,17,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1471,18,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1472,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1472,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1472,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1473,1,Noninfective conjunctivitis,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1474,1,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1474,2,Aortic dissection,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
1474,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1474,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1474,5,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1474,6,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1475,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1475,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1475,3,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
1475,4,Intestinal diaphragm disease,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1475,5,Normocytic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1475,6,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
1475,7,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1475,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1476,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1476,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1476,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1476,4,Granuloma,Inflammations,General system disorders NEC,Genrl,N
1476,5,Mycobacterium marinum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1476,6,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1476,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1476,8,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1476,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1477,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
1477,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1477,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1478,1,Gastrointestinal ulcer,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
1478,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1479,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1480,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1481,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1481,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1482,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
1483,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1484,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1484,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1484,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1485,1,Granuloma,Inflammations,General system disorders NEC,Genrl,N
1486,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1486,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1486,3,Glomerulonephritis membranoproliferative,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1486,4,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1486,5,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1486,6,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1486,7,Post streptococcal glomerulonephritis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1486,8,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1486,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1486,10,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1486,11,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1486,12,Streptococcus test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
1486,13,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1486,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1487,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1487,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1487,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1487,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1487,5,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1487,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1487,7,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1487,8,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1487,9,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1487,10,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
1487,11,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1488,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1489,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1489,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1490,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1490,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1490,3,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
1491,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1491,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1491,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1491,4,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1492,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1492,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1493,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1493,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1494,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1494,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1495,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1495,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1495,3,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1495,4,Tubulointerstitial nephritis and uveitis syndrome,Nephritis NEC,Nephropathies,Renal,N
1496,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1496,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1496,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1496,4,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1496,5,Faecaloma,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1496,6,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1496,7,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1496,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1496,9,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1496,10,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,N
1496,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1496,12,Pleural thickening,Pleural conditions NEC,Pleural disorders,Resp,N
1496,13,Pulmonary vasculitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1496,14,Respiratory gas exchange disorder,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1496,15,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1496,16,Spirometry abnormal,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
1496,17,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1496,18,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1497,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1497,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1498,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1498,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1499,1,Gastroenteritis viral,Viral infections NEC,Viral infectious disorders,Infec,N
1499,2,Infective exacerbation of bronchiectasis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1499,3,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1500,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1500,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1500,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1500,4,Peripheral circulatory failure,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1501,1,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1501,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1502,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1502,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1502,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1502,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1503,1,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1503,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1503,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1503,4,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1503,5,Ulna fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1504,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1505,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1505,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1505,3,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1506,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1506,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1506,3,Headache,Headaches NEC,Headaches,Nerv,N
1506,4,Ileus paralytic,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
1506,5,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1506,6,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1506,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1506,8,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1506,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1506,10,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,N
1507,1,Abortion missed,Abortions not specified as induced or spontaneous,Abortions and stillbirth,Preg,N
1507,2,Clostridium test,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
1507,3,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1507,4,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1508,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1508,2,Mycobacterium avium complex infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1508,3,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1508,4,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1508,5,Testicular swelling,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
1508,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1509,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1510,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1511,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1511,2,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1511,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1511,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1511,5,Sputum increased,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1512,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1512,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1512,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1512,4,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
1512,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1512,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1512,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1513,1,Staphylococcal skin infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1514,1,Molluscum contagiosum,Molluscum contagiosum viral infections,Viral infectious disorders,Infec,N
1515,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
1515,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
1515,3,Herpes simplex hepatitis,Herpes viral infections,Viral infectious disorders,Infec,N
1515,4,Herpes zoster disseminated,Herpes viral infections,Viral infectious disorders,Infec,N
1516,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1516,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1516,3,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
1516,4,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1517,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1517,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1517,3,Infectious mononucleosis,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1517,4,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
1517,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1517,6,Nasal septum disorder,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1517,7,Otitis media,Ear infections,Infections - pathogen unspecified,Infec,N
1517,8,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1518,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1518,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1519,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1519,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1519,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1519,4,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
1519,5,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1519,6,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
1519,7,Laryngeal stenosis,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
1519,8,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1519,9,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1519,10,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1519,11,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1520,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1520,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1521,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1521,2,Bronchostenosis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1521,3,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1521,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1521,5,Nasal septum disorder,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1521,6,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1521,7,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1522,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1522,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1522,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1522,4,Gaze palsy,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1522,5,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
1523,1,Night blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1523,2,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1523,3,Tunnel vision,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
1523,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1524,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1525,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1525,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1525,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1525,4,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
1525,5,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1525,6,Mediastinal disorder,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
1525,7,Oesophageal perforation,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
1525,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1525,9,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1525,10,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1525,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1525,12,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1525,13,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1526,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1526,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1526,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1526,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1526,5,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1526,6,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1526,7,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1526,8,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1526,9,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1526,10,Hunger,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1526,11,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1526,12,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1526,13,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1526,14,Oral infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1526,15,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1527,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1527,2,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1528,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1529,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
1530,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1530,2,Pneumonia necrotising,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1530,3,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1530,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1531,1,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1531,2,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1531,3,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
1531,4,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1531,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1531,6,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1532,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1533,1,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
1533,2,Ocular procedural complication,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1534,1,Ocular procedural complication,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1535,1,Eye luxation,Eye injuries NEC,Injuries NEC,Inj&P,N
1536,1,Ocular procedural complication,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1537,1,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
1537,2,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
1537,3,Ocular procedural complication,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1538,1,Ocular procedural complication,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1539,1,Eye luxation,Eye injuries NEC,Injuries NEC,Inj&P,N
1539,2,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
1540,1,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
1540,2,Corneal striae,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1540,3,Ocular procedural complication,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1541,1,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
1541,2,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
1541,3,Ocular procedural complication,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1542,1,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
1542,2,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
1542,3,Ocular procedural complication,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1543,1,Angiosarcoma,Cardiovascular neoplasms malignant and unspecified,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1543,2,Metastases to lung,Metastases to specified sites,Metastases,Neopl,Y
1544,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1544,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1544,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1544,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1544,5,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1544,6,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1544,7,Upper motor neurone lesion,Motor neurone diseases,Neuromuscular disorders,Nerv,N
1545,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1545,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1546,1,Hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,N
1547,1,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1547,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1547,3,Hyperplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
1547,4,Mycetoma mycotic,Fungal infections NEC,Fungal infectious disorders,Infec,N
1547,5,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1547,6,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1547,7,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1547,8,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1547,9,Subcutaneous abscess,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1548,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
1548,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1548,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1549,1,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
1549,2,Intestinal malrotation,Intestinal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
1550,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1550,2,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1551,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1551,2,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1551,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1551,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1551,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1552,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1552,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1552,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1552,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1552,5,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1552,6,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1552,7,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1552,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1552,9,Myalgia,Muscle pains,Muscle disorders,Musc,N
1552,10,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1552,11,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1552,12,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1552,13,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1552,14,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1552,15,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1552,16,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1552,17,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1553,1,Psychotic disorder due to a general medical condition,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1554,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1554,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1555,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1555,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1556,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1556,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1557,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1557,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1557,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1557,4,Grandiosity,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1557,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1557,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1557,7,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1557,8,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1558,1,Conjunctival hyperaemia,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1558,2,Corneal defect,Corneal disorders NEC,Eye disorders NEC,Eye,N
1558,3,Corneal erosion,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1558,4,Corneal oedema,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
1558,5,Corneal reflex decreased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1558,6,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1558,7,Herpes ophthalmic,Herpes viral infections,Viral infectious disorders,Infec,N
1558,8,Hypopyon,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1558,9,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1558,10,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
1559,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1559,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1559,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1560,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1560,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1561,1,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
1562,1,Headache,Headaches NEC,Headaches,Nerv,N
1562,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1562,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1562,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
1563,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1563,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1563,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1563,4,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1563,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1564,1,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1564,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1564,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1564,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1564,5,Pneumatosis intestinalis,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1564,6,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1565,1,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1565,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1565,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1565,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1565,5,Pneumatosis intestinalis,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1565,6,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1566,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1566,2,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1566,3,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1567,1,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1568,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1568,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1569,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1569,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1569,3,Headache,Headaches NEC,Headaches,Nerv,N
1569,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1569,5,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1569,6,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1569,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1570,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1571,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
1571,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1571,3,Diffuse large B-cell lymphoma stage II,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1571,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1571,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1571,6,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1571,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1571,8,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1571,9,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1571,10,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1571,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1571,12,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1572,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1572,2,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1572,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1573,1,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1573,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1573,3,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1573,4,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
1573,5,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1573,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1574,1,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1575,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1575,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1575,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1575,4,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1575,5,Parainfluenzae virus infection,Parainfluenzae viral infections,Viral infectious disorders,Infec,N
1576,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1576,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1576,3,Parainfluenzae virus infection,Parainfluenzae viral infections,Viral infectious disorders,Infec,N
1576,4,Stenotrophomonas infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1577,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
1577,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1577,3,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
1577,4,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1577,5,Parainfluenzae virus infection,Parainfluenzae viral infections,Viral infectious disorders,Infec,N
1577,6,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1578,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1578,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1578,3,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1578,4,Parainfluenzae virus infection,Parainfluenzae viral infections,Viral infectious disorders,Infec,N
1579,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1579,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1579,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1579,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1579,5,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1579,6,Respiratory tract infection fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
1580,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1580,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1580,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1580,4,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1580,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1581,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1582,1,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1582,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1582,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1582,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1583,1,Glomerulonephritis acute,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1584,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1585,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1585,2,Peritonitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1586,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1586,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1587,1,Bile acid malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1587,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1587,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1587,4,Gastrointestinal ulcer,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
1587,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1588,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1588,2,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
1589,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
1589,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1589,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1590,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1590,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1590,3,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1591,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
1591,2,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1591,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1592,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1592,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1592,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1592,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1593,1,Laboratory test interference,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1594,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
1594,2,Intestinal dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1594,3,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1595,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
1595,2,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,Y
1596,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1596,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1597,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1597,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
1597,3,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1597,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1597,5,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1597,6,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1597,7,Mycobacterium fortuitum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1597,8,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1597,9,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
1597,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1598,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1598,2,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
1598,3,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1598,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1599,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1599,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1599,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1599,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1600,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1600,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1600,3,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1600,4,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1600,5,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1600,6,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1600,7,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1600,8,Stress fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
1601,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1601,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1601,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1601,4,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1601,5,Leiomyosarcoma,Leiomyosarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1601,6,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
1601,7,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1601,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1602,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1602,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1602,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1602,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1602,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1603,1,Leiomyosarcoma,Leiomyosarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1603,2,Metastases to lung,Metastases to specified sites,Metastases,Neopl,Y
1604,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1604,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1604,3,Metabolic alkalosis,Metabolic alkaloses,Acid-base disorders,Metab,N
1605,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1605,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1605,3,Granulomatosis with polyangiitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1605,4,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1606,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1607,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1608,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1609,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1610,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1610,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1611,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1611,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1612,1,Enterocolitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1612,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1612,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1613,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1614,1,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1614,2,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1615,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1615,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1616,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1617,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1617,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1618,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1619,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1620,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1621,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1622,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1623,1,Follicular thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
1624,1,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1624,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1624,3,CSF protein increased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
1624,4,Dysmetria,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1624,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1624,6,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1624,7,Vitamin B12 decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1625,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1625,2,Abnormal faeces,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1625,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1625,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1625,5,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1625,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1626,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1626,2,Cryptosporidiosis infection,Cryptosporidia infections,Protozoal infectious disorders,Infec,N
1626,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1626,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1626,5,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1626,6,Hepatic cyst,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1626,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1626,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1626,9,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1626,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1627,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1628,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1628,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1628,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1629,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1629,2,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
1629,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1629,4,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
1629,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1629,6,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1629,7,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
1629,8,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1629,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1629,10,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1630,1,Liver transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1631,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1632,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1632,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
1633,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1633,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1634,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1634,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1634,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1634,4,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1634,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1635,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
1635,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1635,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1636,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1636,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1637,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1637,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
1638,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
1638,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1639,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
1639,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1640,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1640,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1641,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1641,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1642,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1642,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1643,1,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1644,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1645,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1646,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1647,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1647,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1647,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1647,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1647,5,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
1647,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1647,7,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1648,1,Tendon pain,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
1648,2,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1649,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
1649,2,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1649,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1650,1,Atypical femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1650,2,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1650,3,Tibia fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1651,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1651,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1651,3,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1651,4,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1651,5,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1652,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
1652,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1652,3,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1652,4,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1652,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1652,6,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1652,7,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1652,8,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1652,9,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1652,10,Mycobacterium fortuitum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1652,11,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1652,12,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1652,13,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1652,14,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1652,15,Sepsis syndrome,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1652,16,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
1653,1,Cholestasis of pregnancy,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1653,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1653,3,Granuloma,Inflammations,General system disorders NEC,Genrl,N
1653,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1653,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1653,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1653,7,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1654,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1654,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
1654,3,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1654,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1655,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1655,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1655,3,Kidney fibrosis,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1655,4,Polyomavirus-associated nephropathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1655,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1655,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1656,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1656,2,Kidney fibrosis,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1656,3,Polyomavirus-associated nephropathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1656,4,Renal cyst,Renal neoplasms,Renal disorders (excl nephropathies),Renal,N
1656,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1656,6,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1656,7,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
1657,1,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1657,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1657,3,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1657,4,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1657,5,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1657,6,Pseudocyst,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1657,7,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1657,8,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1658,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1658,2,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1658,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
1658,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1659,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1659,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1660,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1661,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1661,2,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1662,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1662,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1662,3,Intraocular pressure fluctuation,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1662,4,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1662,5,Optic nerve cupping,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
1662,6,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1663,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1663,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
1663,3,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1663,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1664,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1664,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1664,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1664,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1664,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1664,6,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1665,1,Meningococcal infection,Neisseria infections,Bacterial infectious disorders,Infec,N
1666,1,Suicidal behaviour,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1667,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1667,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1667,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1667,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
1667,5,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1667,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1667,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1668,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1668,2,Follicular thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
1668,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1668,4,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1669,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1669,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1669,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1669,4,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1669,5,Pulmonary sarcoidosis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1670,1,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
1670,2,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1670,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1670,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1670,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1670,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1670,7,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1670,8,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
1670,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1670,10,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1671,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1671,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1671,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1672,1,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
1672,2,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
1672,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1672,4,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1673,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1674,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1675,1,Bowen's disease,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1675,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1675,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1675,4,Nail growth abnormal,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1675,5,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1675,6,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
1675,7,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1675,8,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1675,9,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1676,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
1676,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1677,1,Blood pressure systolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1677,2,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1677,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1677,4,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1677,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1677,6,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1678,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1678,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1678,3,Granuloma skin,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
1678,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1678,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1678,6,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1678,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1679,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1679,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1679,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1680,1,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1680,2,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,Y
1680,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1680,4,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1681,1,Cutaneous amyloidosis,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1682,1,Bowen's disease,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1682,2,Nail growth abnormal,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1682,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1682,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1682,5,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1682,6,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1683,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1683,2,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1683,3,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1684,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1684,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1684,3,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
1684,4,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
1684,5,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
1684,6,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1684,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1684,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1684,9,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1685,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1685,2,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1685,3,Osteoporotic fracture,Fractures NEC,Fractures,Musc,N
1686,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1687,1,Acute febrile neutrophilic dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1687,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1687,3,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
1687,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1687,5,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1687,6,Panniculitis,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
1687,7,Purulence,Infections NEC,Infections - pathogen unspecified,Infec,N
1687,8,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
1687,9,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1687,10,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1687,11,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1687,12,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1688,1,Acute left ventricular failure,Left ventricular failures,Heart failures,Card,Y
1688,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1688,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1689,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1689,2,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1689,3,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1690,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1690,2,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1691,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1691,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1691,3,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1692,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1693,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1694,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1694,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1695,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1695,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1695,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1695,4,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1696,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1696,2,Addison's disease,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1696,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1696,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1696,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1696,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1696,7,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1696,8,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1696,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1696,10,Toxic cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1696,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1697,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1697,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1697,3,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1698,1,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1698,2,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1699,1,Neuropathic arthropathy,Osteoarthropathies,Joint disorders,Musc,N
1700,1,Neuropathic arthropathy,Osteoarthropathies,Joint disorders,Musc,N
1701,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1701,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
1702,1,Colonic abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1703,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1703,2,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
1703,3,Gallbladder rupture,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
1703,4,Haemobilia,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1703,5,Hypovolaemic shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1703,6,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1703,7,Intra-abdominal fluid collection,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1703,8,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1704,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1704,2,Abscess rupture,Infections NEC,Infections - pathogen unspecified,Infec,N
1704,3,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1705,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1705,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1706,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1707,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1708,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1708,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1708,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1709,1,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1709,2,Gallbladder rupture,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
1709,3,Hypovolaemic shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1709,4,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1710,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1711,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1711,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1711,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1711,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1711,5,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1712,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1712,2,Helicobacter infection,Helicobacter infections,Bacterial infectious disorders,Infec,N
1713,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1713,2,Coronary artery dissection,Coronary artery disorders NEC,Coronary artery disorders,Card,N
1714,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1715,1,Coronary artery dissection,Coronary artery disorders NEC,Coronary artery disorders,Card,N
1716,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1716,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1716,3,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1717,1,Choroiditis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
1717,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1717,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1717,4,Necrotising retinitis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
1717,5,Retinal artery occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1717,6,Sudden visual loss,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1717,7,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1717,8,Vitritis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
1718,1,Gallbladder rupture,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
1718,2,Hypovolaemic shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1719,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1720,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1720,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1720,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1720,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1721,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1721,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1721,3,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1721,4,Headache,Headaches NEC,Headaches,Nerv,N
1721,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1721,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1722,1,Temporomandibular pain and dysfunction syndrome,Joint related disorders NEC,Joint disorders,Musc,N
1722,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1722,3,Trismus,Muscle tone abnormalities,Muscle disorders,Musc,N
1723,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1723,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1723,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1723,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1723,5,Enterobacter infection,Enterobacter infections,Bacterial infectious disorders,Infec,N
1723,6,Excessive granulation tissue,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1723,7,Helicobacter infection,Helicobacter infections,Bacterial infectious disorders,Infec,N
1723,8,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1723,9,Joint range of motion decreased,Joint related signs and symptoms,Joint disorders,Musc,N
1723,10,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
1723,11,Skin fibrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1723,12,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1723,13,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1723,14,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
1724,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1724,2,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1724,3,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1724,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1724,5,Gallbladder rupture,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
1724,6,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1724,7,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1724,8,Hypovolaemic shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1724,9,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1724,10,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1724,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1725,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1726,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1727,1,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1728,1,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
1729,1,Leukoerythroblastic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1730,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1730,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1730,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1730,4,Energy increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1730,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1730,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1730,7,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1730,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1730,9,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1730,10,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1731,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1731,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1731,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1731,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1731,5,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1731,6,Violence-related symptom,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1732,1,Corneal infiltrates,Corneal disorders NEC,Eye disorders NEC,Eye,N
1732,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1732,3,Keratitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1732,4,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1733,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1733,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1733,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1733,4,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1733,5,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1734,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1734,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1734,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1734,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1734,5,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1734,6,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
1734,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1734,8,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1734,9,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1735,1,Thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
1736,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1737,1,Ocular hypertension,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1738,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1738,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1739,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1740,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1741,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1742,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1742,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1742,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1742,4,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1743,1,Colour blindness,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
1743,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1743,3,Cryptococcosis,Cryptococcal infections,Fungal infectious disorders,Infec,N
1743,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1743,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1743,6,Headache,Headaches NEC,Headaches,Nerv,N
1743,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1743,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1744,1,Calciphylaxis,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1745,1,Calciphylaxis,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1745,2,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1745,3,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
1745,4,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1746,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1746,2,Headache,Headaches NEC,Headaches,Nerv,N
1746,3,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1746,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1747,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1747,2,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1747,3,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1747,4,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1747,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1747,6,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1747,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1747,8,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1747,9,Pyuria,Infections NEC,Infections - pathogen unspecified,Infec,N
1747,10,Pyuria,Infections NEC,Infections - pathogen unspecified,Infec,N
1747,11,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
1747,12,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1748,1,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1749,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1750,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
1750,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1751,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
1751,2,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1752,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
1752,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1752,3,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1752,4,Spinal osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
1753,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1753,2,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1753,3,Bone marrow disorder,Haematological disorders,Haematological disorders NEC,Blood,N
1753,4,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1753,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1753,6,Haemoperitoneum,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
1753,7,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1753,8,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1753,9,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1753,10,Myalgia,Muscle pains,Muscle disorders,Musc,N
1753,11,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1753,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1753,13,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1753,14,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1753,15,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1753,16,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1754,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1755,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1755,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1756,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1756,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1756,3,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1756,4,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1756,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1756,6,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1756,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1756,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1756,9,Headache,Headaches NEC,Headaches,Nerv,N
1756,10,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1756,11,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1756,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1756,13,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1756,14,Polymyalgia rheumatica,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
1756,15,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1757,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1757,2,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1757,3,Muscle abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
1758,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1758,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1758,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1759,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1759,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1759,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1759,4,Energy increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1759,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1759,6,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1759,7,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1759,8,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1759,9,Intelligence increased,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1759,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1759,11,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1759,12,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1759,13,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1759,14,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1759,15,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1760,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1760,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1760,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1760,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1760,5,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1761,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1761,2,Abnormal faeces,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1761,3,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1761,4,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1761,5,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1761,6,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1761,7,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1761,8,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1761,9,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1761,10,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1761,11,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1761,12,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1761,13,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1761,14,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1761,15,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1761,16,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1761,17,Headache,Headaches NEC,Headaches,Nerv,N
1761,18,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1761,19,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1761,20,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1761,21,Increased upper airway secretion,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1761,22,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1761,23,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1761,24,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1761,25,Onychomadesis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1761,26,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1761,27,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1761,28,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1761,29,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1761,30,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1761,31,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1761,32,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1761,33,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1761,34,Urine odour abnormal,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1761,35,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1762,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1762,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1762,3,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
1762,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1762,5,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1762,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1762,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1762,8,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1763,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1763,2,Sebaceous carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1763,3,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1764,1,Deformity,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1764,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1764,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1764,4,Fat redistribution,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
1764,5,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
1764,6,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
1764,7,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1764,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1764,9,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
1765,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
1766,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1766,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1766,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1766,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1766,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1767,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1767,2,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1767,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1767,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1767,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1767,6,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
1767,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1768,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1768,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1769,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1769,2,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
1769,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1769,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1770,1,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
1770,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1771,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1772,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1773,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1774,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1775,1,Fibrous histiocytoma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1776,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1776,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1777,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1778,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1778,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1778,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1778,4,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1779,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1780,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
1780,2,Sensation of foreign body,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1781,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1782,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1783,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1784,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1784,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1785,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1785,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1786,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1787,1,Osmotic demyelination syndrome,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
1788,1,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
1788,2,Breast haematoma,Breast signs and symptoms,Breast disorders,Repro,N
1788,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1788,4,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1788,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1788,6,Retroperitoneal haematoma,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
1788,7,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1789,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1790,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1791,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1791,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1791,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1792,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1792,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1792,3,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1792,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1793,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1794,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1795,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
1795,2,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
1795,3,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1795,4,Herpes simplex hepatitis,Herpes viral infections,Viral infectious disorders,Infec,N
1795,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1796,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1796,2,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
1796,3,Breast haematoma,Breast signs and symptoms,Breast disorders,Repro,N
1796,4,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1796,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1796,6,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1796,7,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1796,8,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1796,9,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1796,10,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1796,11,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1796,12,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1797,1,Infertility female,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
1798,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1798,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1798,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1798,4,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1798,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1798,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1798,7,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1798,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1798,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1798,10,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1799,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1799,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1799,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1800,1,Adenoidal hypertrophy,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1800,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1800,3,Lymphoid tissue hyperplasia,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1800,4,Obstructive sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1800,5,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1800,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1800,7,Tongue disorder,Tongue disorders,Tongue conditions,Gastr,N
1800,8,Tonsillar hypertrophy,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1801,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1801,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1801,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1802,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1802,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1802,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1802,4,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1803,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1804,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1804,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1804,3,Ketoacidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1804,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1804,5,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1804,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1805,1,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1806,1,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1806,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1807,1,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
1807,2,Oesophageal perforation,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
1807,3,Pneumomediastinum,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
1807,4,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1808,1,Anogenital warts,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1809,1,Osmotic demyelination syndrome,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
1810,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1810,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1810,3,Headache,Headaches NEC,Headaches,Nerv,N
1810,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1811,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1811,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1811,3,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1812,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1812,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1812,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1813,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1813,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1814,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1814,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1815,1,Laryngeal oedema,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
1816,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1816,2,Iris neovascularisation,Iris and ciliary body bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
1816,3,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1816,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1817,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1817,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1817,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1817,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1817,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1817,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1818,1,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1819,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1819,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1819,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1820,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1821,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1821,2,Headache,Headaches NEC,Headaches,Nerv,N
1822,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1822,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1822,3,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1822,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1823,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1824,1,Pharyngeal ulceration,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1824,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1824,3,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1824,4,Splenic lesion,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1825,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1825,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1826,1,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1826,2,Calciphylaxis,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1826,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1826,4,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1827,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1827,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1827,3,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1828,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1828,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1828,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1828,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1828,5,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1828,6,Electrocardiogram ST segment elevation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1828,7,Eosinophilic myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,Y
1828,8,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1828,9,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
1828,10,Lymphocytic infiltration,Leukocytoses NEC,White blood cell disorders,Blood,N
1828,11,Myocardial necrosis,Myocardial disorders NEC,Myocardial disorders,Card,N
1828,12,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1828,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1828,14,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1828,15,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1828,16,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1828,17,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1829,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1829,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1829,3,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
1829,4,Ecthyma,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1829,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1829,6,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1829,7,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
1829,8,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1829,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1829,10,Pseudomonal sepsis,Pseudomonal infections,Bacterial infectious disorders,Infec,Y
1829,11,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1829,12,Psoas abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
1829,13,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1829,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1829,15,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1830,1,Breast cancer male,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1831,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1832,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1832,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1832,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1832,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1833,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1834,1,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1834,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1835,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1835,2,Myopathy,Myopathies,Muscle disorders,Musc,N
1836,1,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1836,2,Hyposmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1837,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1838,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1839,1,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1839,2,Hypogeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1840,1,Allodynia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1840,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1840,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1840,4,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1840,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1840,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1840,7,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1840,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1840,9,Hypoglossal nerve paralysis,Hypoglossal nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1840,10,IVth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1840,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1841,1,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1841,2,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1842,1,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
1843,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1843,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1843,3,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
1843,4,Lymphogranuloma venereum,Chlamydial infections,Chlamydial infectious disorders,Infec,N
1844,1,Allodynia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1844,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1844,3,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1844,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1844,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1844,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1844,7,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1844,8,IVth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1844,9,Mononeuropathy multiplex,Mononeuropathies,Peripheral neuropathies,Nerv,N
1844,10,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1844,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1845,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1845,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1845,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1845,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1845,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1845,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1845,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1845,8,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1845,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1846,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1847,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1848,1,Acinetobacter test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,Y
1849,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1849,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1849,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1849,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1849,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1849,6,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1849,7,Immobile,Disability issues,Lifestyle issues,SocCi,N
1849,8,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1849,9,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1849,10,Juvenile idiopathic arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1849,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1849,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1849,13,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1849,14,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
1849,15,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1849,16,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1849,17,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1849,18,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1849,19,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1849,20,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1849,21,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1850,1,Lower gastrointestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1850,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1851,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1851,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1852,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1852,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1852,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1852,4,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1852,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1853,1,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1854,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1855,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1855,2,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1855,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1856,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1856,2,Anastomotic ulcer,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1856,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1856,4,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1856,5,Enteritis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1856,6,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1856,7,Norovirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1856,8,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1856,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1856,10,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1856,11,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1856,12,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
1856,13,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1857,1,Abulia,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1857,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1857,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1857,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1857,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1857,6,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1858,1,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1858,2,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1858,3,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1858,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1858,5,Violence-related symptom,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1859,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1860,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1860,2,Septic arthritis staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1860,3,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1861,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1861,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1861,3,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
1861,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1861,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1861,6,Septic arthritis staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1861,7,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1862,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1862,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1863,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1863,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1864,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1864,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1864,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1865,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1865,2,Adrenocorticotropic hormone deficiency,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
1865,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1865,4,Central obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1865,5,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1865,6,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1865,7,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1865,8,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1865,9,Glucose tolerance impaired,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1865,10,Hyperaemia,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1865,11,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1865,12,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1865,13,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1865,14,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1865,15,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1865,16,Telangiectasia,Telangiectasia and related conditions,Skin vascular abnormalities,Skin,N
1865,17,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1866,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1867,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1867,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1867,3,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1867,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1867,5,Sarcoma,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,N
1867,6,Sarcoma metastatic,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,N
1867,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1867,8,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1868,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1868,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1868,3,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1868,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1868,5,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1869,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1869,2,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1869,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1869,4,Polyomavirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1869,5,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1869,6,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1870,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1870,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1871,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1871,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1871,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1871,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1871,5,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1871,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1871,7,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1872,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1872,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1872,3,Faecal volume decreased,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
1872,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1872,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1872,6,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1873,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1874,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1875,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1875,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1876,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1877,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1878,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1879,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1879,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1879,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1880,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1881,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1882,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1882,2,Hypervigilance,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1882,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1882,4,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
1882,5,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1883,1,Testicular neoplasm,Reproductive neoplasms male unspecified malignancy,Reproductive neoplasms male malignant and unspecified,Neopl,N
1884,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1884,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1884,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1884,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1884,5,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1885,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1885,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1885,3,Headache,Headaches NEC,Headaches,Nerv,N
1885,4,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1885,5,Infusion site nerve damage,Infusion site reactions,Administration site reactions,Genrl,N
1885,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1885,7,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
1886,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1886,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1886,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1886,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1886,5,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1886,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1887,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1887,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1887,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1888,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1888,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1888,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1888,4,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1888,5,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1888,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1888,7,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1888,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1889,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1889,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1890,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1890,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1890,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1891,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,Y
1891,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1891,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1891,4,Vascular injury,Cardiovascular injuries,Injuries NEC,Inj&P,N
1891,5,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1892,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1893,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1893,2,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1893,3,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1893,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1893,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1893,6,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
1893,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1894,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1895,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1896,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1897,1,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
1898,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1898,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1898,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1899,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1900,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1901,1,Eye abscess,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1901,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1902,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1902,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1903,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1903,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1904,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1904,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1905,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1905,2,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
1905,3,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
1905,4,Placental disorder,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
1905,5,Vasoconstriction,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1906,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1906,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1906,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1906,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1906,5,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1906,6,Headache,Headaches NEC,Headaches,Nerv,N
1906,7,Joint warmth,Joint related signs and symptoms,Joint disorders,Musc,N
1906,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1906,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1906,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1906,11,Pharyngeal erythema,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1906,12,Tongue erythema,Tongue signs and symptoms,Tongue conditions,Gastr,N
1907,1,Coronary artery dissection,Coronary artery disorders NEC,Coronary artery disorders,Card,N
1908,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1908,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1908,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1909,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1909,2,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1909,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1909,4,Complications of transplanted liver,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1909,5,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1909,6,Liver transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1909,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1909,8,Transaminases abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1909,9,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1910,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1911,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1911,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1912,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1912,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1912,3,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1912,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1913,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1913,2,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1913,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1913,4,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1913,5,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
1913,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1913,7,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1913,8,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1914,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1914,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1914,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1915,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1915,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1915,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1915,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1915,5,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1915,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1915,7,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1915,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1915,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1916,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
1916,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1916,3,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1916,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1916,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1916,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1916,7,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1917,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1917,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
1917,3,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1917,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1918,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1918,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1918,3,Headache,Headaches NEC,Headaches,Nerv,N
1918,4,Infection susceptibility increased,Infections NEC,Infections - pathogen unspecified,Infec,N
1918,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1918,6,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
1918,7,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1918,8,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1918,9,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1919,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1920,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1920,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1920,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1920,4,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1920,5,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1921,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1921,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1921,3,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1922,1,Acute graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1922,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1922,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1922,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1922,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1922,6,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1922,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1922,8,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1922,9,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1922,10,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1922,11,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1922,12,Peripheral T-cell lymphoma unspecified recurrent,Peripheral T-cell lymphomas NEC,Lymphomas non-Hodgkin's T-cell,Neopl,N
1922,13,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1922,14,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1922,15,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1923,1,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1923,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1923,3,Brachial plexopathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1923,4,Demyelinating polyneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
1923,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1923,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1923,7,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1923,8,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1923,9,Median nerve injury,Peripheral nerve injuries,Injuries NEC,Inj&P,N
1923,10,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1923,11,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1923,12,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1923,13,Neurological decompensation,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1923,14,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1923,15,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1924,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1924,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1924,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1925,1,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1926,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1926,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1927,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1927,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1927,3,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1927,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1928,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1928,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1928,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1928,4,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1928,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1928,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1929,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1929,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1929,3,Headache,Headaches NEC,Headaches,Nerv,N
1929,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1929,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1929,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1929,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1929,8,Myalgia,Muscle pains,Muscle disorders,Musc,N
1929,9,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1930,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1930,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1931,1,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
1931,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1932,1,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
1932,2,Haemothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1933,1,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
1933,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1934,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1935,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1935,2,Extraocular muscle disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1936,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1936,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1936,3,Duodenal polyp,Benign neoplasms gastrointestinal (excl oral cavity),Benign neoplasms gastrointestinal,Gastr,N
1936,4,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1936,5,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1936,6,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
1936,7,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1936,8,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1936,9,Salmonellosis,Salmonella infections,Bacterial infectious disorders,Infec,N
1936,10,Spinal osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
1937,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1937,2,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1937,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1937,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1937,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1937,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1938,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1939,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1939,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1939,3,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1939,4,Reaction to preservatives,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1939,5,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1940,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1940,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1940,3,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1941,1,Arteritis infective,Vascular infections,Infections - pathogen unspecified,Infec,N
1942,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1943,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1943,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1944,1,Arteritis infective,Vascular infections,Infections - pathogen unspecified,Infec,N
1944,2,Infective aneurysm,Vascular infections,Infections - pathogen unspecified,Infec,N
1945,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1945,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1946,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1947,1,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1947,2,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1948,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1948,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1948,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1948,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1948,5,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1948,6,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1948,7,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1948,8,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1949,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1949,2,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1949,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1949,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1949,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1950,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1950,2,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1950,3,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1950,4,Hyporeflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1950,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1950,6,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1950,7,Osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1950,8,Weight bearing difficulty,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1951,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1951,2,Necrotising herpetic retinopathy,Herpes viral infections,Viral infectious disorders,Infec,N
1951,3,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1952,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1952,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1952,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1952,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1952,5,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1953,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1954,1,Candida sepsis,Candida infections,Fungal infectious disorders,Infec,N
1954,2,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
1954,3,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
1954,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1954,5,Klebsiella sepsis,Klebsiella infections,Bacterial infectious disorders,Infec,Y
1954,6,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1954,7,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1955,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1955,2,Extradural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1955,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1956,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1957,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1957,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1957,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1958,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1959,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1960,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1960,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1960,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1960,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1960,5,Duodenal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1960,6,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1960,7,Intestinal dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1960,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1960,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1960,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1961,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1961,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1961,3,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
1961,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1961,5,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
1962,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1962,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1963,1,Duodenal ulcer repair,Small intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
1963,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1964,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1964,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1965,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1966,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1966,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1966,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1966,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1967,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1967,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1968,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1968,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1968,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1968,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1968,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1969,1,Migraine,Migraine headaches,Headaches,Nerv,N
1969,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1970,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1970,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
1970,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1970,4,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1971,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1971,2,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1971,3,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1971,4,Red cell fragmentation syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1971,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1971,6,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1971,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1972,1,Pneumatosis intestinalis,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1972,2,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1973,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1973,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1973,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1973,4,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1973,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1973,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1974,1,Factitious disorder,Factitious disorders,Somatic symptom and related disorders,Psych,N
1975,1,Peripheral T-cell lymphoma unspecified,Peripheral T-cell lymphomas NEC,Lymphomas non-Hodgkin's T-cell,Neopl,N
1976,1,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
1976,2,Gastroenteritis salmonella,Salmonella infections,Bacterial infectious disorders,Infec,N
1976,3,Infective aortitis,Vascular infections,Infections - pathogen unspecified,Infec,N
1976,4,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1976,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1976,6,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1976,7,Salmonella bacteraemia,Salmonella infections,Bacterial infectious disorders,Infec,N
1977,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1978,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1978,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1978,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1978,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1979,1,Circumstance or information capable of leading to device use error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1979,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1979,3,Product package associated injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1979,4,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1979,5,Rectal perforation,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1980,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1981,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1981,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1982,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
1982,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1982,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1983,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1983,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1983,3,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1983,4,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
1983,5,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1983,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1983,7,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1983,8,Intussusception,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1983,9,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1983,10,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1983,11,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1983,12,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1983,13,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1983,14,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1983,15,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1983,16,Respiratory gas exchange disorder,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1983,17,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1983,18,Sputum retention,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1984,1,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1984,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1985,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1986,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1986,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1987,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1988,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1989,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1989,2,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1990,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1990,2,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
1991,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1991,2,Headache,Headaches NEC,Headaches,Nerv,N
1991,3,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1991,4,Nuchal rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
1991,5,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1992,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1992,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1992,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1992,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1992,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1992,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1992,7,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1992,8,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1992,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1992,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1992,11,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1992,12,Spinal cord disorder,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
1993,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1993,2,Atypical fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
1993,3,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
1993,4,Callus formation delayed,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1993,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1993,6,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1993,7,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1993,8,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1993,9,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
1993,10,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
1994,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1995,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1995,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1995,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1995,4,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1995,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1996,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
1996,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1996,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1996,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1996,5,Subileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1997,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1997,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1998,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1998,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1998,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1998,4,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1998,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1998,6,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1998,7,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1999,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2000,1,Angle closure glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
2000,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2001,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2001,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2001,3,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
2001,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2002,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2003,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2004,1,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
2004,2,Meningitis listeria,Listeria infections,Bacterial infectious disorders,Infec,N
2004,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2005,1,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2005,2,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
2005,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2006,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2007,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2007,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2008,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2009,1,Septic arthritis staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
2010,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
2011,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2011,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2011,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2011,4,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2011,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2011,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2011,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2011,8,Post herpetic neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2011,9,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2011,10,Wheelchair user,Disability issues,Lifestyle issues,SocCi,N
2012,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2013,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2014,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2015,1,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2015,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2015,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2015,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2015,5,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2015,6,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2015,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2015,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2015,9,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2015,10,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2015,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2015,12,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2016,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2016,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
2016,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2016,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2016,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2016,6,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2016,7,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2017,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2018,1,Benign ovarian tumour,Ovarian neoplasms benign,Reproductive neoplasms female benign,Neopl,N
2019,1,Alpha haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
2019,2,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,Y
2019,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2019,4,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
2019,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2020,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2021,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2022,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2023,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2024,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2024,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2025,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2026,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2027,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2028,1,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
2029,1,Hyperinsulinaemic hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2030,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2031,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
2031,2,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2032,1,Fungating wound,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2032,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2032,3,Mycetoma mycotic,Fungal infections NEC,Fungal infectious disorders,Infec,N
2033,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
2034,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
2034,2,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,N
2035,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2035,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2035,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2035,4,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2035,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2035,6,Food allergy,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2035,7,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2035,8,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
2035,9,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2035,10,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2035,11,Nipple disorder,Breast disorders NEC,Breast disorders,Repro,N
2035,12,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
2035,13,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2035,14,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2035,15,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2035,16,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2035,17,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2035,18,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
2035,19,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2035,20,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2036,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2036,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
2036,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2036,4,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
2037,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2037,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
2038,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2038,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2039,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2040,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2040,2,Barrett's oesophagus,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
2040,3,Gastritis erosive,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2040,4,Peptic ulcer,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2040,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2040,6,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2041,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2042,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2042,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2043,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2043,2,Cerebellar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2043,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2043,4,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2043,5,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2043,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2044,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2044,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2045,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2045,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2045,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2045,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2045,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2045,6,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
2045,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2045,8,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2045,9,Walking aid user,Disability issues,Lifestyle issues,SocCi,N
2046,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2046,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2046,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2047,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2047,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2048,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2048,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2048,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
2048,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2048,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2049,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2050,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2050,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2050,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2051,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
2051,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
2051,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2051,4,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2051,5,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
2051,6,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
2052,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
2052,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2053,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2053,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2053,3,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2053,4,Cervix enlargement,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
2053,5,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2053,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2053,7,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2053,8,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
2053,9,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
2053,10,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
2053,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2053,12,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2053,13,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
2053,14,Oligohydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
2053,15,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2053,16,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
2053,17,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
2053,18,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2053,19,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2053,20,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
2053,21,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2053,22,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
2054,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2054,2,Pneumatosis intestinalis,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2054,3,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
2055,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2056,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2056,2,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
2057,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2058,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2058,2,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2058,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
2058,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2058,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2058,6,Hepatic fibrosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
2058,7,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
2058,8,Hepatitis B DNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
2058,9,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,N
2058,10,Hepatitis B surface antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2058,11,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2058,12,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
2058,13,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2058,14,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2058,15,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2059,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
2059,2,Disability,Disability issues,Lifestyle issues,SocCi,N
2059,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2059,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2059,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2060,1,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
2061,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2061,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
2062,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2062,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2063,1,Hyperglycaemic hyperosmolar nonketotic syndrome,Diabetic complications neurological,Diabetic complications,Metab,N
2064,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2064,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2064,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2064,4,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2064,5,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2064,6,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
2064,7,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
2064,8,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2064,9,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2064,10,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2064,11,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2064,12,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2064,13,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2064,14,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2064,15,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2064,16,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2064,17,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
2064,18,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2064,19,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
2064,20,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2064,21,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2064,22,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2064,23,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2064,24,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2064,25,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2064,26,Onychoclasis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
2064,27,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
2064,28,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2064,29,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
2064,30,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2064,31,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2064,32,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2064,33,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
2064,34,Urine potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
2064,35,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2065,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2066,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2066,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2067,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2067,2,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
2068,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2068,2,Bipolar I disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
2068,3,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2068,4,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
2068,5,Pressure of speech,Speech articulation and rhythm disturbances,Communication disorders and disturbances,Psych,N
2068,6,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
2068,7,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2069,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2069,2,Headache,Headaches NEC,Headaches,Nerv,N
2069,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2069,4,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2069,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2069,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2069,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2070,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,Y
2071,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2072,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2072,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2072,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2072,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2073,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2074,1,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2075,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2075,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2076,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2076,2,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2077,1,Appendix disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2077,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2077,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2078,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2078,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2078,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2078,4,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2079,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2079,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2079,3,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
2079,4,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2079,5,Internal haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2080,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2080,2,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
2080,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2081,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2081,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2081,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2081,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2081,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2081,6,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2082,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2082,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2083,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2083,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2083,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2084,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2084,2,Myopathy,Myopathies,Muscle disorders,Musc,N
2084,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2084,4,Visceral leishmaniasis,Leishmania infections,Protozoal infectious disorders,Infec,N
2084,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2085,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2086,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
2086,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2086,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2086,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2086,5,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2086,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2086,7,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2086,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2087,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2088,1,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
2088,2,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
2089,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2090,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2091,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2091,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2091,3,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
2091,4,Feeling of despair,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2091,5,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
2091,6,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2092,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2093,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2093,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2093,3,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2094,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2094,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2094,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2094,4,Headache,Headaches NEC,Headaches,Nerv,N
2095,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2095,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2095,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2095,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2095,5,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
2095,6,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2095,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2095,8,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2096,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2097,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2097,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2097,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2098,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2099,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2099,2,Hunger,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2099,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2099,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2099,5,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2100,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
2100,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2100,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2100,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2101,1,Abnormal sensation in eye,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
2101,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2101,3,Anorgasmia,Orgasmic disorders and disturbances,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
2101,4,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2101,5,Body temperature fluctuation,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2101,6,Bradyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
2101,7,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2101,8,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2101,9,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2101,10,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2101,11,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2101,12,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2101,13,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
2101,14,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2101,15,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2101,16,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2101,17,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2101,18,Genital herpes,Herpes viral infections,Viral infectious disorders,Infec,N
2101,19,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2101,20,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
2101,21,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2101,22,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
2101,23,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
2101,24,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2101,25,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2101,26,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
2101,27,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2101,28,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2101,29,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2101,30,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2101,31,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
2101,32,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2101,33,Slow response to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2101,34,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2101,35,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2102,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2102,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2103,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
2103,2,Eye operation,Eye therapeutic procedures NEC,Eye therapeutic procedures,Surg,N
2103,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2103,4,Ophthalmic herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
2103,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2104,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
2104,2,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,Y
2104,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2105,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2105,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2105,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
2105,4,Headache,Headaches NEC,Headaches,Nerv,N
2105,5,Pathological fracture,Fractures NEC,Fractures,Musc,N
2106,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2107,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2107,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2107,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2107,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2108,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2109,1,Dark circles under eyes,Ocular disorders NEC,Eye disorders NEC,Eye,N
2109,2,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
2109,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2110,1,Pathological fracture,Fractures NEC,Fractures,Musc,N
2111,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2111,2,Seronegative arthritis,Arthropathies NEC,Joint disorders,Musc,N
2112,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2112,2,Headache,Headaches NEC,Headaches,Nerv,N
2112,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2113,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2114,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2114,2,Visceral leishmaniasis,Leishmania infections,Protozoal infectious disorders,Infec,N
2114,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2115,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2115,2,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2116,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2116,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
2117,1,Myopathy,Myopathies,Muscle disorders,Musc,N
2118,1,Palmar erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2118,2,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
2118,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2119,1,Anxiety disorder,Anxiety disorders NEC,Anxiety disorders and symptoms,Psych,N
2119,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2120,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2120,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2120,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2120,4,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2120,5,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2121,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
2121,2,Bowen's disease,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2121,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2122,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2123,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2123,2,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2123,3,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
2123,4,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2123,5,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
2123,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2123,7,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2124,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
2124,2,Bowen's disease,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2124,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
2124,4,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2125,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2126,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2126,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2126,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2126,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2127,1,Rhesus antibodies positive,Blood grouping and cross-matching analyses,Haematology investigations (incl blood groups),Inv,N
2128,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2128,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2128,3,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
2129,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2130,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
2131,1,Septic arthritis staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2131,2,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2132,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2132,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2132,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2133,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2134,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2135,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2136,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
2137,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2137,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2137,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2137,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2137,5,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
2137,6,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
2137,7,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
2138,1,Renal transplant,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
2139,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
2140,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2140,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2141,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
2141,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
2141,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2142,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
2142,2,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
2142,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2143,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2143,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2143,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2144,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2144,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2145,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2145,2,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
2145,3,Endoscopy upper gastrointestinal tract abnormal,Gastrointestinal and abdominal imaging procedures,Gastrointestinal investigations,Inv,N
2145,4,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2145,5,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2145,6,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2145,7,Herpes virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
2145,8,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2145,9,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2145,10,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2145,11,Oesophagitis haemorrhagic,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2145,12,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2145,13,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2145,14,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2145,15,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2146,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2146,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2146,3,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2146,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2146,5,Visual field defect,Visual field disorders,Vision disorders,Eye,N
2146,6,Vitritis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
2147,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2147,2,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
2148,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2148,2,Eye infection toxoplasmal,Toxoplasma infections,Protozoal infectious disorders,Infec,N
2148,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2149,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2149,2,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2149,3,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2150,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2150,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2151,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2152,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2152,2,Urogenital haemorrhage,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
2153,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2154,1,Eye infection toxoplasmal,Toxoplasma infections,Protozoal infectious disorders,Infec,N
2155,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2155,2,Cytomegalovirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2155,3,Epstein-Barr virus antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2155,4,Eye infection toxoplasmal,Toxoplasma infections,Protozoal infectious disorders,Infec,N
2156,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2157,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2157,2,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2157,3,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
2157,4,Vitritis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
2158,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2158,2,Pancreatitis necrotising,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
2159,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
2160,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2161,1,Eye infection toxoplasmal,Toxoplasma infections,Protozoal infectious disorders,Infec,N
2162,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2162,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2162,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2162,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2162,5,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2162,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2163,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2164,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2164,2,Chronic graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2164,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2164,4,Haemangioma of skin,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
2164,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2164,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2164,7,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
2164,8,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2164,9,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
2165,1,Cytomegalovirus gastroenteritis,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
2165,2,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
2165,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2165,4,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
2165,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2165,6,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2165,7,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2165,8,Shock haemorrhagic,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2165,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2165,10,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2166,1,Pancreatitis necrotising,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
2167,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2168,1,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2168,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
2168,3,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
2168,4,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2168,5,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2168,6,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2168,7,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2169,1,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2170,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
2170,2,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
2170,3,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
2170,4,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2170,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2171,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2172,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2172,2,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
2173,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2173,2,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2173,3,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
2173,4,Vitritis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
2174,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2175,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2175,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2176,1,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
2177,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
2178,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2179,1,Salmonellosis,Salmonella infections,Bacterial infectious disorders,Infec,N
2180,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2181,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
2182,1,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2183,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2183,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2183,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2184,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2185,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2186,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2187,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
2187,2,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
2187,3,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
2187,4,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
2188,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2188,2,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
2188,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2188,4,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
2188,5,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
2188,6,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2189,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2190,1,Anorexia nervosa,Eating disorders NEC,Eating disorders and disturbances,Psych,N
2190,2,Body dysmorphic disorder,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
2190,3,Bulimia nervosa,Eating disorders NEC,Eating disorders and disturbances,Psych,N
2190,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2190,5,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2190,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2190,7,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2191,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
2191,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2192,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2192,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2193,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
2193,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2194,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2194,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2195,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
2195,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2195,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2195,4,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2195,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2196,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2197,1,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2198,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
2198,2,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2199,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2199,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
2200,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2200,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2201,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2202,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2203,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2203,2,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
2204,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2204,2,Choking sensation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2204,3,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2204,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2204,5,Neck mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2205,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2205,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2206,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2206,2,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2207,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
2207,2,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2207,3,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2207,4,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
2208,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2208,2,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2208,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2209,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2210,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2211,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2212,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2212,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2212,3,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
2213,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2214,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2215,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2215,2,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2215,3,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2216,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2217,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2218,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2219,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2220,1,African trypanosomiasis,Trypanosomal infections,Protozoal infectious disorders,Infec,N
2220,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2221,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
2221,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2222,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2222,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2223,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2223,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2223,3,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
2223,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2223,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2224,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2224,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2225,1,Myopathy,Myopathies,Muscle disorders,Musc,N
2226,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
2226,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2227,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2227,2,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
2227,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2227,4,Asthmatic crisis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2227,5,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
2227,6,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2227,7,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2227,8,Giant cell arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
2227,9,Headache,Headaches NEC,Headaches,Nerv,N
2227,10,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
2227,11,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2227,12,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
2228,1,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
2229,1,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
2230,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2230,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2230,3,Recall phenomenon,Skin procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2231,1,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
2232,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2233,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
2233,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2234,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2234,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2235,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2235,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2235,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2235,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2235,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2236,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2236,2,Open globe injury,Eye injuries NEC,Injuries NEC,Inj&P,N
2237,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2237,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2237,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2237,4,Hyperacusis,Hyperacusia,Hearing disorders,Ear,N
2237,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2237,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2237,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2237,8,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2238,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2238,2,Megacolon,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
2239,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2239,2,Respiratory disorder neonatal,Newborn respiratory disorders NEC,Neonatal respiratory disorders,Resp,N
2240,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2240,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2240,3,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2240,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2240,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2240,6,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
2240,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2240,8,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2240,9,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2241,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2242,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2242,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2243,1,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,Y
2244,1,Acute hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,Y
2244,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2245,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2246,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2246,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,Y
2246,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2246,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2247,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2247,2,Mycobacterium test positive,Mycobacteria identification and serology,Microbiology and serology investigations,Inv,N
2247,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2247,4,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
2247,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,Y
2247,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2248,1,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2249,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2249,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2249,3,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
2249,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2250,1,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
2250,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2250,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,Y
2251,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2251,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
2252,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2253,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2253,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2253,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2254,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2254,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2254,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
2255,1,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2256,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2256,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2256,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2257,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2257,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2258,1,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
2258,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2259,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2259,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2259,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2259,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2259,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2260,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2260,2,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2261,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2261,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2261,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2262,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2262,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2262,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2262,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2262,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2263,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2264,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2265,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2266,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2266,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2267,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2268,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2268,2,Headache,Headaches NEC,Headaches,Nerv,N
2268,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2268,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2269,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2269,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2270,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2270,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2270,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2271,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2271,2,Scleroderma renal crisis,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2272,1,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2272,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2272,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2272,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2272,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2273,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2274,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2275,1,Dialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
2275,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2276,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2276,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2277,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2277,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
2277,3,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2277,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2277,5,Scleroderma renal crisis,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2278,1,Lactation insufficiency,Lactation disorders,Breast disorders,Repro,N
2279,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2280,1,Dialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
2280,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2280,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2281,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2282,1,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
2283,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
2283,2,Cervical dysplasia,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
2283,3,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2283,4,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2284,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2284,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2285,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2285,2,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
2285,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2285,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2286,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2286,2,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2286,3,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2286,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2286,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2286,6,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2287,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2287,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2287,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2287,4,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2287,5,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2287,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2288,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2288,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2288,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2288,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2289,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2289,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2290,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
2290,2,Leishmaniasis,Leishmania infections,Protozoal infectious disorders,Infec,N
2291,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
2291,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2291,3,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2291,4,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2291,5,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
2291,6,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2292,1,Pulmonary veno-occlusive disease,Vascular pulmonary disorders NEC,Pulmonary vascular disorders,Resp,N
2293,1,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
2294,1,Cardiopulmonary failure,Heart failures NEC,Heart failures,Card,Y
2294,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
2294,3,Pulmonary veno-occlusive disease,Vascular pulmonary disorders NEC,Pulmonary vascular disorders,Resp,N
2295,1,Fat tissue increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2295,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2296,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
2297,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2297,2,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
2298,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2299,1,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
2300,1,Viral test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2301,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
2301,2,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
2301,3,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2301,4,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2301,5,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2301,6,Drug monitoring procedure incorrectly performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2301,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2301,8,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2301,9,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2301,10,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2301,11,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2301,12,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2301,13,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2302,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2303,1,Calciphylaxis,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
2303,2,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
2303,3,Hyperphosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
2303,4,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2303,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2303,6,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2303,7,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2303,8,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2303,9,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2303,10,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2304,1,Asbestosis,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
2304,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2305,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2306,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2306,2,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2306,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2307,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
2307,2,Acanthosis,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
2307,3,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
2307,4,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
2307,5,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2307,6,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2307,7,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2308,1,Calciphylaxis,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
2308,2,Glomerulosclerosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
2308,3,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2308,4,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2309,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2310,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2310,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2310,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2311,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2312,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2312,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2312,3,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
2313,1,Leishmaniasis,Leishmania infections,Protozoal infectious disorders,Infec,N
2314,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2314,2,Drug titration error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2314,3,Immobile,Disability issues,Lifestyle issues,SocCi,N
2314,4,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
2314,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2314,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
2314,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2314,8,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
2314,9,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2314,10,Walking disability,Disability issues,Lifestyle issues,SocCi,N
2315,1,Cardiopulmonary failure,Heart failures NEC,Heart failures,Card,Y
2315,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
2316,1,Leishmaniasis,Leishmania infections,Protozoal infectious disorders,Infec,N
2316,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2317,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2318,1,Cutaneous leishmaniasis,Leishmania infections,Protozoal infectious disorders,Infec,N
2319,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2320,1,Oropharyngeal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
2321,1,Legionella infection,Legionella infections,Bacterial infectious disorders,Infec,N
2322,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
2322,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2322,3,Myopathy,Myopathies,Muscle disorders,Musc,Y
2322,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
2323,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2324,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2325,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2326,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2326,2,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2327,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2328,1,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
2328,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2328,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
2328,4,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2328,5,IIIrd nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2328,6,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
2328,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2328,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2329,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
2329,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2329,3,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
2329,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2329,5,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
2329,6,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,Y
2329,7,IIIrd nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2329,8,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
2329,9,Magnetic resonance imaging abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2329,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2330,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2331,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2332,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2332,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2332,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2333,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2333,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,Y
2334,1,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2335,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2336,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2337,1,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
2337,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2338,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2338,2,Mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2338,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2339,1,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
2339,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2340,1,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2341,1,Infection in an immunocompromised host,Infections NEC,Infections - pathogen unspecified,Infec,N
2342,1,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2342,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
2342,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2343,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2343,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2343,3,Pelvic fracture,Pelvic fractures and dislocations,Bone and joint injuries,Inj&P,N
2344,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2344,2,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2344,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2345,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2345,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2345,3,Headache,Headaches NEC,Headaches,Nerv,N
2345,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2345,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2345,6,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2345,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2346,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2346,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2346,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2347,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2347,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2347,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2347,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
2348,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2349,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2350,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2350,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2351,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2351,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
2351,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2351,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2352,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2352,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2353,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2354,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2354,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2354,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2354,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2354,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2354,6,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
2355,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2356,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
2356,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2357,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2358,1,Mental status changes,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
2359,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2360,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
2361,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2362,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2362,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2362,3,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
2362,4,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2363,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2364,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2365,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2365,2,Transfusion,Blood and blood product treatment,Haematological and lymphoid tissue therapeutic procedures,Surg,N
2366,1,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
2366,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2366,3,Oesophagitis haemorrhagic,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
2367,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2367,2,Myopathy,Myopathies,Muscle disorders,Musc,N
2368,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
2368,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2368,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2368,4,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
2368,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2369,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2370,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2370,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2370,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2370,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2371,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2371,2,Protein C deficiency,Coagulation disorders congenital,Blood and lymphatic system disorders congenital,Cong,N
2372,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2372,2,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
2373,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2373,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2374,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2374,2,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,Y
2374,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2375,1,Meningitis listeria,Listeria infections,Bacterial infectious disorders,Infec,N
2376,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2376,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2376,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2376,4,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
2376,5,Vitamin D deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
2377,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2377,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2378,1,African trypanosomiasis,Trypanosomal infections,Protozoal infectious disorders,Infec,N
2378,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
2378,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2378,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2378,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2379,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2380,1,Empyema,Infections NEC,Infections - pathogen unspecified,Infec,N
2380,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2381,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2381,2,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
2381,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2381,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2381,5,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
2382,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2382,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2383,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
2383,2,Removal of renal transplant,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
2384,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2385,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2386,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2387,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2388,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2389,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2390,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2391,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2392,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2393,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2394,1,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2394,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2394,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2394,4,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
2394,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2394,6,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
2394,7,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
2394,8,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
2395,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2395,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2395,3,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2395,4,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
2396,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2397,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2397,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2397,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2397,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2397,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2397,6,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2397,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2397,8,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2397,9,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2397,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2397,11,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2397,12,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2397,13,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2398,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2399,1,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2400,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2400,2,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
2400,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2400,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2401,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2402,1,African trypanosomiasis,Trypanosomal infections,Protozoal infectious disorders,Infec,N
2402,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
2402,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2403,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2403,2,Agitated depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2403,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2403,4,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2403,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
2404,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
2404,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2404,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2404,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2404,5,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2404,6,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2404,7,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
2405,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
2406,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2406,2,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2406,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2406,4,Dizziness exertional,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2406,5,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2406,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2406,7,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
2406,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2406,9,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
2406,10,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2407,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2407,2,Atypical femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2407,3,Body mass index increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2407,4,Glucose tolerance impaired,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2407,5,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
2407,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2407,7,Obstructive sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2407,8,Pancreatic failure,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
2407,9,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2408,1,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2409,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2410,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2410,2,Osteoporotic fracture,Fractures NEC,Fractures,Musc,N
2411,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
2412,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2413,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2414,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2415,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2416,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2417,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2417,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2418,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2418,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2419,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
2419,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2419,3,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
2419,4,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,Y
2420,1,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
2420,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
2420,3,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
2420,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2420,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2420,6,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,Y
2421,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2421,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2421,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2422,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2423,1,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
2424,1,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
2424,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
2424,3,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
2424,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2424,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2424,6,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,Y
2425,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2425,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2425,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
2425,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2425,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2426,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2427,1,Haemoglobin increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2427,2,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2428,1,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2429,1,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2430,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2431,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
2431,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2432,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2432,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2432,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2432,4,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2432,5,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2432,6,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2432,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2432,8,Muscle swelling,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2432,9,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2432,10,Myalgia,Muscle pains,Muscle disorders,Musc,N
2432,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2432,12,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2432,13,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2432,14,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2432,15,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
2432,16,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2433,1,Acute biphenotypic leukaemia,Leukaemias acute NEC,Leukaemias,Neopl,N
2434,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2434,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2434,3,Balanitis candida,Candida infections,Fungal infectious disorders,Infec,N
2434,4,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2434,5,Genital rash,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
2434,6,Pearly penile papules,Reproductive neoplasms male benign NEC,Reproductive neoplasms male benign,Neopl,N
2435,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2435,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2435,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2435,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2435,5,Energy increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2435,6,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2435,7,Flat affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
2435,8,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2435,9,Impulsive behaviour,Impulse control disorders,Impulse control disorders NEC,Psych,N
2435,10,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2435,11,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2435,12,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
2435,13,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2435,14,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
2435,15,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2435,16,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2435,17,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2436,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2437,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2438,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2438,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2438,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2439,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
2439,2,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
2439,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2439,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
2439,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2439,6,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2439,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2440,1,Acne,Acnes,Skin appendage conditions,Skin,N
2441,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2441,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2441,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2441,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2441,5,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
2442,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2442,2,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2442,3,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2442,4,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2442,5,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2442,6,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2442,7,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2442,8,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2442,9,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2442,10,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2442,11,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2442,12,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2442,13,Spinal stenosis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
2442,14,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2442,15,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2443,1,Duodenal perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
2444,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2445,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2446,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2447,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2448,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2449,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2449,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2450,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2451,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2452,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2453,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2454,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2455,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2456,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2457,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2458,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2458,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2458,3,Atypical fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
2458,4,Biopsy bone abnormal,Musculoskeletal and soft tissue histopathology procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
2458,5,Body mass index increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2458,6,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
2458,7,Callus formation delayed,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2458,8,Cystic fibrosis,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
2458,9,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2458,10,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2458,11,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2458,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2458,13,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
2458,14,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
2458,15,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
2458,16,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2459,1,Pneumonia staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
2460,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2460,2,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
2460,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2460,4,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
2461,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2461,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2461,3,Product container seal issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2462,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
2463,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2463,2,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
2463,3,Meningitis listeria,Listeria infections,Bacterial infectious disorders,Infec,N
2463,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2464,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2465,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2465,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2465,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2466,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2466,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2466,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2467,1,Acne,Acnes,Skin appendage conditions,Skin,N
2467,2,Acne,Acnes,Skin appendage conditions,Skin,N
2467,3,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2467,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2468,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2468,2,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
2468,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2468,4,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2468,5,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2468,6,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
2468,7,Right ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
2468,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2469,1,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
2469,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2469,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2470,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2470,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2470,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2470,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
2470,5,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2471,1,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2472,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2473,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2474,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2475,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2476,1,Pneumonia staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2477,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2477,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2478,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
2479,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2480,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2480,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2480,3,Cutibacterium acnes infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2480,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2480,5,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
2480,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2480,7,Lung abscess,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2480,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
2480,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2481,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
2481,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2482,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2482,2,CSF pressure increased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
2482,3,Fundoscopy abnormal,Ophthalmic histopathology and imaging procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2482,4,Headache,Headaches NEC,Headaches,Nerv,N
2482,5,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
2482,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2483,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2483,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2483,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2484,1,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2484,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2485,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2485,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2485,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
2486,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
2487,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2488,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2488,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2488,3,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2488,4,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2488,5,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2488,6,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2488,7,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
2488,8,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
2488,9,Chondrocalcinosis,Crystal arthropathic disorders,Joint disorders,Musc,N
2488,10,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2488,11,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2488,12,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2488,13,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
2488,14,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2488,15,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2488,16,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2488,17,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2488,18,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2488,19,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
2488,20,Fat tissue increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2488,21,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2488,22,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2488,23,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
2488,24,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2488,25,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2488,26,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
2488,27,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
2488,28,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2488,29,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2488,30,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
2488,31,Jaw disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2488,32,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2488,33,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2488,34,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
2488,35,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2488,36,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2488,37,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2488,38,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2488,39,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2488,40,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2488,41,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2488,42,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2488,43,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2488,44,Plicated tongue,Tongue disorders,Tongue conditions,Gastr,N
2488,45,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
2488,46,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2488,47,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
2488,48,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2488,49,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
2488,50,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2488,51,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
2488,52,Tendon discomfort,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
2488,53,Tendon pain,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
2488,54,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2488,55,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2488,56,Urine output increased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
2488,57,Vascular pain,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2488,58,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2488,59,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2488,60,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2489,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2489,2,Chest X-ray abnormal,Respiratory tract and thoracic imaging procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
2489,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2489,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2489,5,Cutibacterium acnes infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2489,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2489,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2489,8,Lung abscess,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2489,9,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
2489,10,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2489,11,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
2489,12,Purulent discharge,Infections NEC,Infections - pathogen unspecified,Infec,N
2489,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2490,1,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
2491,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
2491,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2491,3,Tongue erythema,Tongue signs and symptoms,Tongue conditions,Gastr,N
2492,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2493,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2493,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2493,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2493,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2494,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2494,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
2494,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2494,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2494,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2494,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2494,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2495,1,HIV-associated neurocognitive disorder,Retroviral infections,Viral infectious disorders,Infec,N
2495,2,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
2495,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2496,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2496,2,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
2497,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2498,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
2498,2,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
2498,3,HIV-associated neurocognitive disorder,Retroviral infections,Viral infectious disorders,Infec,N
2498,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2498,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2499,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2499,2,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2499,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2499,4,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
2499,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2500,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2501,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2501,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2501,3,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
2502,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2502,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2502,3,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2502,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2503,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2503,2,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2504,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2505,1,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
2506,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2506,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2507,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2508,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2508,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2508,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2508,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2509,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2509,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2509,3,Incoherent,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2509,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2510,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2511,1,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
2511,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2511,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2511,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2511,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2511,6,Osteomalacia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
2511,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2511,8,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2511,9,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2511,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2512,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2513,1,Acne,Acnes,Skin appendage conditions,Skin,N
2513,2,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2513,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2514,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2515,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2516,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2516,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2516,3,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2516,4,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2516,5,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2517,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2518,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2518,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2518,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2518,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2518,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2519,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2519,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2519,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2520,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2521,1,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
2521,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2522,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2522,2,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
2522,3,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
2523,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2523,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2523,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2524,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2525,1,Breast atrophy,Breast disorders NEC,Breast disorders,Repro,N
2525,2,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
2526,1,Aneurysm,Aneurysms and dissections non-site specific,Aneurysms and artery dissections,Vasc,N
2527,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2527,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
2527,3,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
2527,4,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2527,5,Spindle cell sarcoma,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,Y
2528,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2529,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2529,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2530,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2531,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2532,1,Abnormal palmar/plantar creases,Skin and subcutaneous tissue disorders congenital NEC,Skin and subcutaneous tissue disorders congenital,Cong,N
2532,2,Cafe au lait spots,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
2532,3,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2532,4,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
2532,5,Cranial sutures widening,"Musculoskeletal and connective tissue deformities of skull, face and buccal cavity",Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
2532,6,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
2532,7,Myopia,Refractive and accommodative disorders,Vision disorders,Eye,N
2532,8,Otospondylomegaepiphyseal dysplasia,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
2532,9,Strabismus congenital,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
2533,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2534,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2535,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2536,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2536,2,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
2536,3,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2537,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2537,2,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2538,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2538,2,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2539,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
2539,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2540,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2540,2,Pelvic fracture,Pelvic fractures and dislocations,Bone and joint injuries,Inj&P,N
2540,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2541,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2541,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2541,3,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2541,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
2542,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2542,2,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
2542,3,Tendon pain,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
2542,4,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
2543,1,Periorbital cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2544,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
2544,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2544,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2544,4,Trabeculectomy,Iris and ciliary body therapeutic procedures,Eye therapeutic procedures,Surg,N
2545,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2545,2,Fat tissue increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2545,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2546,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2546,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2546,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2546,4,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2546,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2546,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2546,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2546,8,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2546,9,Tunnel vision,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
2547,1,Sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2548,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2549,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2549,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2550,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
2550,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2550,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2550,4,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2550,5,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2550,6,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2550,7,Faecaloma,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
2550,8,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2550,9,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2550,10,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
2550,11,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
2551,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2551,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2551,3,Urethral stent insertion,Urethral therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
2551,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2552,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2553,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2554,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2555,1,Myeloid leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,Y
2555,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2556,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2557,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2558,1,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2559,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2559,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2559,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2559,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2559,5,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2559,6,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
2560,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2560,2,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
2561,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2562,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2563,1,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
2563,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2563,3,Satoyoshi syndrome,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2564,1,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2564,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
2564,3,Pseudo Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2565,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2565,2,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2566,1,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2566,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
2567,1,Intestinal infarction,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,Y
2567,2,Mesenteric vein thrombosis,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
2568,1,Superior sagittal sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
2569,1,Superior sagittal sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,Y
2570,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2571,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
2571,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2571,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2571,4,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2571,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2571,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2571,7,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2571,8,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2571,9,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2571,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2571,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2571,12,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2572,1,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
2573,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2574,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2574,2,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
2574,3,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2574,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2574,5,Menstruation delayed,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
2574,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2574,7,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2575,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2575,2,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
2575,3,Congestive hepatopathy,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
2575,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2575,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2575,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2575,7,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
2575,8,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2575,9,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
2575,10,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2575,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2575,12,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2575,13,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2575,14,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
2575,15,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2575,16,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
2575,17,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2575,18,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2576,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2576,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2576,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
2577,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2578,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2578,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2579,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2580,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2581,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2582,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2582,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
2582,3,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2582,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2583,1,Systemic scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
2584,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
2584,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2584,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2585,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2586,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2587,1,Chronic gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2588,1,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
2588,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2589,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2590,1,Central obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2590,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2590,3,Pseudo Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2590,4,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
2590,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2591,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2591,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2592,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2592,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2592,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2593,1,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2593,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2594,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2595,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
2595,2,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
2596,1,Eye infection toxoplasmal,Toxoplasma infections,Protozoal infectious disorders,Infec,N
2596,2,Rhegmatogenous retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
2597,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2598,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2598,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2598,3,Psychotic behaviour,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2599,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2599,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2600,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2600,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2600,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2600,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2600,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2600,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2601,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2601,2,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2602,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2602,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2603,1,Subcutaneous abscess,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2603,2,Urinary tract infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2604,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2604,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
2604,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2605,1,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2605,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2606,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2607,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2607,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2607,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2607,4,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2607,5,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2607,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2607,7,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2607,8,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2607,9,Prostatic obstruction,"Prostatic signs, symptoms and disorders NEC",Prostatic disorders (excl infections and inflammations),Repro,N
2607,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2608,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2609,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2609,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2610,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2611,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2611,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2611,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2611,4,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2611,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2611,6,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2612,1,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
2612,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2612,3,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2613,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2613,2,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
2614,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2614,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2615,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
2615,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
2615,3,Encephalitis autoimmune,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
2616,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2616,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2616,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2616,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2616,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2616,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2616,7,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
2617,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2617,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2618,1,Hepatic infection,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
2619,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2619,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2619,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2620,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2621,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2621,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2621,3,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
2622,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2623,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
2623,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2624,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2625,1,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2625,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2626,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2626,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2626,3,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
2627,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2628,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2629,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2630,1,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2631,1,Duodenal perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2631,2,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
2631,3,Symptom masked,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2632,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2633,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2634,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2635,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2635,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
2636,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2636,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2637,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2638,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
2638,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2638,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2638,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2638,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2638,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2638,7,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2638,8,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2638,9,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
2638,10,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2639,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2639,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2639,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2639,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2639,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2639,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2639,7,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2639,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2640,1,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2640,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2640,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2641,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2641,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2641,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2641,4,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2641,5,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2641,6,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2641,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2642,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2642,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2642,3,Hepatitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
2642,4,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2642,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2643,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2644,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2645,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2646,1,Aphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2646,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2646,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2646,4,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2646,5,Sputum abnormal,Respiratory tract and thoracic histopathology procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
2647,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
2648,1,Arteriospasm coronary,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2648,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2648,3,Electrocardiogram ST segment depression,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2648,4,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2649,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2649,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2649,3,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2649,4,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2649,5,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2649,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2649,7,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
2649,8,Lung opacity,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2649,9,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2649,10,PO2 decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2649,11,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
2649,12,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2649,13,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2649,14,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2650,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2650,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2650,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2650,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2650,5,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2650,6,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2650,7,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2650,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2650,9,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2650,10,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2650,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2650,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2650,13,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2650,14,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
2651,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2651,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
2651,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2651,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2651,5,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
2652,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2652,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2652,3,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
2652,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2652,5,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
2652,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2652,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2652,8,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2652,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2652,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2652,11,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2652,12,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2652,13,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2652,14,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2652,15,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2653,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2653,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2653,3,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
2653,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2654,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2655,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2655,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2655,3,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2656,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2656,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2657,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2657,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2658,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2658,2,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
2658,3,CD8 lymphocytes increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2658,4,CSF protein increased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
2658,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2658,6,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2658,7,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2658,8,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2658,9,Headache,Headaches NEC,Headaches,Nerv,N
2658,10,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2658,11,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2658,12,White matter lesion,Structural brain disorders NEC,Structural brain disorders,Nerv,N
2659,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2660,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2661,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2662,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2663,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2663,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2663,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2663,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2663,5,Telangiectasia,Telangiectasia and related conditions,Skin vascular abnormalities,Skin,N
2664,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2665,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2665,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2666,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2666,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2667,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2667,2,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2668,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2668,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2668,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2669,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2669,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2670,1,"Follicle centre lymphoma, follicular grade I, II, III recurrent",Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2670,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2671,1,Breech presentation,Foetal position and presentation abnormalities,Foetal complications,Preg,N
2671,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2671,3,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
2672,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2672,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2673,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2673,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2673,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2673,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2673,5,Transfusion,Blood and blood product treatment,Haematological and lymphoid tissue therapeutic procedures,Surg,N
2673,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2673,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2674,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2674,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2674,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2675,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2675,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2675,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2675,4,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2676,1,Meningitis cryptococcal,Cryptococcal infections,Fungal infectious disorders,Infec,N
2677,1,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
2677,2,Middle cerebral artery stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2678,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2679,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2679,2,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2680,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2681,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2681,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
2682,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2683,1,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2683,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2683,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2684,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2685,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2685,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2685,3,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2686,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2686,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2686,3,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2686,4,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2686,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2686,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2686,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2686,8,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2686,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2686,10,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2687,1,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
2687,2,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
2687,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2687,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2687,5,Umbilical cord abnormality,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
2688,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2689,1,Halo vision,Visual disorders NEC,Vision disorders,Eye,N
2689,2,Ocular hypertension,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
2689,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2690,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2691,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2692,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2693,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2694,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2695,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2696,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2697,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2698,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2699,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2700,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2701,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2702,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2703,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2703,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2703,3,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2703,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2703,5,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2703,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2704,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2705,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2705,2,Clonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2705,3,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2705,4,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2705,5,Decreased vibratory sense,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2705,6,Epidural lipomatosis,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
2705,7,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
2705,8,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2705,9,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2705,10,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
2705,11,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
2705,12,Loss of proprioception,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2705,13,Magnetic resonance imaging abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2705,14,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2705,15,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2705,16,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2705,17,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
2705,18,Walking aid user,Disability issues,Lifestyle issues,SocCi,N
2706,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2706,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2707,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2707,2,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2708,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2709,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2710,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2711,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2712,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2713,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2713,2,Eosinophilic granulomatosis with polyangiitis,Vasculitides,Immune disorders NEC,Immun,Y
2713,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2714,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2714,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2714,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2714,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
2715,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2716,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2717,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2718,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2719,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2719,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2719,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2720,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2720,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2720,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2720,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2720,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
2721,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2721,2,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
2721,3,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2721,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2721,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2721,6,Epiretinal membrane,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
2721,7,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
2721,8,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
2721,9,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
2721,10,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2721,11,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
2721,12,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2721,13,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
2721,14,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2721,15,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2721,16,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2721,17,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2721,18,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2722,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2722,2,Nephritis,Nephritis NEC,Nephropathies,Renal,N
2722,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2722,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2722,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2723,1,Nephritis,Nephritis NEC,Nephropathies,Renal,N
2723,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2723,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2723,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2724,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2724,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2724,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2725,1,Klebsiella sepsis,Klebsiella infections,Bacterial infectious disorders,Infec,N
2725,2,Liver abscess,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
2726,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
2726,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2726,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2726,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2727,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2728,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2729,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2730,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2730,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2730,3,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2730,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2730,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
2730,6,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2730,7,New daily persistent headache,Headaches NEC,Headaches,Nerv,N
2730,8,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2730,9,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
2730,10,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2731,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
2731,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2731,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2732,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2732,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2733,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2733,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2734,1,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2734,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2735,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2735,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2735,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2735,4,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
2735,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2735,6,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2735,7,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2735,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2735,9,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2735,10,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2735,11,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2736,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2736,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2736,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2736,4,Initial insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2736,5,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2736,6,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
2737,1,Abdominal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2737,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2737,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2737,4,Bile acids increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2737,5,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
2737,6,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
2737,7,Chest X-ray abnormal,Respiratory tract and thoracic imaging procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
2737,8,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2737,9,Disseminated cytomegaloviral infection,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
2737,10,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2737,11,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2737,12,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2737,13,HELLP syndrome,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
2737,14,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2737,15,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2737,16,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2737,17,Oesophageal rupture,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2737,18,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2737,19,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
2737,20,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2737,21,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2737,22,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2737,23,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2737,24,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2737,25,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2737,26,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2737,27,Tracheo-oesophageal fistula,Laryngeal and tracheal disorders congenital,Respiratory disorders congenital,Cong,N
2737,28,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2737,29,Urine protein/creatinine ratio increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2738,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2738,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2738,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2739,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2739,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2739,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2740,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2741,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2742,1,Removal of renal transplant,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
2743,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2743,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2743,3,Langerhans' cell histiocytosis,Histiocytoses,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2743,4,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
2743,5,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
2743,6,Subcutaneous emphysema,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
2744,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
2745,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2745,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2746,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2746,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2747,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2748,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2748,2,Headache,Headaches NEC,Headaches,Nerv,N
2749,1,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2749,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2750,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
2750,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2750,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2750,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2750,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2751,1,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
2751,2,Hyperaesthesia teeth,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
2752,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2753,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2754,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
2755,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2755,2,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2755,3,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2756,1,Acne,Acnes,Skin appendage conditions,Skin,N
2756,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2757,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
2757,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
2757,3,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2757,4,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2757,5,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2757,6,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2758,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2759,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2759,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2759,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2759,4,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2759,5,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2759,6,Intra-abdominal fluid collection,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
2759,7,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2759,8,Oesophageal rupture,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2759,9,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2759,10,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
2759,11,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
2759,12,Tracheo-oesophageal fistula,Laryngeal and tracheal disorders congenital,Respiratory disorders congenital,Cong,N
2759,13,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2760,1,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2761,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2761,2,Hepatic cyst,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
2762,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2762,2,Conjunctival scar,Eye injuries NEC,Injuries NEC,Inj&P,N
2762,3,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2762,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2763,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2764,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2765,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2765,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2765,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2765,4,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
2766,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2767,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
2767,2,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2768,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2769,1,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2770,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2771,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
2771,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2772,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
2772,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
2772,3,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2772,4,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2772,5,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2772,6,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2773,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2774,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2775,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
2776,1,"Brief psychotic disorder, with postpartum onset",Brief psychotic disorder,Schizophrenia and other psychotic disorders,Psych,N
2776,2,Computerised tomogram abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2776,3,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
2776,4,Electroencephalogram abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2776,5,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
2776,6,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2776,7,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
2776,8,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
2776,9,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
2777,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2777,2,"Brief psychotic disorder, with postpartum onset",Brief psychotic disorder,Schizophrenia and other psychotic disorders,Psych,N
2777,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2777,4,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2777,5,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2777,6,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2777,7,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2777,8,Feeling of despair,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2777,9,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2777,10,Staring,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
2777,11,Suspiciousness,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2778,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2779,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2780,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2780,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2780,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2780,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2780,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2780,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2780,7,Nerve compression,Mononeuropathies,Peripheral neuropathies,Nerv,N
2780,8,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2780,9,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2780,10,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2780,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2781,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2782,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2782,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2782,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2783,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2783,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2783,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2784,1,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2784,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2785,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2785,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2785,3,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2785,4,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2785,5,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2786,1,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2787,1,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2788,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2789,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
2790,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2791,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2791,2,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2792,1,Meningitis cryptococcal,Cryptococcal infections,Fungal infectious disorders,Infec,Y
2792,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2792,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2792,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2793,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2793,2,Meningitis cryptococcal,Cryptococcal infections,Fungal infectious disorders,Infec,Y
2793,3,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2794,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2794,2,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
2795,1,Fat tissue increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2796,1,Duodenal perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2797,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2797,2,Anal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2797,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2797,4,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2797,5,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2797,6,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2797,7,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2797,8,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
2797,9,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2797,10,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2797,11,Dysacusis,Hearing disorders NEC,Hearing disorders,Ear,N
2797,12,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2797,13,Headache,Headaches NEC,Headaches,Nerv,N
2797,14,Lack of spontaneous speech,Speech articulation and rhythm disturbances,Communication disorders and disturbances,Psych,N
2797,15,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2797,16,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2797,17,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2797,18,Sudden onset of sleep,Sleep disturbances NEC,Sleep disturbances (incl subtypes),Nerv,N
2797,19,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2798,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2798,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
2799,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
2799,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2799,3,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
2800,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2800,2,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2800,3,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2800,4,Adrenal mass,Adrenal gland disorders NEC,Adrenal gland disorders,Endo,N
2800,5,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2800,6,Blood catecholamines,Adrenal medulla tests,Endocrine investigations (incl sex hormones),Inv,N
2800,7,Blood catecholamines increased,Adrenal medulla tests,Endocrine investigations (incl sex hormones),Inv,N
2800,8,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2800,9,Blood pH decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2800,10,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2800,11,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
2800,12,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2800,13,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2800,14,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2800,15,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2800,16,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2800,17,Hyperosmolar state,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
2800,18,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2800,19,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2800,20,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
2800,21,Magnetic resonance imaging abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2800,22,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2800,23,PCO2 decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2800,24,PO2 decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2800,25,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2800,26,Phaeochromocytoma crisis,Islet cell neoplasms and APUDoma NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
2800,27,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2800,28,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2800,29,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2800,30,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2800,31,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2800,32,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2800,33,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2800,34,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2800,35,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2800,36,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
2800,37,Use of accessory respiratory muscles,Respiratory signs and symptoms NEC,Respiratory tract signs and symptoms,Resp,N
2800,38,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
2800,39,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2800,40,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2801,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2801,2,Hyperchlorhydria,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
2801,3,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2802,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2802,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2803,1,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
2803,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2804,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2804,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2804,3,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2804,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2804,5,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
2804,6,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
2804,7,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
2804,8,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2804,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2804,10,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2804,11,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2804,12,Tongue blistering,Tongue signs and symptoms,Tongue conditions,Gastr,N
2804,13,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2804,14,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
2805,1,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2806,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2807,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2808,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2808,2,Meningitis cryptococcal,Cryptococcal infections,Fungal infectious disorders,Infec,Y
2808,3,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2809,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2810,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
2810,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2810,3,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2810,4,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2810,5,Hostility,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2810,6,Incoherent,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2810,7,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2810,8,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
2810,9,Persecutory delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
2810,10,Pressure of speech,Speech articulation and rhythm disturbances,Communication disorders and disturbances,Psych,N
2810,11,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2810,12,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2811,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2812,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2812,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2813,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2814,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
2815,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2816,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
2816,2,Joint destruction,Joint related disorders NEC,Joint disorders,Musc,N
2817,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2817,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2817,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2817,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2818,1,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
2818,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
2819,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2820,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2820,2,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2821,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
2822,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
2822,2,Joint destruction,Joint related disorders NEC,Joint disorders,Musc,N
2823,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2823,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2824,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2824,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2824,3,Head titubation,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2824,4,Hyperaesthesia teeth,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
2824,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2824,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2824,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2825,1,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2826,1,Meningitis cryptococcal,Cryptococcal infections,Fungal infectious disorders,Infec,Y
2826,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2826,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2826,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2827,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
2827,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2828,1,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2828,2,Product packaging confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2828,3,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
2829,1,Biopsy colon abnormal,Gastrointestinal histopathology procedures,Gastrointestinal investigations,Inv,N
2829,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2829,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2829,4,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
2829,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2829,6,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2829,7,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2829,8,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2829,9,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
2829,10,Gastric mucosa erythema,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2829,11,Headache,Headaches NEC,Headaches,Nerv,N
2829,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2829,13,Oedema mucosal,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2829,14,Pharyngeal inflammation,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2829,15,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2830,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2830,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2831,1,Liver transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
2831,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2832,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2832,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2833,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2833,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2834,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2834,2,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
2835,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2836,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2836,2,Phaeochromocytoma,Islet cell neoplasms and APUDoma NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
2837,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2837,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2837,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2837,4,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2837,5,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2837,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2837,7,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2838,1,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
2839,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2840,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2841,1,Varicella zoster pneumonia,Herpes viral infections,Viral infectious disorders,Infec,Y
2842,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2843,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2843,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2843,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2843,4,Lipohypertrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
2843,5,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
2843,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2844,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
2844,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2844,3,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2844,4,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2845,1,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
2846,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2846,2,Agitated depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2847,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2848,1,Critical illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2849,1,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2849,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2850,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2851,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
2852,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2853,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2853,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2853,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2854,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2855,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2856,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,Y
2856,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2856,3,Epstein-Barr virus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2856,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2857,1,Biopsy skin abnormal,Skin histopathology and skin investigations NEC,Skin investigations,Inv,N
2857,2,Lyme disease,Borrelial infections,Bacterial infectious disorders,Infec,N
2857,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2858,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2859,1,Throat cancer,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
2860,1,Epidermodysplasia verruciformis,Papilloma viral infections,Viral infectious disorders,Infec,N
2861,1,Malacoplakia vesicae,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
2862,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2863,1,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
2864,1,Fungaemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2865,1,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2866,1,Biopsy skin abnormal,Skin histopathology and skin investigations NEC,Skin investigations,Inv,N
2866,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2866,3,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
2866,4,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
2866,5,Purulent discharge,Infections NEC,Infections - pathogen unspecified,Infec,N
2866,6,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
2867,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
2867,2,Groin abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
2867,3,Histology abnormal,Histopathology procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2867,4,Malacoplakia vesicae,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
2867,5,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
2867,6,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2868,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
2869,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2870,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2870,2,Muscle rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
2871,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2872,1,Alternaria infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2872,2,Biopsy skin abnormal,Skin histopathology and skin investigations NEC,Skin investigations,Inv,N
2872,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2872,4,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
2872,5,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2873,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2874,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
2874,2,Mycobacterium marinum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2874,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2875,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2875,2,Aneurysm,Aneurysms and dissections non-site specific,Aneurysms and artery dissections,Vasc,N
2875,3,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2875,4,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2875,5,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2875,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2875,7,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
2875,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2875,9,Gastrointestinal lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
2875,10,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2875,11,Horner's syndrome,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
2875,12,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
2875,13,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2875,14,Myalgia,Muscle pains,Muscle disorders,Musc,N
2875,15,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
2875,16,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2875,17,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2875,18,Polyarteritis nodosa,Vasculitides NEC,Vascular infections and inflammations,Vasc,Y
2875,19,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2875,20,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2875,21,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2876,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2877,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
2877,2,Groin abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
2877,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2877,4,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2878,1,Acarodermatitis,Ectoparasitic infestations,Ectoparasitic disorders,Infec,N
2879,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2879,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2879,3,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2879,4,Headache,Headaches NEC,Headaches,Nerv,N
2879,5,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2879,6,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2879,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2879,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2879,9,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2880,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2880,2,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2880,3,Skin hypopigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
2881,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2882,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2882,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2883,1,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2883,2,Product contamination,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2883,3,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2884,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2885,1,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2886,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2887,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2887,2,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
2887,3,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2887,4,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2887,5,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2887,6,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2887,7,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
2887,8,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2887,9,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2887,10,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2887,11,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2887,12,Hepatitis fulminant,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2887,13,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2887,14,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2887,15,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
2887,16,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2888,1,Campylobacter gastroenteritis,Campylobacter infections,Bacterial infectious disorders,Infec,N
2888,2,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
2889,1,Cluster headache,Headaches NEC,Headaches,Nerv,N
2890,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
2890,2,Cutaneous T-cell lymphoma stage IV,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
2890,3,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2890,4,Histology abnormal,Histopathology procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2890,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2890,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2890,7,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2890,8,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2891,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2892,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2893,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2894,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
2894,2,Systemic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2895,1,Back injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
2895,2,Clavicle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2895,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2896,1,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2897,1,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2897,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2898,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2899,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2900,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2900,2,Cardiac flutter,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2900,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2900,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2901,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2902,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2903,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2904,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2905,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2905,2,Myopathy,Myopathies,Muscle disorders,Musc,N
2905,3,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2906,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2907,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2907,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2908,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2908,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2908,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2909,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2910,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2911,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
2912,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2913,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2913,2,Chest X-ray abnormal,Respiratory tract and thoracic imaging procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
2913,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2913,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2913,5,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2913,6,Histology abnormal,Histopathology procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2913,7,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
2913,8,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2913,9,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2913,10,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2913,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2914,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2915,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2916,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2916,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2916,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
2916,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2916,5,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
2916,6,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
2916,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2916,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2916,9,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
2916,10,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2917,1,Cow pox,Orthopox viral infections,Viral infectious disorders,Infec,N
2917,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2917,3,Mandibular mass,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2917,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2917,5,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
2917,6,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2917,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2917,8,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2917,9,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2917,10,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2917,11,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2917,12,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
2917,13,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2917,14,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2917,15,Tonsillar inflammation,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2917,16,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2917,17,Upper airway obstruction,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2918,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
2919,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2919,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2920,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2920,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2921,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
2922,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2922,2,Blood pressure systolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2922,3,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2922,4,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2922,5,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
2922,6,Hypoperfusion,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2923,1,Infection in an immunocompromised host,Infections NEC,Infections - pathogen unspecified,Infec,N
2923,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2924,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2925,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2925,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2925,3,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
2925,4,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2925,5,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
2926,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2927,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2927,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2927,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2927,4,Muscle discomfort,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2927,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2928,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2928,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2928,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2928,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
2929,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2929,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2930,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2930,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2931,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2932,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2932,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2932,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2932,4,Muscle rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
2932,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2933,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2934,1,Viral cardiomyopathy,Viral infections NEC,Viral infectious disorders,Infec,N
2935,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2935,2,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2935,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2935,4,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2935,5,Complement factor C3 decreased,Immune response protein analyses NEC,Immunology and allergy investigations,Inv,N
2935,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2935,7,Glomerulonephritis rapidly progressive,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
2935,8,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2935,9,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2935,10,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
2935,11,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2935,12,Red blood cells urine positive,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
2936,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2937,1,Anterograde amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2937,2,B-lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2937,3,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
2937,4,Human herpesvirus 6 infection reactivation,Herpes viral infections,Viral infectious disorders,Infec,N
2937,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2937,6,Pleocytosis,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2938,1,Bladder injury,Renal and urinary tract injuries NEC,Injuries NEC,Inj&P,N
2939,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2939,2,Hypoperfusion,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2939,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2940,1,Anterograde amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2940,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2940,3,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
2940,4,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2940,5,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2940,6,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2940,7,Encephalitis autoimmune,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
2940,8,Encephalitis herpes,Herpes viral infections,Viral infectious disorders,Infec,N
2940,9,Headache,Headaches NEC,Headaches,Nerv,N
2940,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2940,11,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2940,12,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2940,13,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2940,14,Pleocytosis,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2940,15,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2940,16,Simple partial seizures,Partial simple seizures NEC,Seizures (incl subtypes),Nerv,N
2941,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
2941,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2942,1,Aortic valve incompetence,Aortic valvular disorders,Cardiac valve disorders,Card,N
2942,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2942,3,Cardiac valve vegetation,Cardiac infections,Infections - pathogen unspecified,Infec,N
2942,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2942,5,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
2942,6,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2942,7,Endocarditis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2942,8,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
2942,9,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
2942,10,Magnetic resonance imaging head abnormal,Central nervous system imaging procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2942,11,Orbital myositis,"Orbital infections, inflammations and irritations","Ocular infections, irritations and inflammations",Eye,N
2942,12,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2942,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2942,14,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2942,15,Whipple's disease,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2943,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2943,2,Viral cardiomyopathy,Viral infections NEC,Viral infectious disorders,Infec,N
2944,1,Anterograde amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2944,2,Encephalitis herpes,Herpes viral infections,Viral infectious disorders,Infec,N
2944,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2945,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2945,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2945,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2946,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2946,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
2947,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2947,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2948,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2948,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2949,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2949,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2949,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2950,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2951,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2951,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
2952,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2952,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2953,1,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2954,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2954,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2955,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2955,2,Haemorrhagic diathesis,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
2955,3,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
2956,1,Dermal cyst,Skin cysts and polyps,Cutaneous neoplasms benign,Skin,N
2957,1,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2958,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2959,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2959,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
2959,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2959,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2959,5,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2959,6,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2959,7,Pharyngeal ulceration,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2959,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2959,9,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2959,10,Vocal cord disorder,Laryngeal and adjacent sites disorders NEC (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2960,1,Disability,Disability issues,Lifestyle issues,SocCi,N
2960,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2961,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2961,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2961,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2961,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2961,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2961,6,Headache,Headaches NEC,Headaches,Nerv,N
2961,7,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2961,8,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2961,9,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2961,10,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2961,11,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2962,1,Clavicle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2962,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2962,3,Pelvic fracture,Pelvic fractures and dislocations,Bone and joint injuries,Inj&P,N
2963,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2964,1,Lower gastrointestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2965,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
2965,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2966,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2967,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2968,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2968,2,Headache,Headaches NEC,Headaches,Nerv,N
2968,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2968,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2968,5,Respiratory tract oedema,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
2968,6,Sinus congestion,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2968,7,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2968,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2968,9,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2969,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2970,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2970,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2970,3,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
2970,4,Headache,Headaches NEC,Headaches,Nerv,N
2970,5,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2971,1,Airway peak pressure increased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
2971,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2971,3,Blood bicarbonate decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2971,4,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2971,5,Blood pH decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2971,6,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2971,7,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2971,8,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2971,9,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2971,10,Hypercapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
2971,11,Lung hyperinflation,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2971,12,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2971,13,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2971,14,PCO2 increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2971,15,PO2 decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2971,16,Respiratory acidosis,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
2971,17,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2971,18,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2972,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2973,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2974,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2974,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2975,1,Autoimmune disorder,Autoimmune disorders NEC,Autoimmune disorders,Immun,Y
2975,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2975,3,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2975,4,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2975,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2975,6,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2975,7,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
2975,8,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
2975,9,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
2975,10,Mucosal erosion,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2975,11,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2975,12,Pseudomonal sepsis,Pseudomonal infections,Bacterial infectious disorders,Infec,N
2975,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2975,14,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2975,15,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2975,16,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2975,17,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2975,18,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
2975,19,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2976,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2977,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2978,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2979,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2980,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2980,2,Influenza B virus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2980,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2980,4,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2980,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2980,6,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2980,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2980,8,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2980,9,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2981,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2982,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2983,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2984,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2985,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2986,1,Aortic thrombosis,Aortic embolism and thrombosis,Embolism and thrombosis,Vasc,N
2987,1,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
2988,1,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
2989,1,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2989,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2990,1,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
2990,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2990,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2990,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2990,5,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2990,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2990,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2991,1,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
2992,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2992,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2992,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2993,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2993,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2994,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2995,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2995,2,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2996,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2997,1,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2997,2,Osteochondrosis,Cartilage disorders,"Tendon, ligament and cartilage disorders",Musc,N
2998,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
2999,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2999,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3000,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3000,2,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
3000,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3000,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3001,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
3002,1,Multiple fractures,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
3003,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
3003,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3003,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
3003,4,Faeces pale,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
3003,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3003,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3003,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3003,8,Tension headache,Headaches NEC,Headaches,Nerv,N
3003,9,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3004,1,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
3004,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3004,3,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
3004,4,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
3005,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
3005,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3005,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
3006,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3007,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3008,1,Cow pox,Orthopox viral infections,Viral infectious disorders,Infec,N
3008,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3008,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
3009,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
3009,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
3009,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3010,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3010,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3010,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
3010,4,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3010,5,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3011,1,Diabetic hyperglycaemic coma,Coma states,Neurological disorders NEC,Nerv,N
3012,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3012,2,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3012,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3013,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3014,1,Scedosporium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
3015,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3015,2,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
3016,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3016,2,Headache,Headaches NEC,Headaches,Nerv,N
3016,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3016,4,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3016,5,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
3017,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
3017,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3018,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
3019,1,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3020,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3020,2,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3020,3,Food interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3020,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3020,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3020,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3021,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3021,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3021,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
3021,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3021,5,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3022,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3022,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3023,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
3023,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3023,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3023,4,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
3023,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3024,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3025,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3026,1,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3026,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3026,3,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
3027,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3028,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3028,2,Mantle cell lymphoma recurrent,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
3028,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3028,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3029,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3030,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3030,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3031,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3032,1,Cluster headache,Headaches NEC,Headaches,Nerv,N
3032,2,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3033,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3033,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3034,1,Myopathy,Myopathies,Muscle disorders,Musc,N
3034,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
3035,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
3035,2,Breast fibrosis,Breast disorders NEC,Breast disorders,Repro,N
3035,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3035,4,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3036,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
3036,2,Pseudopolyp,Inflammations,General system disorders NEC,Genrl,N
3036,3,Renal transplant,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
3037,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
3037,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
3037,3,Lateral medullary syndrome,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3038,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
3038,2,Acanthosis,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
3038,3,Biopsy skin abnormal,Skin histopathology and skin investigations NEC,Skin investigations,Inv,N
3038,4,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
3038,5,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
3038,6,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
3038,7,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
3039,1,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
3040,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3040,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
3040,3,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
3041,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3041,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3041,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3041,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
3041,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3041,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3041,7,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3041,8,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3041,9,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3042,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3042,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3043,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3043,2,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3043,3,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3043,4,Hostility,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3043,5,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3043,6,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3043,7,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
3044,1,Biopsy kidney abnormal,Urinary tract histopathology procedures,Renal and urinary tract investigations and urinalyses,Inv,N
3044,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3044,3,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
3044,4,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
3044,5,Herpes simplex reactivation,Herpes viral infections,Viral infectious disorders,Infec,N
3044,6,Herpes simplex test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
3044,7,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3044,8,Mucocutaneous haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
3044,9,Pyelonephritis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3044,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3044,11,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
3044,12,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
3045,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
3045,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
3046,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
3046,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
3047,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3048,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3048,2,Mantle cell lymphoma recurrent,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
3048,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3048,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3048,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3049,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3049,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3049,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3049,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3050,1,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
3051,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3052,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3053,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3054,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3054,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3054,3,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
3054,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3054,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3054,6,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
3054,7,Hypervigilance,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
3054,8,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
3054,9,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
3054,10,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3054,11,Suspiciousness,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3055,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3056,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3056,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3056,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3057,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3057,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3057,3,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3058,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3059,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3060,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3060,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3060,3,Cystitis interstitial,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
3061,1,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
3061,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3061,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3061,4,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
3061,5,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
3061,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3061,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3062,1,Cryptococcosis,Cryptococcal infections,Fungal infectious disorders,Infec,N
3063,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
3063,2,Groin abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
3063,3,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
3063,4,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
3064,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3064,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3064,3,Headache,Headaches NEC,Headaches,Nerv,N
3064,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3064,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3064,6,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3064,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3065,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3066,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3067,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3067,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
3067,3,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
3067,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3068,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3069,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3069,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
3070,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3070,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
3071,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3071,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3071,3,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
3071,4,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
3072,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3073,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3074,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3074,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3075,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3076,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3076,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3076,3,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
3076,4,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
3076,5,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
3076,6,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
3076,7,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3076,8,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3076,9,Lower gastrointestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3076,10,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3076,11,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,N
3076,12,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
3076,13,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
3076,14,Protein total decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
3076,15,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3076,16,Red cell distribution width increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3077,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
3078,1,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3079,1,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3079,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
3080,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3081,1,Mycetoma mycotic,Fungal infections NEC,Fungal infectious disorders,Infec,N
3082,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3082,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3082,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3082,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
3082,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3082,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3082,7,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3083,1,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
3083,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3083,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3084,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
3085,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
3085,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
3085,3,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3085,4,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
3085,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
3086,1,Exaggerated startle response,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3086,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3086,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3087,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3087,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3087,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3088,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3088,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3088,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3089,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
3090,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
3091,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3092,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3093,1,Azotaemia,Renal failure complications,Renal disorders (excl nephropathies),Renal,N
3093,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
3093,3,Blood phosphorus increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
3093,4,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
3093,5,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
3093,6,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
3093,7,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
3093,8,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3093,9,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3093,10,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
3094,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3094,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3095,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3095,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3096,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
3096,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3096,3,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3096,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3096,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3096,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3096,7,Scedosporium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
3096,8,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
3096,9,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3097,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3097,2,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
3097,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3097,4,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
3097,5,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
3097,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3097,7,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3097,8,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3097,9,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
3098,1,Brain hypoxia,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
3098,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
3098,3,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
3098,4,Evans syndrome,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
3098,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3098,6,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
3098,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3098,8,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
3098,9,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3098,10,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3099,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3099,2,Incorrect product formulation administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3099,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3100,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3100,2,Escherichia bacteraemia,Escherichia infections,Bacterial infectious disorders,Infec,N
3100,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
3101,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
3101,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
3101,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3102,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3102,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3102,3,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
3102,4,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3103,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3104,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3105,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
3106,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3107,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3107,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3108,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3109,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3109,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
3109,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3109,4,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
3109,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3109,6,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
3109,7,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
3110,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
3110,2,Neutrophilic dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3110,3,Panniculitis,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
3111,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3111,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3111,3,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
3111,4,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3112,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3112,2,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
3113,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3113,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3113,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3113,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3113,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3114,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3115,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3116,1,Exposure via body fluid,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
3116,2,Pregnancy on contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
3117,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3117,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3118,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3119,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3120,1,Administration site discomfort,Administration site reactions NEC,Administration site reactions,Genrl,N
3120,2,Administration site hypersensitivity,Administration site reactions NEC,Administration site reactions,Genrl,N
3120,3,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
3120,4,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3120,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3121,1,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3121,2,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
3122,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3123,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3123,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3123,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3123,4,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
3123,5,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
3123,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3124,1,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,Y
3124,2,Hepatitis B e antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
3124,3,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,N
3124,4,Hepatitis B surface antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
3124,5,Liver function test decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3124,6,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3125,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3125,2,Headache,Headaches NEC,Headaches,Nerv,N
3125,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3126,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
3126,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3126,3,Hostility,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3126,4,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3126,5,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3126,6,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3127,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3127,2,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
3128,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3129,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3130,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3131,1,Cerebral atrophy,Structural brain disorders NEC,Structural brain disorders,Nerv,N
3132,1,Cerebral atrophy,Structural brain disorders NEC,Structural brain disorders,Nerv,N
3133,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3133,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3134,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3134,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3134,3,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
3135,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3135,2,Cytomegalovirus duodenitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3135,3,Duodenal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
3135,4,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
3135,5,Helicobacter gastritis,Helicobacter infections,Bacterial infectious disorders,Infec,N
3135,6,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
3136,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3136,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3136,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
3137,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3138,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3139,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3139,2,Aura,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3139,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3139,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3139,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3139,6,Migraine,Migraine headaches,Headaches,Nerv,N
3139,7,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3139,8,Myalgia,Muscle pains,Muscle disorders,Musc,N
3139,9,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
3139,10,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
3139,11,Vitamin D deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
3140,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
3141,1,Computerised tomogram abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
3141,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3141,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3141,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3141,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3141,6,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3141,7,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
3141,8,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3142,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3143,1,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
3143,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3143,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3143,4,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3143,5,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
3144,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
3144,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
3144,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3145,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3145,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3145,3,Hunger,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3145,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3146,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3146,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
3146,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3147,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3147,2,Death,Death and sudden death,Fatal outcomes,Genrl,N
3148,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3148,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3149,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3149,2,Behcet's syndrome,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
3149,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
3149,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3149,5,Enteritis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
3149,6,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
3149,7,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3149,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3149,9,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3149,10,Small intestine ulcer,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
3150,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3150,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3150,3,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3151,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3152,1,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
3152,2,Pelvic deformity,Trunk deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
3152,3,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
3153,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
3153,2,Ocular hypertension,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
3154,1,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3155,1,Blood osmolarity decreased,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
3155,2,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
3155,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3155,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
3155,5,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
3156,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
3156,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3156,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
3156,4,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
3156,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3157,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3158,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3158,2,Anal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
3158,3,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3158,4,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3158,5,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3158,6,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
3158,7,Functional gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
3158,8,Genital ulceration,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
3158,9,Impetigo,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
3158,10,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
3158,11,Morganella infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3158,12,Nail discolouration,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
3158,13,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
3158,14,Tinea pedis,Tinea infections,Fungal infectious disorders,Infec,N
3159,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3159,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3160,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3160,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3160,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3160,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3160,5,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3160,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3160,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3160,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3161,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3161,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3162,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
3162,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
3163,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3163,2,Scedosporium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
3164,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
3164,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3164,3,Nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
3165,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3166,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
3166,2,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
3166,3,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
3167,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
3168,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
3169,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3170,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3170,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3170,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
3170,4,Myopathy,Myopathies,Muscle disorders,Musc,N
3170,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3170,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3171,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
3171,2,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3171,3,Urine output increased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
3172,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3172,2,Headache,Headaches NEC,Headaches,Nerv,N
3172,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3172,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3173,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
3173,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3173,3,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3173,4,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3173,5,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3173,6,Stress fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
3173,7,Tibia fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3174,1,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
3174,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3174,3,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3175,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
3176,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3177,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
3177,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3178,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3179,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3180,1,Tooth erosion,Dental disorders NEC,Dental and gingival conditions,Gastr,N
3181,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3181,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3181,3,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3181,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3182,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
3183,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
3184,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
3184,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3184,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3185,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3185,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3186,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3186,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3186,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3186,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3186,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3187,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
3187,2,Mastication disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3187,3,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
3188,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3188,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
3188,3,Headache,Headaches NEC,Headaches,Nerv,N
3188,4,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
3188,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3189,1,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
3189,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3189,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
3190,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
3190,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3191,1,Biliary tract disorder,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
3191,2,Pelvic fracture,Pelvic fractures and dislocations,Bone and joint injuries,Inj&P,N
3191,3,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
3192,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3192,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3192,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
3192,4,Chronic graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
3192,5,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
3192,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3192,7,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
3192,8,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3192,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3192,10,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3192,11,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
3192,12,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
3193,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3193,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3193,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3194,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3194,2,Headache,Headaches NEC,Headaches,Nerv,N
3194,3,Headache,Headaches NEC,Headaches,Nerv,N
3194,4,Headache,Headaches NEC,Headaches,Nerv,N
3194,5,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3194,6,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3194,7,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3195,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
3195,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3195,3,Parainfluenzae virus infection,Parainfluenzae viral infections,Viral infectious disorders,Infec,N
3195,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3195,5,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
3196,1,Antineutrophil cytoplasmic antibody increased,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
3196,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3196,3,Lacrimal haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
3197,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3198,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3199,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
3199,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3199,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3200,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3200,2,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3201,1,Dermatillomania,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
3201,2,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3201,3,Soliloquy,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3202,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
3202,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
3202,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
3203,1,Chest expansion decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3203,2,Forced expiratory volume decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
3203,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3203,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3204,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3205,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3205,2,Documented hypersensitivity to administered product,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3205,3,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
3205,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3206,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3206,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3207,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
3208,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3208,2,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3209,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3209,2,Glomerulonephritis membranous,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
3209,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3210,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3210,2,Glomerulonephritis membranous,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
3210,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3210,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3211,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
3211,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3211,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3211,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
3211,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3211,6,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
3212,1,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3212,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3213,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3213,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
3213,3,Infective exacerbation of chronic obstructive airways disease,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3214,1,Catatonia,Decreased physical activity levels,Changes in physical activity,Psych,N
3214,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3215,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3215,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3215,3,Infective aneurysm,Vascular infections,Infections - pathogen unspecified,Infec,N
3215,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3215,5,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3215,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3215,7,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
3215,8,Vascular pseudoaneurysm,Cardiac and vascular procedural complications,Procedural related injuries and complications NEC,Inj&P,N
3216,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
3216,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
3216,3,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3216,4,Headache,Headaches NEC,Headaches,Nerv,N
3217,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
3217,2,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
3217,3,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
3217,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3217,5,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
3218,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3218,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
3218,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3218,4,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
3219,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
3220,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3220,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3220,3,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
3220,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3220,5,Nocardia sepsis,Nocardia infections,Bacterial infectious disorders,Infec,N
3220,6,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
3221,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3222,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3222,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3222,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3223,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3223,2,Headache,Headaches NEC,Headaches,Nerv,N
3224,1,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
3224,2,Stress fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
3225,1,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
3225,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3226,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
3226,2,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
3227,1,Product after taste,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3228,1,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
3228,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3228,3,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3229,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3229,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3229,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3230,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
3230,2,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
3230,3,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
3230,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3230,5,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
3230,6,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
3230,7,Primary adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
3231,1,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3232,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3232,2,Peptic ulcer perforation,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
3233,1,"Brief psychotic disorder, with postpartum onset",Brief psychotic disorder,Schizophrenia and other psychotic disorders,Psych,N
3233,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3234,1,"Brief psychotic disorder, with postpartum onset",Brief psychotic disorder,Schizophrenia and other psychotic disorders,Psych,N
3235,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3235,2,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3235,3,Enterococcal sepsis,Enterococcal infections,Bacterial infectious disorders,Infec,N
3235,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
3235,5,Helicobacter infection,Helicobacter infections,Bacterial infectious disorders,Infec,N
3235,6,Histoplasmosis,Histoplasma infections,Fungal infectious disorders,Infec,N
3235,7,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3236,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3236,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3236,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3236,4,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
3237,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3238,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3238,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
3238,3,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
3238,4,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3238,5,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3239,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
3240,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
3240,2,Viral rash,Viral infections NEC,Viral infectious disorders,Infec,N
3241,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3241,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3241,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3241,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3241,5,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
3241,6,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3241,7,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3241,8,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3241,9,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
3241,10,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3241,11,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3241,12,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
3241,13,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3241,14,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3241,15,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3242,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3242,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3242,3,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
3242,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
3242,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
3243,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3243,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
3243,3,Infective exacerbation of chronic obstructive airways disease,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3244,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3244,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3244,3,Histoplasmosis,Histoplasma infections,Fungal infectious disorders,Infec,N
3244,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
3245,1,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3245,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
3246,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3246,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3246,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3247,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3247,2,Intercepted product selection error,Product selection errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3247,3,Product packaging confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3247,4,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
3248,1,Acne,Acnes,Skin appendage conditions,Skin,N
3248,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3248,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3248,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3249,1,Ecthyma,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,Y
3249,2,Pseudomonal sepsis,Pseudomonal infections,Bacterial infectious disorders,Infec,N
3249,3,Psoas abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
3250,1,Perioral dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3251,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3251,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
3252,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
3252,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3252,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3252,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
3252,5,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
3252,6,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
3252,7,Patent ductus arteriosus,Persistent foetal circulation disorders,Cardiac and vascular disorders congenital,Cong,N
3252,8,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
3252,9,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
3253,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3253,2,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
3253,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3254,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
3254,2,Gastrointestinal necrosis,Gastrointestinal necrosis and gangrene (excl gangrenous hernia),Gastrointestinal vascular conditions,Gastr,N
3255,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
3256,1,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
3257,1,Chronic hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
3257,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3257,3,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
3257,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
3258,1,Ecthyma,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
3258,2,Psoas abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
3258,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
3259,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3260,1,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
3260,2,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
3260,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3260,4,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
3261,1,Chronic hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
3261,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3261,3,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
3261,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
3262,1,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
3263,1,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
3264,1,Cryptococcal cutaneous infection,Cryptococcal infections,Fungal infectious disorders,Infec,N
3264,2,Cryptococcosis,Cryptococcal infections,Fungal infectious disorders,Infec,N
3265,1,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
3266,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
3266,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3267,1,Thoracic vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
3267,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3268,1,Chronic graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
3268,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3268,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3268,4,Graft versus host disease in eye,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
3269,1,Chronic hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
3269,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3269,3,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
3269,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
3269,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3270,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
3270,2,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
3271,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3271,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3272,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3273,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
3273,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3273,3,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
3273,4,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
3274,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3274,2,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
3275,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
3275,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3276,1,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
3276,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
3276,3,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
3276,4,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
3277,1,Basilar artery occlusion,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3277,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3277,3,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
3277,4,Infarction,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
3278,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3279,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
3279,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
3279,3,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
3279,4,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
3279,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3280,1,Cryptococcal cutaneous infection,Cryptococcal infections,Fungal infectious disorders,Infec,N
3281,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
3281,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
3281,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
3282,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
3283,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3284,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3284,2,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
3285,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3286,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
3286,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3286,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3286,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3286,5,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3286,6,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3286,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3287,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3287,2,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
3288,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3288,2,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
3289,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3290,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3291,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
3292,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3293,1,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
3294,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3294,2,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3295,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3295,2,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3295,3,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
3295,4,Impulsive behaviour,Impulse control disorders,Impulse control disorders NEC,Psych,N
3295,5,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3296,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3296,2,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
3296,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3297,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
3298,1,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3299,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3299,2,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
3299,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3299,4,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
3300,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3301,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3301,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3302,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3303,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3303,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3303,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3304,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3304,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3304,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
3304,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3304,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3304,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3305,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3306,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3306,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3306,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
3306,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3306,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3306,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3307,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3307,2,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
3308,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3308,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3308,3,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3308,4,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
3308,5,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3308,6,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3308,7,Catatonia,Decreased physical activity levels,Changes in physical activity,Psych,N
3308,8,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3308,9,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
3308,10,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3308,11,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3308,12,Delirium,Deliria,Deliria (incl confusion),Psych,N
3308,13,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3308,14,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
3308,15,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
3308,16,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3308,17,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
3308,18,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3308,19,Headache,Headaches NEC,Headaches,Nerv,N
3308,20,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3308,21,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3308,22,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3308,23,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3308,24,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3308,25,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3308,26,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3308,27,Urine odour abnormal,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
3309,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3309,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3309,3,Mycobacterium kansasii infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
3309,4,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
3309,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3309,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3309,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3309,8,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
3309,9,Tenosynovitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
3309,10,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3310,1,Mucous membrane pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
3310,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3311,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3311,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
3311,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3311,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3312,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3312,2,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3312,3,Hypervigilance,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
3312,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3313,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3313,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3313,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3313,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3313,5,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
3313,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3313,7,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3314,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
3314,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3315,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3315,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3315,3,Labelled drug-drug interaction issue,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3315,4,Oligohydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
3316,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3316,2,Foetal methotrexate syndrome,Chemically-induced congenital syndromes,Congenital and hereditary disorders NEC,Cong,N
3317,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
3318,1,Cryptococcosis,Cryptococcal infections,Fungal infectious disorders,Infec,N
3318,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3318,3,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
3319,1,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
3320,1,Adactyly,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
3320,2,Congenital musculoskeletal disorder of skull,Musculoskeletal and connective tissue disorders of skull congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
3320,3,Craniosynostosis,Musculoskeletal and connective tissue disorders of skull congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
3320,4,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3320,5,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
3320,6,Foetal methotrexate syndrome,Chemically-induced congenital syndromes,Congenital and hereditary disorders NEC,Cong,N
3320,7,Oligohydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
3320,8,Synostosis,Musculoskeletal and connective tissue disorders of trunk congenital (excl spine),Musculoskeletal and connective tissue disorders congenital,Cong,N
3321,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
3321,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
3322,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
3322,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3323,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3323,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3323,3,Dissociation,Dissociative states,Dissociative disorders,Psych,N
3323,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3323,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3323,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3323,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3323,8,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3323,9,Hyperacusis,Hyperacusia,Hearing disorders,Ear,N
3323,10,Hypervigilance,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
3323,11,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3323,12,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
3323,13,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3323,14,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3324,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3324,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3324,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
3324,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3324,5,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3325,1,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
3326,1,Epstein Barr virus positive mucocutaneous ulcer,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
3326,2,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3327,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3327,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3327,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
3327,4,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
3327,5,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
3327,6,Pseudo Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
3327,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3327,8,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3328,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3329,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3330,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3331,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
3332,1,Epstein Barr virus positive mucocutaneous ulcer,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
3333,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
3333,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
3333,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3333,4,Pneumonia legionella,Legionella infections,Bacterial infectious disorders,Infec,N
3333,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3334,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
3334,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
3334,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3334,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
3335,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3335,2,Labelled drug-drug interaction issue,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3335,3,Oligohydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
3336,1,Connective tissue disorder,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
3336,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3336,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
3336,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3337,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3337,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
3338,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3338,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3339,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
3339,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3339,3,Mucosal haemorrhage,Mucosal findings abnormal,General system disorders NEC,Genrl,N
3339,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
3339,5,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
3339,6,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3340,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
3341,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3341,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3341,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3342,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3342,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
3342,3,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
3342,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3342,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3342,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3342,7,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
3343,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3344,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3345,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
3345,2,Headache,Headaches NEC,Headaches,Nerv,N
3345,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3346,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3346,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
3347,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3348,1,Ocular hypertension,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
3349,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
3349,2,Cryptococcosis,Cryptococcal infections,Fungal infectious disorders,Infec,N
3349,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3349,4,Delayed graft function,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
3349,5,Diabetic retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
3349,6,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
3349,7,Headache,Headaches NEC,Headaches,Nerv,N
3349,8,Optic discs blurred,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
3349,9,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
3349,10,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3349,11,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
3350,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3351,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
3351,2,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
3351,3,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
3351,4,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
3351,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3351,6,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
3351,7,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
3351,8,Myopathy,Myopathies,Muscle disorders,Musc,N
3351,9,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3352,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3352,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3352,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3352,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3352,5,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3352,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3352,7,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
3353,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
3353,2,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
3353,3,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
3353,4,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
3353,5,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3353,6,Encephalitis autoimmune,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
3353,7,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3353,8,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3353,9,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
3353,10,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3353,11,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3353,12,Radiculopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
3354,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3354,2,Headache,Headaches NEC,Headaches,Nerv,N
3354,3,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3355,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3355,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3355,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3356,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3356,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3356,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
3356,4,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3356,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
3356,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
3356,7,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3356,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3357,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
3357,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3358,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
3358,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
3358,3,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3358,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
3358,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3359,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
3360,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
3360,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
3360,3,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
3361,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3361,2,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3361,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
3361,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3361,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3361,6,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3361,7,Headache,Headaches NEC,Headaches,Nerv,N
3361,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3361,9,Oral blood blister,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
3361,10,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
3361,11,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
3361,12,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
3361,13,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3362,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3362,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3362,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3362,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3363,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3363,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3363,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
3363,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3364,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3365,1,Myopathy,Myopathies,Muscle disorders,Musc,N
3366,1,Cutaneous T-cell lymphoma recurrent,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
3367,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3367,2,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3368,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3368,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
3368,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3369,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3369,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3369,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3369,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3369,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3369,6,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3369,7,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
3369,8,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
3369,9,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3369,10,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3369,11,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3369,12,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3369,13,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3369,14,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
3370,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3371,1,Fibrosarcoma,Fibrosarcomas malignant,Soft tissue neoplasms malignant and unspecified,Neopl,N
3372,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3373,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
3373,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
3374,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3375,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3376,1,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
3376,2,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
3377,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3377,2,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3377,3,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
3377,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3377,5,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3378,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3378,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3379,1,Alternaria infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
3379,2,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
3379,3,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
3379,4,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
3380,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
3380,2,Eye infection staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
3381,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3382,1,Abscess bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3382,2,Ecthyma,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
3382,3,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
3382,4,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
3383,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
3384,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
3385,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
3386,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
3386,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
3386,3,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
3386,4,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
3386,5,Scopulariopsis infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
3386,6,Trichophytic granuloma,Tinea infections,Fungal infectious disorders,Infec,N
3386,7,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
3387,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3388,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3388,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3389,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3389,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3389,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3389,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3390,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
3390,2,Cavernous sinus thrombosis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
3390,3,Central nervous system vasculitis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
3390,4,Cerebellar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3390,5,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
3390,6,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
3390,7,Rhinocerebral mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,Y
3390,8,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3390,9,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3391,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3391,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3391,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
3391,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3391,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
3392,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3392,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3392,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3392,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3393,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3393,2,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3394,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3395,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
3395,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3395,3,Bulbar palsy,Mixed cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
3395,4,Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
3395,5,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3395,6,Epstein-Barr virus associated lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
3395,7,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
3395,8,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3395,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3395,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3395,11,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3396,1,Catarrh,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3396,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3396,3,Increased viscosity of upper respiratory secretion,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3396,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3397,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3398,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
3398,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3398,3,Nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
3398,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3399,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3399,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3400,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
3401,1,Rectal cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
3402,1,Chronic hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
3402,2,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
3403,1,Lumbar vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
3403,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
3403,3,Osteoporotic fracture,Fractures NEC,Fractures,Musc,N
3404,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
3405,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3405,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3405,3,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
3405,4,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
3405,5,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
3405,6,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
3405,7,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
3405,8,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
3406,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3407,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
3407,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
3407,3,Ventricular hypokinesia,Myocardial disorders NEC,Myocardial disorders,Card,N
3408,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3408,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3408,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3409,1,Starvation,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3410,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3410,2,High-grade B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
3410,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
3410,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
3410,5,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3410,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
3410,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
3410,8,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3411,1,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
3411,2,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3411,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3412,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3412,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
3412,3,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3413,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3413,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3413,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3413,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3413,5,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3413,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3413,7,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
3413,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3413,9,Headache,Headaches NEC,Headaches,Nerv,N
3414,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
3415,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
3415,2,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
3415,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
3415,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3416,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
3417,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3417,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3417,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3418,1,Angle closure glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
3419,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3419,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3419,3,Paranasal sinus discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3419,4,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3420,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
3420,2,Oesophageal disorder,Oesophageal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
3420,3,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
3420,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3420,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3421,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3421,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3421,3,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
3421,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
3421,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3422,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3422,2,Abdominal rigidity,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3422,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3422,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3422,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3422,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3422,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3422,8,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3423,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
3423,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
3424,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3424,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3425,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3425,2,Wrong patient received product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3426,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3426,2,Poor sucking reflex,Abnormal reflexes,Neurological disorders NEC,Nerv,N
3427,1,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3427,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3428,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
3429,1,Glioblastoma multiforme,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
3429,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
3429,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3430,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3430,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
3430,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3430,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3430,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
3430,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3431,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3431,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3431,3,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3432,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
3432,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3432,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3433,1,Disorganised speech,Speech and language usage disturbances,Communication disorders and disturbances,Psych,N
3433,2,Headache,Headaches NEC,Headaches,Nerv,N
3433,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3433,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3433,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3434,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
3434,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3434,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3435,1,Lumbar vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
3435,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
3436,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3436,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
3436,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3436,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
3437,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3437,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
3438,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3438,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3438,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3438,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3438,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3438,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3439,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3439,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3439,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3439,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3439,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
3439,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3440,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
3441,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
3442,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3442,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
3443,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3443,2,Headache,Headaches NEC,Headaches,Nerv,N
3443,3,Vertigo positional,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3443,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3444,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3444,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3444,3,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3445,1,Headache,Headaches NEC,Headaches,Nerv,N
3446,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3446,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3446,3,Choking sensation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3446,4,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3446,5,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3446,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3446,7,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3446,8,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3446,9,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3446,10,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3447,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3448,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
3448,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3448,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3448,4,Regurgitation,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3448,5,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
3448,6,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3449,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
3450,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
3450,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3450,3,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3450,4,Headache,Headaches NEC,Headaches,Nerv,N
3450,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
3450,6,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
3450,7,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3451,1,Deafness,Hearing losses,Hearing disorders,Ear,N
3451,2,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3451,3,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3452,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3452,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3452,3,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
3452,4,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
3452,5,Tachyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
3453,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
3454,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
3454,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3455,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
3456,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
3457,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3457,2,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3458,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3458,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3458,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3458,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3458,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3459,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3460,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
3460,2,Airway peak pressure increased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
3460,3,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3460,4,Asthmatic crisis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3460,5,Blood bicarbonate decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
3460,6,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
3460,7,Blood pH decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
3460,8,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3460,9,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3460,10,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3460,11,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3460,12,Hypercapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
3460,13,Lung hyperinflation,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3460,14,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3460,15,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
3460,16,PCO2 increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
3460,17,PO2 decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
3460,18,Respiratory acidosis,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
3460,19,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3460,20,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3461,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
3462,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3463,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
3463,2,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3463,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3464,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3464,2,Arteriovenous fistula,Vascular malformations and acquired anomalies,Vascular disorders NEC,Vasc,N
3464,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
3464,4,Cavernous sinus thrombosis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
3464,5,Cerebellar artery occlusion,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3464,6,Cerebellar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3464,7,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
3464,8,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
3464,9,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
3464,10,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
3464,11,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
3464,12,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
3464,13,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
3464,14,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
3464,15,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
3464,16,Periorbital cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3464,17,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
3464,18,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3464,19,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
3464,20,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3464,21,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
3465,1,Infection in an immunocompromised host,Infections NEC,Infections - pathogen unspecified,Infec,N
3465,2,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
3466,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3467,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3467,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3467,3,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
3467,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3467,5,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3467,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3467,7,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
3468,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3468,2,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
3468,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3469,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3469,2,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
3469,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
3470,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3471,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
3472,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3472,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
3472,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
3473,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3473,2,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
3473,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3473,4,Renal and pancreas transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
3474,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3474,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3474,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3474,4,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
3474,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3475,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
3475,2,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3476,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3476,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3476,3,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3477,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
3478,1,Cerebral fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
3478,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
3478,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3478,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
3478,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3478,6,Fungaemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
3478,7,Fungal endocarditis,Fungal infections NEC,Fungal infectious disorders,Infec,N
3478,8,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
3478,9,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
3478,10,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
3478,11,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3478,12,Intracardiac mass,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3478,13,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
3478,14,Noninfective encephalitis,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
3478,15,Oral fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
3478,16,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3478,17,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3478,18,Pulmonary cavitation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3478,19,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3478,20,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3479,1,Diabetic coma,Coma states,Neurological disorders NEC,Nerv,N
3480,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
3481,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
3482,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3482,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3482,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3483,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3483,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3483,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3484,1,Anal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3485,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3486,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3486,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3486,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3487,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
3487,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
3487,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3488,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3488,2,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
3488,3,HELLP syndrome,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
3488,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3489,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3490,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3490,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3490,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3490,4,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3491,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3491,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3492,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
3493,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3493,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3494,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3495,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
3496,1,Gastroenteritis salmonella,Salmonella infections,Bacterial infectious disorders,Infec,N
3496,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3497,1,Essential tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3498,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3499,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
3499,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3499,3,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3499,4,Cerebral aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
3499,5,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3499,6,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
3499,7,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
3499,8,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
3499,9,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
3499,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3499,11,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3499,12,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3500,1,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
3500,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3501,1,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
3501,2,Stenotrophomonas infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3502,1,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
3502,2,Stenotrophomonas infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3503,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
3503,2,Oral pustule,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
3503,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3503,4,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3504,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
3504,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3505,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3506,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3506,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3506,3,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
3507,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3507,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3507,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3508,1,Cataract subcapsular,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
3509,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
3510,1,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
3510,2,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3511,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3511,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3512,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3513,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3514,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3514,2,Myopathy,Myopathies,Muscle disorders,Musc,N
3514,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
3515,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
3515,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3515,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3515,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3516,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3516,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3516,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3516,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3516,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3516,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3516,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3516,8,Scleroderma renal crisis,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3516,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3517,1,Behcet's syndrome,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
3517,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3517,3,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
3517,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3517,5,Septic vasculitis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3517,6,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
3517,7,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
3518,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3518,2,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
3518,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3519,1,High-grade B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
3519,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
3519,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
3519,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3519,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
3519,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
3519,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3520,1,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
3520,2,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3521,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3521,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3521,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3521,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3522,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3522,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3523,1,Pyomyositis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3524,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3524,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
3524,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
3524,4,Thrombotic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3524,5,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
3525,1,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3526,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3526,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3527,1,Infective myositis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
3527,2,Muscle swelling,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3527,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3527,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
3527,5,Myopathy,Myopathies,Muscle disorders,Musc,N
3527,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3527,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3527,8,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
3527,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3528,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3528,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3528,3,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
3528,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3529,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
3529,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3529,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
3529,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3530,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3530,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3530,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3530,4,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
3530,5,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3531,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3532,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
3532,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3532,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3532,4,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
3532,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3532,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3532,7,Still's disease,Rheumatoid arthropathies,Joint disorders,Musc,N
3533,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
3533,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
3533,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3533,4,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3533,5,Varicella zoster pneumonia,Herpes viral infections,Viral infectious disorders,Infec,N
3533,6,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
3534,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3534,2,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
3534,3,Breath odour,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3534,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3534,5,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3534,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3534,7,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3534,8,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3534,9,Nipple swelling,Breast signs and symptoms,Breast disorders,Repro,N
3534,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3534,11,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3534,12,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3534,13,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3534,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3535,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3536,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
3536,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
3536,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3537,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
3537,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3537,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3537,4,Cardiogenic shock,Heart failures NEC,Heart failures,Card,Y
3538,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
3538,2,Pneumonia viral,Viral infections NEC,Viral infectious disorders,Infec,N
3538,3,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
3539,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
3540,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3540,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3540,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3540,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
3540,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3540,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3540,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3541,1,Pyomyositis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3541,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
3542,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3543,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3543,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
3543,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
3543,4,Thrombotic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3543,5,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
3544,1,Symptom masked,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3545,1,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
3545,2,Vitamin D deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
3546,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3546,2,Cutaneous T-cell lymphoma stage IV,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,Y
3546,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3546,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
3546,5,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
3546,6,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3546,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3546,8,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3546,9,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
3546,10,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3546,11,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
3546,12,Unmasking of previously unidentified disease,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3547,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3547,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3547,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3547,4,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3548,1,Cleft lip and palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
3548,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3549,1,Headache,Headaches NEC,Headaches,Nerv,N
3550,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3550,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3551,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3551,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3551,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3551,4,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3551,5,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
3551,6,Logorrhoea,Speech and language usage disturbances,Communication disorders and disturbances,Psych,N
3551,7,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3551,8,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3551,9,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
3551,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3551,11,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
3551,12,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3551,13,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3552,1,Asthenopia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
3552,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
3552,3,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
3553,1,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
3554,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
3555,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3556,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
3557,1,Endocarditis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3557,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3558,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
3558,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3558,3,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
3558,4,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
3558,5,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3558,6,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3558,7,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3558,8,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3558,9,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3558,10,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
3558,11,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
3558,12,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
3558,13,Spinal disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
3558,14,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
3559,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3559,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3559,3,Headache,Headaches NEC,Headaches,Nerv,N
3559,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3559,5,Tunnel vision,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
3560,1,Scleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
3561,1,Genotoxicity,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3562,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3563,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3563,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3563,3,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3563,4,Headache,Headaches NEC,Headaches,Nerv,N
3563,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3563,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
3563,7,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
3563,8,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
3563,9,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3563,10,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3564,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3565,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3566,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3567,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3568,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3568,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
3568,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
3569,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3569,2,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3569,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3569,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3569,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
3569,6,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
3570,1,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
3570,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
3570,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3570,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
3571,1,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
3571,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3571,3,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
3572,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3572,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
3573,1,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
3574,1,Nephrostomy,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
3575,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3575,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3576,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3577,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3577,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3577,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3577,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3577,5,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3577,6,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
3577,7,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3577,8,Eyelid function disorder,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
3577,9,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3577,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3577,11,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3577,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3577,13,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
3578,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3578,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3579,1,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
3580,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
3580,2,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,Y
3581,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3582,1,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3582,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3583,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3583,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3583,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3583,4,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3583,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3583,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3583,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3583,8,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3584,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3584,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3584,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3584,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3585,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3586,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
3587,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3587,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
3587,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3587,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3587,5,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3587,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3587,7,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
3587,8,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3587,9,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
3587,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3588,1,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3589,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3589,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3589,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3589,4,Headache,Headaches NEC,Headaches,Nerv,N
3589,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3589,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3589,7,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
3589,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3589,9,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3590,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3590,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
3590,3,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
3590,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
3591,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
3592,1,Hyperaesthesia teeth,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
3593,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3593,2,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
3594,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3595,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
3596,1,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
3596,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
3597,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
3597,2,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
3598,1,Epstein-Barr virus associated lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
3599,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
3600,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3600,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3600,3,Starvation ketoacidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
3601,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3601,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3601,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3601,4,Headache,Headaches NEC,Headaches,Nerv,N
3601,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3602,1,Hypogeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3602,2,Hyposmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
3603,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3603,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3603,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3603,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3603,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3603,6,Near death experience,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
3603,7,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3603,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3604,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3605,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3605,2,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
3606,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3606,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3606,3,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
3606,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
3606,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3606,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3606,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3606,8,Pharyngeal ulceration,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
3607,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3607,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3608,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3608,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3608,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
3609,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3609,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3609,3,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
3609,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3609,5,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
3609,6,Starvation ketoacidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
3610,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3610,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3611,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
3612,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3612,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3612,3,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3612,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3612,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3612,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
3612,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3612,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3613,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3613,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3613,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
3613,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3614,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3614,2,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3614,3,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
3615,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3615,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3615,3,Starvation ketoacidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
3616,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3616,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3616,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
3616,4,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3616,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3616,6,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3616,7,Flat affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
3616,8,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
3616,9,Headache,Headaches NEC,Headaches,Nerv,N
3616,10,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3616,11,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3616,12,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3616,13,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3616,14,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3616,15,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3616,16,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3616,17,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3616,18,Slow response to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3616,19,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3617,1,Ocular hypertension,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
3618,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3618,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3618,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3618,4,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,Y
3618,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3619,1,Gastric perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
3620,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3620,2,Ocular hypertension,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
3620,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3621,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3622,1,Papillary renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
3622,2,Tumour invasion,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3623,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3624,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3625,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3626,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3627,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3628,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
3629,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3630,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3631,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3631,2,Pulmonary function test abnormal,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,Y
3631,3,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
3632,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
3632,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3633,1,Antiphospholipid syndrome,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
3633,2,Aortic occlusion,Aortic necrosis and vascular insufficiency,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
3633,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3633,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3633,5,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
3634,1,Granulomatous dermatitis,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
3634,2,Molluscum contagiosum,Molluscum contagiosum viral infections,Viral infectious disorders,Infec,N
3634,3,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3634,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3634,5,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
3634,6,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3634,7,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
3635,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3635,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3635,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
3635,4,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
3635,5,Insulin resistance,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3635,6,Pancreatic disorder,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
3636,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3636,2,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3637,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3637,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3638,1,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
3639,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3639,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3640,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3640,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3640,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
3640,4,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
3641,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3641,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3641,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3641,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3641,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
3641,6,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3641,7,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3642,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3642,2,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
3642,3,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
3643,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3643,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3643,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3644,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3644,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3645,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3646,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3647,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
3648,1,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3648,2,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
3648,3,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
3648,4,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
3649,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
3649,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3649,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
3650,1,Human polyomavirus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
3650,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
3650,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3650,4,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
3651,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
3652,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3652,2,Cerebral toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
3652,3,Hemianopia homonymous,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
3652,4,Quadrantanopia,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
3652,5,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
3653,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
3654,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3655,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
3655,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3655,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
3655,4,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
3655,5,Myopathy,Myopathies,Muscle disorders,Musc,N
3655,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
3655,7,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
3656,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
3656,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3656,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3657,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
3657,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3657,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3658,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3658,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3658,3,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
3658,4,Infected skin ulcer,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
3658,5,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
3659,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3659,2,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
3659,3,Radius fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3659,4,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
3660,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
3660,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3660,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3660,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3660,5,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3660,6,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3660,7,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
3660,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3660,9,Headache,Headaches NEC,Headaches,Nerv,N
3660,10,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3660,11,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
3660,12,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3660,13,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
3660,14,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3661,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3661,2,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
3662,1,Anorectal swelling,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
3662,2,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
3663,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
3663,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3663,3,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
3663,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3664,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
3664,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3664,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
3664,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3664,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3665,1,Atypical femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3665,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3665,3,Tibia fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3666,1,Atypical femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3667,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
3667,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
3667,3,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
3668,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3668,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3669,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
3669,2,Fat tissue increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3669,3,Pituitary-dependent Cushing's syndrome,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
3669,4,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
3670,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
3670,2,Myopathy,Myopathies,Muscle disorders,Musc,N
3670,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
3671,1,Sweat gland tumour,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
3672,1,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
3672,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3672,3,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
3672,4,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
3673,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3673,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3674,1,Oesophageal adenocarcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
3675,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
3676,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3676,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3676,3,Hunger,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3676,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3676,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
3676,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3677,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
3677,2,Myopathy,Myopathies,Muscle disorders,Musc,N
3677,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
3678,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3678,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3678,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3678,4,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3678,5,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3678,6,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3678,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3679,1,Biopsy,Histopathology procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
3680,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
3680,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
3681,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3682,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3682,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3683,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
3684,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3685,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
3685,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3685,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3686,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3686,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3686,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3686,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3686,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3686,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3686,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3687,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
3688,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
3689,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
3689,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3689,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3690,1,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
3690,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3690,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3690,4,Oligohydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
3690,5,Placenta praevia,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
3690,6,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
3690,7,Uterine leiomyoma,Uterine neoplasms benign,Reproductive neoplasms female benign,Neopl,N
3691,1,Akinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
3691,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3691,3,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
3691,4,Catatonia,Decreased physical activity levels,Changes in physical activity,Psych,N
3691,5,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3691,6,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3691,7,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3691,8,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
3692,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3693,1,Zika virus infection,Flaviviral infections,Viral infectious disorders,Infec,N
3694,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3694,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
3694,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
3694,4,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3695,1,Headache,Headaches NEC,Headaches,Nerv,N
3695,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3696,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3696,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3697,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
3697,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3698,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3699,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3699,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3700,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3700,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3700,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3700,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3700,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3700,6,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
3701,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3701,2,Headache,Headaches NEC,Headaches,Nerv,N
3702,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3702,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
3702,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3702,4,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
3702,5,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
3703,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3703,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3703,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3703,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3703,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3703,6,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
3703,7,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3703,8,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3704,1,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
3705,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3706,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3707,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3707,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
3707,3,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
3707,4,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
3707,5,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3707,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3708,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3708,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3708,3,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3708,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3708,5,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
3708,6,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
3708,7,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
3708,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3708,9,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3708,10,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3708,11,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3708,12,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
3708,13,Retinal scar,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
3708,14,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3709,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3710,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3710,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3710,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3710,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3710,5,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3711,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3711,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3711,3,Heart rate abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3711,4,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
3712,1,Keratopathy,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
3712,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3713,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3713,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3713,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3714,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
3714,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
3714,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
3714,4,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3714,5,Disseminated cytomegaloviral infection,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
3714,6,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
3714,7,Histoplasmosis disseminated,Histoplasma infections,Fungal infectious disorders,Infec,N
3714,8,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
3714,9,Intestinal mass,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
3714,10,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
3714,11,Orchitis,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
3714,12,Panniculitis,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
3714,13,Panniculitis,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
3714,14,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3714,15,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3714,16,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
3715,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
3715,2,Headache,Headaches NEC,Headaches,Nerv,N
3715,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3716,1,Autophobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
3716,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3716,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3716,4,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3716,5,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3716,6,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3716,7,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
3717,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3717,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3718,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
3718,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3718,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3718,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
3718,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3719,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3719,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3719,3,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
3719,4,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3719,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3719,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3719,7,Food allergy,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
3719,8,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
3719,9,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3719,10,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3719,11,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
3719,12,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3719,13,Nasal polyps,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
3719,14,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3719,15,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3719,16,Rubber sensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
3719,17,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
3719,18,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3719,19,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3719,20,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
3719,21,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3720,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3721,1,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
3721,2,Skin fragility,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3722,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3722,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3722,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
3722,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3722,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3722,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3723,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3723,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
3724,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3725,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
3725,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3725,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3725,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3726,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3726,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
3726,3,Lower respiratory tract inflammation,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3726,4,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
3726,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3726,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
3726,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3726,8,Oxygen therapy,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
3726,9,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
3726,10,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
3726,11,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
3726,12,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
3727,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3727,2,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3727,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3728,1,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
3728,2,Infection susceptibility increased,Infections NEC,Infections - pathogen unspecified,Infec,N
3728,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3729,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3729,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
3729,3,Mechanical ventilation,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
3729,4,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
3729,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
3729,6,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
3729,7,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3730,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
3730,2,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3731,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
3731,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3731,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3731,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
3731,5,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
3731,6,PCO2 increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
3732,1,Intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3732,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3732,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3732,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
3732,5,Stoma site reaction,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
3733,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3734,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3734,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3734,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3735,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3736,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3736,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3736,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3737,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3738,1,Chronic fatigue syndrome,Asthenic conditions,General system disorders NEC,Genrl,N
3738,2,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3739,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3739,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3739,3,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3739,4,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
3739,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3739,6,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3739,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
3739,8,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
3740,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3741,1,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3742,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3743,1,Anal cancer,Anal canal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
3743,2,Genital neoplasm malignant female,Female reproductive neoplasms malignant NEC,Reproductive neoplasms female malignant and unspecified,Neopl,N
3743,3,Haemophilus infection,Haemophilus infections,Bacterial infectious disorders,Infec,N
3743,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3743,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3744,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
3745,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3745,2,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
3745,3,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
3745,4,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
3745,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3745,6,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
3745,7,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3746,1,Central nervous system lupus,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
3746,2,Central nervous system vasculitis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
3746,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3746,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3746,5,Meningitis enteroviral,Enteroviral infections NEC,Viral infectious disorders,Infec,N
3746,6,Viral upper respiratory tract infection,Viral infections NEC,Viral infectious disorders,Infec,N
3747,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3747,2,Muscle discomfort,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3748,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3749,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
3749,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3750,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3751,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3752,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
3753,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3753,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3753,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
3754,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3754,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3754,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3754,4,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3755,1,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
3755,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3755,3,Mechanical ventilation,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
3755,4,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
3755,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
3755,6,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
3755,7,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3756,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3756,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3756,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3756,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3756,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3757,1,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
3757,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3757,3,Mechanical ventilation,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
3757,4,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
3757,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
3757,6,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
3757,7,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3758,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
3758,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3758,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3758,4,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
3759,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
3759,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3760,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
3760,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3761,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3761,2,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3761,3,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
3761,4,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
3761,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
3761,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3761,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3761,8,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3761,9,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
3762,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
3762,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3763,1,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
3764,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3764,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3764,3,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3764,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3764,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3764,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3765,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3765,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3765,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3765,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3765,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3766,1,Erosive oesophagitis,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
3766,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3766,3,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3767,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3767,2,Headache,Headaches NEC,Headaches,Nerv,N
3768,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
3769,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
3769,2,Headache,Headaches NEC,Headaches,Nerv,N
3770,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3771,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3771,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
3772,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
3772,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3773,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3773,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3773,3,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
3773,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3773,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3774,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3775,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
3775,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3776,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3777,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3778,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3778,2,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3778,3,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
3778,4,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
3778,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
3778,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3778,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3778,8,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3778,9,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
3779,1,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3780,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3780,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3780,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3780,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3781,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3781,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3782,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3782,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3782,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3783,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3783,2,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
3783,3,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
3784,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3784,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3784,3,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
3784,4,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
3784,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3785,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3786,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3786,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3786,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3787,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
3787,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3787,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3788,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3788,2,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
3789,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
3789,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
3789,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3790,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3790,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3791,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
3791,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3791,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3791,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3792,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3792,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
3793,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3794,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3794,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3795,1,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
3796,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3796,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3797,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3797,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3797,3,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3798,1,Auditory disorder,Hearing disorders NEC,Hearing disorders,Ear,N
3798,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3798,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3798,4,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3798,5,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3798,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3799,1,Listeriosis,Listeria infections,Bacterial infectious disorders,Infec,N
3799,2,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
3800,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3800,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3800,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3800,4,Faeces pale,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
3800,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3800,6,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3800,7,Hepatic pain,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
3800,8,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
3800,9,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3800,10,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
3800,11,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3801,1,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
3801,2,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3802,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
3802,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3802,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3803,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
3804,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3804,2,Infective tenosynovitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
3805,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3806,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
3806,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
3806,3,Headache,Headaches NEC,Headaches,Nerv,N
3806,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3806,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3807,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3807,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3808,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
3808,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3808,3,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3808,4,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3808,5,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3808,6,Suicidal behaviour,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3809,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
3810,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3810,2,Immunosuppressant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
3811,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
3812,1,Urine odour abnormal,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
3813,1,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3813,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3814,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3814,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3814,3,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
3814,4,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3814,5,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
3814,6,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3815,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
3815,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3816,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3816,2,Giant cell arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
3816,3,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
3817,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3818,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3819,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3819,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
3819,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3819,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
3820,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
3820,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3821,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3821,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3821,3,Intrusive thoughts,Thinking disturbances,Disturbances in thinking and perception,Psych,N
3821,4,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3821,5,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3821,6,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3821,7,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3822,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
3822,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3822,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3822,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3822,5,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3822,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3823,1,Dermatomyositis,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
3823,2,Symptom masked,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3824,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3824,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3824,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3825,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
3826,1,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
3827,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
3827,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3827,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
3827,4,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
3827,5,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
3827,6,Histiocytic sarcoma,Histiocytoses,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
3827,7,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3827,8,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
3827,9,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
3827,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
3828,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3828,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
3829,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3830,1,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
3830,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3830,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3830,4,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3831,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3831,2,Headache,Headaches NEC,Headaches,Nerv,N
3832,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3833,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3833,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3833,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3833,4,Tension,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3834,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3834,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3835,1,B-lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3835,2,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3835,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3835,4,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
3836,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
3836,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3836,3,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3836,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3836,5,Headache,Headaches NEC,Headaches,Nerv,N
3836,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
3836,7,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3836,8,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3836,9,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3837,1,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3837,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
3838,1,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
3838,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3839,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
3840,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3841,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3841,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
3841,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3841,4,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3841,5,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
3841,6,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
3841,7,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3842,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3842,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
3842,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3842,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3842,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3843,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3844,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3844,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3844,3,Laryngeal disorder,Laryngeal and adjacent sites disorders NEC (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
3844,4,Throat clearing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3844,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3845,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
3845,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3846,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3846,2,Diffuse alveolar damage,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3846,3,Gastrointestinal oedema,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
3846,4,Intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3846,5,Mesenteric haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3846,6,Pleural adhesion,Pleural conditions NEC,Pleural disorders,Resp,N
3846,7,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
3846,8,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
3846,9,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
3846,10,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,N
3847,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
3847,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3847,3,Diffuse alveolar damage,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3847,4,Enterobacter infection,Enterobacter infections,Bacterial infectious disorders,Infec,N
3847,5,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3847,6,Intestinal dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3847,7,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3847,8,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
3847,9,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
3847,10,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3847,11,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3847,12,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,Y
3848,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3848,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3848,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3849,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3850,1,Device dislocation,Device issues NEC,Device issues,Prod,N
3850,2,Foreign body in eye,Eye injuries NEC,Injuries NEC,Inj&P,N
3850,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
3850,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3851,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3852,1,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
3852,2,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
3853,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3854,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
3854,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3854,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
3854,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3854,5,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
3854,6,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3854,7,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
3855,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3855,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
3855,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3856,1,Dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3856,2,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
3856,3,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
3857,1,Hyperaesthesia teeth,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
3857,2,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
3857,3,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
3858,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
3859,1,Loose tooth,Dental disorders NEC,Dental and gingival conditions,Gastr,N
3859,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3859,3,Periodontal disease,Dental disorders NEC,Dental and gingival conditions,Gastr,N
3860,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
3860,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3860,3,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
3861,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3861,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3861,3,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
3861,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3861,5,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
3861,6,Pseudo Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
3862,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3863,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
3863,2,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
3863,3,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
3863,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3863,5,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
3864,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3865,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3865,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3865,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3866,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3867,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3867,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3867,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3867,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3867,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3867,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3867,7,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3867,8,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3867,9,Headache,Headaches NEC,Headaches,Nerv,N
3867,10,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3867,11,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
3867,12,Oesophageal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3867,13,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
3867,14,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3867,15,Somnambulism,Parasomnias,Sleep disorders and disturbances,Psych,N
3868,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
3868,2,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
3868,3,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
3868,4,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
3868,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3868,6,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
3869,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3869,2,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
3869,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3869,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
3870,1,Drooling,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3870,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3871,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3872,1,Brain stem infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3872,2,Cardiac sarcoidosis,Myocardial disorders NEC,Myocardial disorders,Card,N
3872,3,Neurosarcoidosis,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
3872,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3873,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3874,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3874,2,Headache,Headaches NEC,Headaches,Nerv,N
3875,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3876,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3877,1,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3877,2,Headache,Headaches NEC,Headaches,Nerv,N
3877,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3877,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3877,5,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
3878,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
3878,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
3879,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
3879,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3880,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3880,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3880,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3881,1,Paracoccidioides infection,Paracoccidioides infections,Fungal infectious disorders,Infec,N
3882,1,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3883,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3883,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3884,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3885,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
3885,2,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
3885,3,Hepatitis infectious mononucleosis,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
3886,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3886,2,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
3886,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
3886,4,Herpes zoster meningoencephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
3886,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
3886,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3886,7,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
3886,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3887,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3887,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3887,3,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
3887,4,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
3887,5,Microvillous inclusion disease,Intestinal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
3887,6,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
3888,1,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
3888,2,Streptococcus test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
3889,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
3889,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3889,3,Flight of ideas,Thinking disturbances,Disturbances in thinking and perception,Psych,N
3889,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3889,5,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
3889,6,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3890,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
3890,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3890,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3890,4,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3891,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3892,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
3892,2,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
3893,1,Foetal anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
3893,2,Maternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3893,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
3894,1,Paracoccidioides infection,Paracoccidioides infections,Fungal infectious disorders,Infec,N
3895,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3895,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3895,3,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3895,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3895,5,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
3895,6,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
3895,7,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
3896,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3896,2,Fibromyalgia,Muscle pains,Muscle disorders,Musc,N
3896,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3897,1,Blast crisis in myelogenous leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,N
3897,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
3897,3,Chronic myeloid leukaemia recurrent,Leukaemias chronic myeloid,Leukaemias,Neopl,N
3897,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3897,5,Ejection fraction,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3897,6,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3897,7,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3897,8,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3897,9,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
3897,10,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
3897,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3897,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3897,13,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3898,1,Migraine,Migraine headaches,Headaches,Nerv,N
3898,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3899,1,Ophthalmic herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
3899,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3900,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3901,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3902,1,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
3903,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3904,1,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3904,2,Viral upper respiratory tract infection,Viral infections NEC,Viral infectious disorders,Infec,N
3905,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
3905,2,Osteoporotic fracture,Fractures NEC,Fractures,Musc,N
3905,3,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3905,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3906,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
3906,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
3906,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3907,1,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
3907,2,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
3908,1,Chronic graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
3908,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3908,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
3908,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3909,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
3909,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
3909,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3909,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3909,5,Headache,Headaches NEC,Headaches,Nerv,N
3909,6,Migraine with aura,Migraine headaches,Headaches,Nerv,N
3909,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3909,8,Myocardial necrosis marker increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
3909,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3909,10,Prinzmetal angina,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3910,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
3910,2,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,Y
3911,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
3911,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3911,3,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
3912,1,Disseminated trichosporonosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
3913,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
3913,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
3914,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3915,1,Catarrh,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3915,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3915,3,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
3915,4,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3916,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
3916,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
3916,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3917,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
3917,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
3917,3,Squamous cell carcinoma of head and neck,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3918,1,Metastatic squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3918,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3918,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3919,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
3919,2,Inferior vena cava stenosis,Site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
3919,3,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
3919,4,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
3920,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
3921,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3922,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
3923,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3923,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3924,1,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
3925,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3925,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3925,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3925,4,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3925,5,Headache,Headaches NEC,Headaches,Nerv,N
3926,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3927,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3928,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3928,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3928,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3928,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3929,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
3929,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3929,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3929,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3929,5,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
3929,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3929,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3929,8,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
3929,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3929,10,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
3929,11,Headache,Headaches NEC,Headaches,Nerv,N
3929,12,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3929,13,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
3929,14,Inflammation,Inflammations,General system disorders NEC,Genrl,N
3929,15,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3929,16,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3929,17,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3929,18,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3929,19,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3929,20,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3929,21,Myalgia,Muscle pains,Muscle disorders,Musc,N
3929,22,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
3929,23,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3929,24,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3929,25,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
3929,26,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3929,27,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3929,28,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3929,29,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
3929,30,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3929,31,Synovial cyst,Synovial disorders,Synovial and bursal disorders,Musc,N
3929,32,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3929,33,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3930,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3931,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3931,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
3931,3,Metastases to adrenals,Metastases to specified sites,Metastases,Neopl,N
3931,4,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
3931,5,Metastases to muscle,Metastases to specified sites,Metastases,Neopl,N
3931,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3932,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3932,2,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3933,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3933,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3933,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3933,4,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
3933,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
3934,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3934,2,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3934,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3934,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3934,5,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
3934,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
3934,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3935,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3935,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
3935,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3936,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3936,2,Asthenopia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
3936,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3936,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
3936,5,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3936,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3936,7,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3936,8,Tension headache,Headaches NEC,Headaches,Nerv,N
3937,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3937,2,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3937,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3937,4,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
3937,5,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3937,6,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
3938,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3939,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
3939,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
3940,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3941,1,Paracoccidioides infection,Paracoccidioides infections,Fungal infectious disorders,Infec,N
3942,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3942,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3942,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3942,4,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
3942,5,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
3942,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3942,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3942,8,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3943,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
3944,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3944,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
3944,3,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
3944,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
3944,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3944,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3944,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3944,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3944,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3944,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3945,1,Hypohidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3945,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3945,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3945,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3946,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3947,1,Infection reactivation,Infections NEC,Infections - pathogen unspecified,Infec,N
3947,2,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
3947,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
3948,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3948,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3948,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3949,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3950,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3950,2,Bone infarction,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
3950,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3950,4,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
3950,5,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
3950,6,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
3951,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3952,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3953,1,Atypical femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3953,2,Atypical femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3954,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3954,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3954,3,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
3954,4,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3955,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
3956,1,Abulia,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
3956,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3956,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3956,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3956,5,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
3956,6,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
3957,1,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
3958,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
3959,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3959,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3960,1,Cold type haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
3960,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
3960,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3960,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3960,5,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3961,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3961,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3961,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3961,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3962,1,Bullous impetigo,Staphylococcal infections,Bacterial infectious disorders,Infec,N
3962,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3963,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3964,1,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
3964,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3965,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
3965,2,Blood creatinine decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
3965,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
3965,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3965,5,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
3965,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3965,7,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,Y
3965,8,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3965,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3966,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3966,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
3966,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3967,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3967,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3967,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3968,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3968,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3968,3,Bowel movement irregularity,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
3968,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3968,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3968,6,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3968,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3968,8,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
3968,9,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
3969,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
3969,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3969,3,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
3969,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
3970,1,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3971,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
3971,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3971,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3972,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
3973,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3973,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
3974,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
3975,1,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3976,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
3977,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3977,2,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3978,1,Ejaculation failure,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
3978,2,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
3978,3,Orgasmic sensation decreased,Orgasmic disorders and disturbances,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
3979,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
3980,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3981,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
3981,2,Failure to suspend medication,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3981,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3982,1,Acne,Acnes,Skin appendage conditions,Skin,N
3982,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3982,3,Weight loss poor,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3983,1,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3983,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
3983,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3983,4,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
3983,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3983,6,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3983,7,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3984,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3984,2,Dyspnoea at rest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3984,3,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3984,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3985,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
3985,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3985,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3985,4,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
3985,5,Short stature,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3986,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3986,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3986,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3986,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3986,5,Hypermagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
3986,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3986,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3986,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3986,9,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3987,1,Central serous chorioretinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
3987,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3988,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3988,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
3988,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
3989,1,Mental status changes,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
3989,2,Shared psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3990,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3991,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3991,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3991,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3991,4,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
3992,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
3992,2,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
3992,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3992,4,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
3993,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3993,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3993,3,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
3993,4,Pressure of speech,Speech articulation and rhythm disturbances,Communication disorders and disturbances,Psych,N
3993,5,Tachyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
3994,1,Genital rash,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
3994,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3995,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
3995,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3995,3,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3995,4,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
3996,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
3997,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3997,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3997,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3997,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3997,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3997,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
3997,7,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
3997,8,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3997,9,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3997,10,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
3998,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
3998,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3998,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
3998,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3998,5,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3998,6,Unmasking of previously unidentified disease,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3999,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4000,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4000,2,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
4000,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4000,4,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
4000,5,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
4001,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4001,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4002,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4002,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4002,3,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4002,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4002,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4002,6,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
4002,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
4002,8,Menstruation delayed,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
4002,9,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4002,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4002,11,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4002,12,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
4002,13,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4002,14,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
4002,15,Skin texture abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4002,16,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4002,17,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4002,18,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
4002,19,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
4003,1,Acne,Acnes,Skin appendage conditions,Skin,N
4003,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4003,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4003,4,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4003,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4003,6,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
4003,7,Inflammation,Inflammations,General system disorders NEC,Genrl,N
4003,8,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4003,9,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
4003,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4003,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4003,12,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4003,13,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4003,14,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
4003,15,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
4003,16,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4003,17,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4003,18,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
4003,19,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4003,20,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4004,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4005,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4006,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
4006,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4006,3,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
4006,4,Cardiac failure,Heart failures NEC,Heart failures,Card,N
4006,5,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
4006,6,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
4006,7,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
4006,8,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
4006,9,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
4006,10,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
4006,11,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4006,12,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4007,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
4007,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4008,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4009,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4009,2,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
4010,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4010,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4010,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4011,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
4011,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
4012,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4013,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
4013,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4013,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4013,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
4013,5,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4013,6,Respiratory tract congestion,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
4013,7,SARS-CoV-2 test negative,Virus identification and serology,Microbiology and serology investigations,Inv,N
4013,8,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4014,1,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
4015,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
4015,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
4016,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
4017,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4017,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4017,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4018,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4019,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4020,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
4020,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4021,1,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
4022,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4022,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4022,3,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
4022,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4022,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4022,6,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4023,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4023,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
4023,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4023,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4023,5,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4024,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
4025,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4026,1,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
4027,1,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
4027,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4028,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
4028,2,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
4028,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
4028,4,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
4029,1,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4029,2,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
4030,1,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
4031,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4031,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4031,3,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
4032,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
4033,1,Adenovirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
4033,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4033,3,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
4033,4,Epstein-Barr virus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
4033,5,Lung opacity,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4033,6,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4033,7,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
4033,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4033,9,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
4034,1,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
4035,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4035,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
4036,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
4036,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4036,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4037,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
4037,2,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
4037,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
4037,4,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
4038,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
4038,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
4038,3,Conversion disorder,Somatic symptom disorders,Somatic symptom and related disorders,Psych,N
4038,4,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4038,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4038,6,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
4038,7,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4039,1,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,Y
4039,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
4040,1,Renal injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4040,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
4041,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
4042,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
4043,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4043,2,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
4043,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4043,4,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
4043,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
4043,6,Rebound psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
4043,7,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
4043,8,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
4043,9,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4044,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
4044,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
4045,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
4045,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
4045,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
4046,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
4046,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
4047,1,Disseminated varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
4048,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
4049,1,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
4049,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4050,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4050,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4050,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
4050,4,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4050,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
4050,6,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
4050,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4050,8,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
4051,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4052,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
4053,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4053,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4054,1,Blood immunoglobulin E increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
4054,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
4054,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4054,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4054,5,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
4054,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4054,7,Tinea infection,Tinea infections,Fungal infectious disorders,Infec,N
4054,8,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4055,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4055,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4055,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4055,4,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
4055,5,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
4055,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4055,7,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
4055,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
4055,9,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4056,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
4057,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4058,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4058,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4058,3,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
4059,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4059,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
4059,3,Pneumococcal bacteraemia,Streptococcal infections,Bacterial infectious disorders,Infec,N
4059,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4059,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4059,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4060,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
4060,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
4061,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
4061,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
4062,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4062,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4063,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,Y
4064,1,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
4065,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
4066,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4067,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
4067,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
4068,1,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
4069,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
4070,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
4071,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
4071,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
4072,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4072,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4072,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4072,4,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
4072,5,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
4072,6,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
4072,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4072,8,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4072,9,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4072,10,Enterocolitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
4072,11,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4072,12,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4072,13,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4072,14,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4072,15,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
4072,16,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4072,17,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4072,18,Pancreatitis chronic,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
4072,19,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
4072,20,Terminal ileitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4072,21,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
4072,22,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4073,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
4073,2,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
4073,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
4073,4,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
4074,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4074,2,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
4075,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
4075,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
4076,1,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
4077,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
4077,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4078,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
4078,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
4079,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4079,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
4079,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
4079,4,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4079,5,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
4080,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
4081,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4081,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
4082,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4082,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
4083,1,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
4084,1,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
4084,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4085,1,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
4085,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4085,3,Autonomic nervous system imbalance,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
4085,4,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
4085,5,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4085,6,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
4085,7,Hepatitis fulminant,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
4085,8,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4085,9,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
4085,10,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
4085,11,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
4085,12,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
4085,13,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4085,14,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4085,15,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4085,16,Pseudomembranous colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
4085,17,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
4086,1,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4086,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
4087,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
4087,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4088,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4088,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
4088,3,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
4088,4,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4088,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
4089,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4089,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4089,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4089,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
4089,5,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4089,6,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
4090,1,Paracoccidioides infection,Paracoccidioides infections,Fungal infectious disorders,Infec,N
4091,1,Autoinflammatory disease,Autoinflammatory diseases,Immune disorders NEC,Immun,N
4091,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4092,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4092,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4092,3,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
4092,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4092,5,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
4092,6,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
4092,7,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
4093,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4093,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4094,1,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
4095,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4095,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4096,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
4096,2,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
4096,3,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
4096,4,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
4097,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4098,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
4098,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
4098,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4098,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4098,5,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
4098,6,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
4098,7,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
4098,8,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4098,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4099,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
4099,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
4099,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4099,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4099,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
4100,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
4100,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4100,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4101,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4102,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4103,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4103,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
4103,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4104,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4105,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
4105,2,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
4105,3,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
4105,4,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
4106,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4107,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4107,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4108,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4108,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4109,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4109,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
4110,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4110,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4110,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
4110,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4110,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
4110,6,Pharyngeal paraesthesia,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
4111,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4111,2,Cerebral toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
4111,3,Hemianopia homonymous,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
4111,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4111,5,Quadrantanopia,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
4111,6,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
4112,1,Genital candidiasis,Candida infections,Fungal infectious disorders,Infec,N
4112,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4112,3,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4112,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4113,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
4113,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
4113,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4113,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
4113,5,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
4113,6,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4113,7,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4113,8,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4113,9,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
4113,10,Metastases to spine,Metastases to specified sites,Metastases,Neopl,N
4113,11,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4113,12,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
4113,13,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
4113,14,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4113,15,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4113,16,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4113,17,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4113,18,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4113,19,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
4114,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
4114,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4114,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4114,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4114,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
4115,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4116,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
4116,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
4116,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4117,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4117,2,Product after taste,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4118,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4119,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4119,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
4119,3,Langerhans' cell histiocytosis,Histiocytoses,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
4119,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
4120,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
4120,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4120,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4120,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
4120,5,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4120,6,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
4120,7,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
4120,8,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
4120,9,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
4120,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4121,1,Encephalitis autoimmune,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
4121,2,Faciobrachial dystonic seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
4121,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4122,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4122,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
4122,3,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
4123,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
4123,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
4124,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
4124,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
4124,3,Squamous cell carcinoma of head and neck,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
4125,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
4126,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4127,1,Metastatic squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
4127,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
4127,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
4128,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
4128,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
4129,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4130,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
4130,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4130,3,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
4130,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4130,5,Headache,Headaches NEC,Headaches,Nerv,N
4130,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
4130,7,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4130,8,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4130,9,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4131,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
4131,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
4131,3,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
4131,4,Bulbar palsy,Mixed cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
4131,5,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
4131,6,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
4131,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4131,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4131,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4131,10,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4132,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4133,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
4133,2,Herpes virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
4134,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
4134,2,Inferior vena cava stenosis,Site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
4134,3,Kaposi sarcoma inflammatory cytokine syndrome,Herpes viral infections,Viral infectious disorders,Infec,N
4134,4,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
4135,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
4135,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
4136,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4136,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4136,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4136,4,Morning sickness,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
4136,5,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
4136,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4137,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4137,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4137,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4138,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
4139,1,Anal ulcer,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
4139,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
4139,3,Cytomegalovirus mucocutaneous ulcer,Cytomegaloviral infections,Viral infectious disorders,Infec,N
4139,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4139,5,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
4139,6,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
4140,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4140,2,Secondary immunodeficiency,Acquired immunodeficiency syndromes,Immunodeficiency syndromes,Immun,N
4140,3,Tinea infection,Tinea infections,Fungal infectious disorders,Infec,N
4141,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
4141,2,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
4141,3,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
4141,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4141,5,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
4141,6,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4141,7,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
4142,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4143,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
4144,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
4144,2,Omental infarction,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
4144,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4145,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
4145,2,Inferior vena cava stenosis,Site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
4145,3,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
4145,4,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
4145,5,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
4146,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
4146,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
4146,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
4146,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4146,5,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
4146,6,Delirium,Deliria,Deliria (incl confusion),Psych,N
4146,7,Gastroenteritis adenovirus,Adenoviral infections,Viral infectious disorders,Infec,N
4146,8,Gastrointestinal stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
4146,9,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
4146,10,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
4146,11,Hyperferritinaemia,Iron excess,Iron and trace metal metabolism disorders,Metab,N
4146,12,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
4146,13,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
4146,14,Hypovolaemia,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
4146,15,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
4146,16,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
4146,17,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
4146,18,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4146,19,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4146,20,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
4146,21,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
4146,22,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4147,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
4147,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4148,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4149,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4149,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
4149,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
4149,4,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
4149,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4149,6,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
4149,7,Delirium,Deliria,Deliria (incl confusion),Psych,N
4149,8,Gastroenteritis adenovirus,Adenoviral infections,Viral infectious disorders,Infec,N
4149,9,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
4149,10,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
4149,11,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
4149,12,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
4149,13,Hypovolaemia,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
4149,14,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
4149,15,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
4149,16,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
4149,17,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4149,18,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4149,19,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
4149,20,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
4149,21,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4150,1,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
4150,2,Disseminated trichosporonosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
4150,3,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
4150,4,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
4150,5,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
4150,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4150,7,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
4150,8,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4150,9,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4150,10,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
4150,11,Trichosporon infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
4151,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
4151,2,Inferior vena cava stenosis,Site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
4151,3,Kaposi sarcoma inflammatory cytokine syndrome,Herpes viral infections,Viral infectious disorders,Infec,N
4151,4,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
4151,5,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
4151,6,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
4152,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4152,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4153,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
4153,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4153,3,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4153,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4153,5,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
4154,1,Hodgkin's disease refractory,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
4155,1,Anal ulcer,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
4155,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
4155,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
4156,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4156,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4157,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4157,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4157,3,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4157,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4157,5,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4157,6,Headache,Headaches NEC,Headaches,Nerv,N
4157,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4157,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4157,9,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
4157,10,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
4158,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
4158,2,Herpes virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
4158,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4159,1,Administration site ulcer,Administration site reactions NEC,Administration site reactions,Genrl,N
4159,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4160,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4161,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4162,1,Faciobrachial dystonic seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
4162,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4163,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
4164,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
4165,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
4165,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
4165,3,Glucose tolerance impaired,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4165,4,Hunger,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4165,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4165,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4165,7,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4165,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4166,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
4166,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4167,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
4167,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4167,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4167,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
4168,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
4168,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4168,3,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
4168,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
4168,5,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
4168,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4168,7,Pancreatic mass,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
4168,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4168,9,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4169,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
4169,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4169,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4169,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
4169,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4169,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4170,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
4170,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
4171,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4172,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4173,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4173,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
4174,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
4174,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4175,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4176,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
4176,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4176,3,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4176,4,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
4176,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4176,6,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
4176,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4176,8,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
4176,9,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4176,10,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4176,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4176,12,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
4176,13,Sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4176,14,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4177,1,Oroantral fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
4178,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4179,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
4180,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
4181,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
4181,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
4181,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
4181,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4181,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
4181,6,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
4181,7,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
4181,8,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4181,9,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4182,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
4182,2,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
4182,3,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
4182,4,Serositis,Inflammations,General system disorders NEC,Genrl,N
4182,5,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4182,6,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
4183,1,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
4184,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
4184,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4184,3,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
4184,4,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
4184,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4185,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4186,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4186,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4186,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4186,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4186,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
4187,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4187,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4187,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4188,1,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4189,1,Oroantral fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
4189,2,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
4190,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
4191,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4191,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4191,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4192,1,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
4193,1,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
4194,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
4194,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
4195,1,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
4196,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
4197,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
4198,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
4199,1,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
4200,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4201,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4201,2,Breast abscess,Breast infections,Infections - pathogen unspecified,Infec,N
4201,3,Salmonellosis,Salmonella infections,Bacterial infectious disorders,Infec,N
4202,1,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
4203,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4204,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
4205,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4205,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4205,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
4205,4,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4206,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
4207,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
4207,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4207,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4207,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4207,5,Peak expiratory flow rate decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
4207,6,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4207,7,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4207,8,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
4208,1,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4209,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
4209,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4209,3,Therapeutic product effect delayed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4210,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4210,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
4210,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
4210,4,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4210,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4211,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
4211,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
4212,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4213,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
4214,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
4214,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4215,1,Breast abscess,Breast infections,Infections - pathogen unspecified,Infec,N
4215,2,Salmonellosis,Salmonella infections,Bacterial infectious disorders,Infec,N
4216,1,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
4217,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4217,2,Disseminated varicella zoster vaccine virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
4217,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4218,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
4219,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
4219,2,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
4219,3,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
4219,4,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
4220,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
4221,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
4221,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
4222,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4222,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4222,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4222,4,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
4222,5,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
4222,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4222,7,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
4222,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
4222,9,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4223,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
4223,2,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
4224,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
4224,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
4224,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
4224,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4224,5,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
4225,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
4225,2,Symptom masked,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4226,1,Disseminated varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
4227,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4227,2,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
4227,3,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
4227,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4227,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
4227,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4227,7,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
4227,8,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4227,9,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4228,1,Enterobacter infection,Enterobacter infections,Bacterial infectious disorders,Infec,N
4228,2,Enterobacter pneumonia,Enterobacter infections,Bacterial infectious disorders,Infec,N
4229,1,Barrett's oesophagus,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
4229,2,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
4229,3,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
4229,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4229,5,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
4229,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4229,7,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
4229,8,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4229,9,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4230,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
4230,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
4231,1,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
4232,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4233,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4233,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4233,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
4234,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
4235,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4235,2,Headache,Headaches NEC,Headaches,Nerv,N
4235,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
4235,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4235,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4236,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4237,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4237,2,Eosinophilic colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4237,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4238,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
4239,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4240,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
4241,1,Feeling of despair,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4241,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4241,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4241,4,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
4242,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4242,2,Pathological fracture,Fractures NEC,Fractures,Musc,N
4242,3,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4242,4,Ureterolithiasis,Urinary tract lithiasis NEC,Urolithiases,Renal,N
4243,1,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
4243,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4244,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4244,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4245,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4245,2,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
4245,3,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
4246,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4247,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4247,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
4247,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
4247,4,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4247,5,Headache,Headaches NEC,Headaches,Nerv,N
4247,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4247,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4247,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4247,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4247,10,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4247,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4247,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4248,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4248,2,Breast abscess,Breast infections,Infections - pathogen unspecified,Infec,N
4248,3,Salmonellosis,Salmonella infections,Bacterial infectious disorders,Infec,N
4249,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4249,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4250,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4251,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4251,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4251,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4251,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4251,5,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4251,6,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
4252,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
4253,1,Polymyalgia rheumatica,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
4254,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
4254,2,Inferior vena cava stenosis,Site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
4254,3,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
4254,4,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
4254,5,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
4255,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4255,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4255,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4256,1,Disseminated varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
4257,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4257,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
4257,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
4257,4,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
4257,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4257,6,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
4257,7,Delirium,Deliria,Deliria (incl confusion),Psych,N
4257,8,Gastroenteritis adenovirus,Adenoviral infections,Viral infectious disorders,Infec,N
4257,9,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
4257,10,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
4257,11,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
4257,12,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
4257,13,Hypovolaemia,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
4257,14,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
4257,15,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4257,16,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
4257,17,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4257,18,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4257,19,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
4257,20,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
4257,21,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4258,1,Oroantral fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
4259,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
4259,2,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
4259,3,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
4259,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
4260,1,Renal artery stenosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
4261,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4261,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
4261,3,Muscle strain,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
4261,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4262,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4262,2,Hypoperfusion,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
4262,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4262,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
4263,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
4263,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
4264,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4264,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4264,3,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
4265,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
4265,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4265,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
4266,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
4266,2,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
4266,3,Intercepted product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4266,4,Laziness,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
4266,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4267,1,Drug titration error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4267,2,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
4267,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
4267,4,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
4267,5,Headache,Headaches NEC,Headaches,Nerv,N
4268,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4268,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4268,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
4269,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4270,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
4270,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
4270,3,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
4271,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4271,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
4271,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4271,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
4272,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
4273,1,Arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
4273,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
4273,3,Vascular headache,Headaches NEC,Headaches,Nerv,N
4274,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4274,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4274,3,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4275,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
4275,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
4275,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
4276,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4276,2,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
4277,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4277,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
4277,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4277,4,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
4278,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
4278,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
4278,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
4278,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
4278,5,Obstructive nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
4278,6,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
4278,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4279,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
4279,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
4279,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
4279,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4280,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4281,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4282,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4283,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4284,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4285,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4286,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4287,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4288,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4289,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4290,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4291,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4292,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4293,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4294,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4295,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4296,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4297,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4298,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4299,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4300,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4301,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4302,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4303,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4304,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4305,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4306,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4307,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4308,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4309,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4310,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4311,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4312,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4313,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4314,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4315,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4316,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4317,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4318,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4319,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4320,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4321,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4322,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4323,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4324,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4325,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4326,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4327,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4328,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4329,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4330,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4331,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4332,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4333,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4334,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4335,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4336,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4337,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4338,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4339,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4340,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4341,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4342,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4343,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4344,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4345,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4346,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4347,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4348,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4349,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4350,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4351,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4352,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4353,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4354,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4355,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4356,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4357,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4358,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4359,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4360,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4361,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4362,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4363,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4364,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4365,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4366,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4367,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4368,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4369,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4370,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4371,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4372,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4373,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4374,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4375,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4376,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4377,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4378,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
4379,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4380,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4381,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4382,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4383,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4384,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4385,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4386,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4387,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4388,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4389,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4390,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4391,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4392,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4393,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4394,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4395,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4396,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4397,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4398,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4399,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4399,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4399,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4400,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
4400,2,Enterococcal bacteraemia,Enterococcal infections,Bacterial infectious disorders,Infec,N
4400,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4401,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4401,2,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
4402,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
4402,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
4403,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
4403,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
4403,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4404,1,Ear disorder,Ear disorders NEC,Aural disorders NEC,Ear,N
4404,2,Eustachian tube obstruction,Eustachian tube disorders,Middle ear disorders (excl congenital),Ear,N
4404,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
4405,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
4405,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4406,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
4406,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
4407,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4407,2,Entropion,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
4407,3,Symblepharon,"Conjunctival structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
4408,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
4408,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4409,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4409,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
4410,1,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
4411,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
4411,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4411,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4411,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4411,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4411,6,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4411,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4411,8,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4411,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4411,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4411,11,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4411,12,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4411,13,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4411,14,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
4411,15,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
4411,16,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
4411,17,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
4411,18,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4411,19,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4411,20,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4411,21,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
4411,22,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
4412,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4413,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
4414,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4415,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4415,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4415,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4416,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
4417,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4418,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4418,2,Myopathy,Myopathies,Muscle disorders,Musc,N
4419,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4419,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4420,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
4420,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
4420,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
4420,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4421,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4421,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
4422,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4422,2,Immune-mediated myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
4423,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4424,1,Pneumococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
4424,2,Severe invasive streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
4425,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
4426,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
4426,2,Autonomic nervous system imbalance,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
4426,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4426,4,Intensive care unit acquired weakness,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
4426,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4426,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4427,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4427,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4428,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4428,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
4428,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
4428,4,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
4428,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4428,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4428,7,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4428,8,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4428,9,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
4428,10,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
4428,11,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
4428,12,Headache,Headaches NEC,Headaches,Nerv,N
4428,13,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4428,14,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
4428,15,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
4428,16,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4428,17,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4428,18,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
4428,19,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
4428,20,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4428,21,Panic disorder,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
4428,22,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4428,23,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4428,24,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4428,25,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
4428,26,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
4428,27,Tongue blistering,Tongue signs and symptoms,Tongue conditions,Gastr,N
4428,28,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
4428,29,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4429,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4429,2,Foetal growth abnormality,Foetal growth complications,Foetal complications,Preg,N
4429,3,Skin oedema,Skin vascular conditions NEC,Skin vascular abnormalities,Skin,N
4430,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4430,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4431,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4431,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
4432,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4432,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4433,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4434,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4434,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4434,3,Peak expiratory flow rate decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
4434,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4434,5,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4435,1,Adrenal atrophy,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
4435,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
4435,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4435,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
4435,5,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
4436,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
4437,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
4438,1,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4438,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4438,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4438,4,Placenta accreta,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
4438,5,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
4439,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4439,2,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
4439,3,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
4439,4,Positive airway pressure therapy,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
4439,5,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
4440,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
4440,2,Heart failure with reduced ejection fraction,Left ventricular failures,Heart failures,Card,N
4440,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
4441,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
4441,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
4441,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4441,4,Food allergy,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
4441,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4441,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4441,7,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
4441,8,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
4441,9,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4441,10,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
4441,11,Vitamin D decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
4442,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4442,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4442,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4442,4,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4442,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
4443,1,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
4443,2,Cerebral aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
4443,3,Headache,Headaches NEC,Headaches,Nerv,N
4443,4,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
4443,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4443,6,Visual field defect,Visual field disorders,Vision disorders,Eye,N
4444,1,Hyperacusis,Hyperacusia,Hearing disorders,Ear,N
4444,2,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
4445,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
4445,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4445,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4445,4,Myopathy,Myopathies,Muscle disorders,Musc,N
4445,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4445,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4446,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4446,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4447,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4447,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
4447,3,Conversion disorder,Somatic symptom disorders,Somatic symptom and related disorders,Psych,N
4447,4,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
4447,5,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4447,6,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4448,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
4448,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4448,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4448,4,Myopathy,Myopathies,Muscle disorders,Musc,N
4448,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4449,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
4449,2,Headache,Headaches NEC,Headaches,Nerv,N
4449,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4449,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4449,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4450,1,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
4450,2,Headache,Headaches NEC,Headaches,Nerv,N
4450,3,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
4450,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4451,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
4451,2,Headache,Headaches NEC,Headaches,Nerv,N
4451,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4451,4,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,Y
4451,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
4451,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4452,1,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
4452,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4452,3,Lung abscess,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4452,4,Pulmonary nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,Y
4452,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4453,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4453,2,Central nervous system infection,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
4453,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
4453,4,Headache,Headaches NEC,Headaches,Nerv,N
4453,5,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,Y
4454,1,Pneumococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
4454,2,Severe invasive streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
4455,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4456,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
4456,2,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
4456,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
4456,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4457,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
4457,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4457,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4457,4,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4457,5,Headache,Headaches NEC,Headaches,Nerv,N
4457,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4457,7,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4457,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4457,9,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
4458,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4458,2,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
4459,1,Product package associated injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
4459,2,Product package associated injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
4459,3,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4460,1,Pharyngeal oedema,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
4460,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4460,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
4461,1,17-hydroxyprogesterone increased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
4461,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4461,3,Benign neoplasm of adrenal gland,Adrenal neoplasms benign,Endocrine neoplasms benign,Neopl,N
4461,4,Blood corticotrophin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
4462,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
4462,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4462,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4462,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
4462,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4462,6,Salivary gland calculus,Salivary gland disorders NEC,Salivary gland conditions,Gastr,N
4463,1,Central nervous system immune reconstitution inflammatory response,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
4463,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
4463,3,Eye infection toxoplasmal,Toxoplasma infections,Protozoal infectious disorders,Infec,N
4463,4,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
4464,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
4464,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4465,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4466,1,Psychotic behaviour,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
4466,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
4467,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
4467,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4467,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4468,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
4468,2,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
4468,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4468,4,Myopathy,Myopathies,Muscle disorders,Musc,N
4468,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4468,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4469,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4470,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4470,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4470,3,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
4471,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
4471,2,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
4471,3,Myopathy,Myopathies,Muscle disorders,Musc,N
4471,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4472,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
4472,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4473,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
4473,2,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
4473,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
4473,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4474,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4474,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
4475,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
4475,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4475,3,Myopathy,Myopathies,Muscle disorders,Musc,N
4475,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4476,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
4477,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
4477,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4477,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4478,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
4479,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
4479,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
4479,3,Headache,Headaches NEC,Headaches,Nerv,N
4479,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
4479,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
4479,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4479,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4480,1,Giant cell arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
4480,2,Headache,Headaches NEC,Headaches,Nerv,N
4480,3,Headache,Headaches NEC,Headaches,Nerv,N
4481,1,Central nervous system immune reconstitution inflammatory response,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
4481,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
4481,3,Eye infection toxoplasmal,Toxoplasma infections,Protozoal infectious disorders,Infec,N
4481,4,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
4482,1,Angiosarcoma,Cardiovascular neoplasms malignant and unspecified,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
4482,2,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
4482,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4483,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4483,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4483,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4483,4,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
4483,5,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4483,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4483,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4484,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4484,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
4484,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
4484,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4484,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4484,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4485,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4485,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4486,1,Central nervous system immune reconstitution inflammatory response,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
4486,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
4486,3,Eye infection toxoplasmal,Toxoplasma infections,Protozoal infectious disorders,Infec,N
4486,4,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
4487,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
4487,2,Sensation of foreign body,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4488,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4488,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4488,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4489,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
4489,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4489,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4490,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
4490,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4490,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4491,1,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
4492,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
4492,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4492,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4493,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
4493,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4493,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4494,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
4495,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4495,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4495,3,Headache,Headaches NEC,Headaches,Nerv,N
4495,4,Migraine,Migraine headaches,Headaches,Nerv,N
4495,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4495,6,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
4495,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
4496,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4497,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4497,2,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
4497,3,Granulomatosis with polyangiitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
4497,4,Headache,Headaches NEC,Headaches,Nerv,N
4497,5,Nasal obstruction,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4497,6,Nasal obstruction,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4497,7,Pneumomediastinum,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
4497,8,Pneumomediastinum,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
4497,9,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4497,10,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4497,11,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4497,12,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
4498,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
4498,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
4498,3,Central nervous system fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
4499,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4500,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4500,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4501,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4502,1,Central nervous system immune reconstitution inflammatory response,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
4502,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
4502,3,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
4502,4,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
4503,1,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
4504,1,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
4504,2,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4504,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
4505,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4506,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4506,2,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
4506,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
4506,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4507,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4507,2,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
4507,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
4507,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4507,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
4508,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
4508,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4508,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4508,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4509,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
4509,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4509,3,Myopathy,Myopathies,Muscle disorders,Musc,N
4509,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4510,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4511,1,Central nervous system immune reconstitution inflammatory response,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
4511,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
4511,3,Eye infection toxoplasmal,Toxoplasma infections,Protozoal infectious disorders,Infec,N
4511,4,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
4512,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
4512,2,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4512,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
4512,4,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
4512,5,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4512,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4512,7,Halo vision,Visual disorders NEC,Vision disorders,Eye,N
4512,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4512,9,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
4512,10,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4512,11,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4513,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4513,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
4513,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4513,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4513,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4513,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4513,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4514,1,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
4515,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4515,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
4515,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
4515,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4515,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4515,6,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
4515,7,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4515,8,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
4515,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4515,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4515,11,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4516,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4516,2,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
4516,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4516,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
4517,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4517,2,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4517,3,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
4517,4,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4517,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4518,1,Cholangitis sclerosing,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
4518,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4518,3,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4518,4,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4519,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
4519,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
4519,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4519,4,Headache,Headaches NEC,Headaches,Nerv,N
4519,5,Hyperacusis,Hyperacusia,Hearing disorders,Ear,N
4519,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4519,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4519,8,Tension headache,Headaches NEC,Headaches,Nerv,N
4520,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4521,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4521,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4522,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4523,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4523,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
4523,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4524,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4525,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
4525,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4525,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4526,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
4527,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
4527,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
4527,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4527,4,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
4527,5,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4527,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4527,7,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
4527,8,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
4527,9,Peak expiratory flow rate decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
4527,10,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4528,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4528,2,Peak expiratory flow rate decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
4529,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
4530,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4530,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4530,3,Eczema asteatotic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4530,4,Migraine,Migraine headaches,Headaches,Nerv,N
4530,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4530,6,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4531,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
4532,1,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4533,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4533,2,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
4534,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
4534,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
4534,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4535,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
4536,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
4537,1,Genital herpes,Herpes viral infections,Viral infectious disorders,Infec,N
4537,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
4538,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
4539,1,Increased bronchial secretion,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4540,1,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
4540,2,Disseminated trichosporonosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
4540,3,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
4540,4,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
4540,5,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
4540,6,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4540,7,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
4541,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4541,2,Sputum increased,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4542,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
4543,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4543,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4543,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
4543,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4543,5,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
4543,6,Gastrointestinal stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
4543,7,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
4543,8,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4543,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4543,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4543,11,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
4543,12,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
4543,13,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4543,14,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4544,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
4544,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4544,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4545,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
4545,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4545,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4546,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
4547,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4547,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4548,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
4548,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4548,3,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
4548,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
4548,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
4549,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
4549,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4549,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
4549,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
4549,5,Headache,Headaches NEC,Headaches,Nerv,N
4549,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4549,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4549,8,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4549,9,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4550,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4550,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4550,3,Migraine,Migraine headaches,Headaches,Nerv,N
4550,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4550,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
4551,1,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
4551,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4551,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4551,4,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
4552,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4552,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4552,3,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
4552,4,Wrong patient received product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4553,1,Autoinflammatory disease,Autoinflammatory diseases,Immune disorders NEC,Immun,N
4553,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4554,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
4554,2,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
4554,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
4555,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
4555,2,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
4555,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
4556,1,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
4557,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4557,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4557,3,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
4557,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4558,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
4559,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
4559,2,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
4560,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4560,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4561,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4561,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4561,3,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4562,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
4563,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4563,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4563,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4563,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4563,5,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4564,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4564,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
4564,3,Urticaria chronic,Urticarias,Angioedema and urticaria,Skin,N
4565,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
4566,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
4566,2,Necrotic lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
4567,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4568,1,Epstein-Barr virus associated lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
4569,1,Bacterial disease carrier,Infectious disorders carrier,Ancillary infectious topics,Infec,N
4569,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
4569,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4569,4,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
4569,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4569,6,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
4569,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
4569,8,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4569,9,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
4569,10,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4570,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4570,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4571,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4572,1,Bacterial disease carrier,Infectious disorders carrier,Ancillary infectious topics,Infec,N
4572,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
4572,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4572,4,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
4572,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4572,6,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
4572,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
4572,8,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4572,9,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
4572,10,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4573,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4573,2,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4573,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
4573,4,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
4574,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4575,1,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
4575,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4575,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4575,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4575,5,Nasal polyps,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
4575,6,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4575,7,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4576,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4576,2,Meningitis eosinophilic,Meningitis NEC,Central nervous system infections and inflammations,Nerv,N
4576,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4576,4,Radicular pain,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
4576,5,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4577,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4578,1,Bradycardia foetal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
4578,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4578,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
4579,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4579,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4579,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
4579,4,Resuscitation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4580,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
4580,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4580,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4580,4,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4580,5,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
4580,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
4581,1,Acne,Acnes,Skin appendage conditions,Skin,N
4581,2,Hordeolum,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
4582,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4583,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4583,2,Linear IgA disease,Bullous conditions,Epidermal and dermal conditions,Skin,N
4583,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4583,4,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
4583,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4584,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4584,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4584,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
4585,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4586,1,Genital swelling,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
4587,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4587,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4587,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4587,4,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4587,5,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
4587,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4587,7,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4587,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
4587,9,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4587,10,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4588,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
4588,2,Infection reactivation,Infections NEC,Infections - pathogen unspecified,Infec,N
4589,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4589,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
4590,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4591,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4591,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
4591,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4591,4,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
4591,5,Irregular sleep phase,Disturbances in sleep phase rhythm,Sleep disturbances (incl subtypes),Nerv,N
4591,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4591,7,Salivary duct obstruction,Salivary gland stenosis and obstruction,Salivary gland conditions,Gastr,N
4592,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
4592,2,Ligament sprain,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
4592,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4593,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4593,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4593,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
4594,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4595,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4596,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
4596,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
4597,1,Myelolipoma,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
4598,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
4598,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4598,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
4598,4,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
4598,5,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
4598,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
4598,7,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4598,8,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
4598,9,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4599,1,Myopathy,Myopathies,Muscle disorders,Musc,N
4600,1,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
4600,2,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
4601,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4602,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
4602,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4602,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
4602,4,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
4602,5,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
4602,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
4602,7,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4602,8,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
4602,9,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4603,1,Pneumococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,N
4603,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4603,3,Spontaneous bacterial peritonitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
4604,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4604,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4604,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4605,1,Adnexa uteri cyst,Pelvis and broad ligament disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
4605,2,Leiomyosarcoma,Leiomyosarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
4606,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
4607,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
4607,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
4607,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4608,1,Myelolipoma,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
4609,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4610,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
4610,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4610,3,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4610,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4610,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4610,6,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
4610,7,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4611,1,Cerebral aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
4611,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4612,1,Myelolipoma,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
4613,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4614,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
4614,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4615,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
4616,1,Eosinophilic granulomatosis with polyangiitis,Vasculitides,Immune disorders NEC,Immun,N
4616,2,Eosinophilic myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
4616,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4617,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4617,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4617,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4617,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4618,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4619,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
4619,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4619,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
4619,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
4619,5,Unmasking of previously unidentified disease,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4620,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4620,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4620,3,Symptom masked,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4621,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4621,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4622,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
4622,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
4623,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4623,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4624,1,Migraine,Migraine headaches,Headaches,Nerv,N
4625,1,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
4626,1,Pyelonephritis acute,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4627,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4627,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4627,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4627,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4628,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4629,1,Conjunctival hyperaemia,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
4629,2,Orbital swelling,"Orbital structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
4629,3,Parophthalmia,"Orbital infections, inflammations and irritations","Ocular infections, irritations and inflammations",Eye,N
4629,4,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4630,1,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
4630,2,Disseminated trichosporonosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
4630,3,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
4630,4,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
4630,5,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
4630,6,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4630,7,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
4631,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4631,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4631,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4631,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4631,5,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4631,6,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4631,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4631,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4631,9,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
4631,10,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
4631,11,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4631,12,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
4631,13,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
4632,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4632,2,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
4632,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4632,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4632,5,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4632,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4632,7,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4632,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
4632,9,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
4632,10,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4632,11,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4633,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
4633,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
4634,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4634,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
4635,1,Diabetic nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
4635,2,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4635,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
4636,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4636,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4636,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
4636,4,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
4636,5,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4637,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4638,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
4638,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4638,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
4639,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
4640,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
4640,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
4641,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
4641,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
4642,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
4642,2,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4642,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
4643,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4644,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4644,2,Headache,Headaches NEC,Headaches,Nerv,N
4644,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
4644,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4645,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
4645,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
4645,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4645,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4646,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
4647,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4647,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4647,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4648,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4648,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
4648,3,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
4648,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4648,5,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
4648,6,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4648,7,Hypomenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
4648,8,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4648,9,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
4648,10,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
4648,11,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
4648,12,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4649,1,Keratopathy,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
4650,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
4650,2,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
4650,3,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
4651,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4652,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
4652,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
4653,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
4653,2,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4653,3,Tendon injury,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
4654,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4654,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4654,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4654,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
4654,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4654,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4655,1,Alternaria infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
4655,2,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
4656,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4656,2,Bone abscess,Bone and joint infections,Infections - pathogen unspecified,Infec,N
4656,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4656,4,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
4656,5,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
4656,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4657,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4657,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
4658,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4659,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
4660,1,Alternaria infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
4661,1,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
4661,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4662,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4662,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4662,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
4662,4,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
4663,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4663,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4663,3,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
4664,1,Opportunistic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4665,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
4666,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4667,1,Bone lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
4668,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4668,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4668,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4669,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
4669,2,Liver abscess,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
4669,3,Proteus infection,Proteus infections,Bacterial infectious disorders,Infec,N
4670,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
4670,2,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
4670,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
4670,4,Herpes zoster meningoencephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
4670,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
4670,6,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
4671,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
4671,2,Wheelchair user,Disability issues,Lifestyle issues,SocCi,N
4672,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
4672,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4672,3,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4672,4,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
4672,5,Hepatic cyst,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
4672,6,Liver abscess,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
4672,7,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4672,8,Proteus infection,Proteus infections,Bacterial infectious disorders,Infec,N
4672,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4673,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
4674,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
4674,2,Liver abscess,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
4674,3,Proteus infection,Proteus infections,Bacterial infectious disorders,Infec,N
4675,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
4675,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4675,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4675,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4675,5,Headache,Headaches NEC,Headaches,Nerv,N
4675,6,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4675,7,Judgement impaired,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
4675,8,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
4675,9,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
4675,10,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
4675,11,Myalgia,Muscle pains,Muscle disorders,Musc,N
4675,12,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4675,13,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4675,14,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4676,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4676,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
4677,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
4678,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4679,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4680,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
4680,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4680,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4681,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4681,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4681,3,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
4681,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
4681,5,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
4682,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4682,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
4682,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
4683,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4684,1,Liver abscess,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
4685,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
4685,2,Wheelchair user,Disability issues,Lifestyle issues,SocCi,N
4686,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4686,2,Headache,Headaches NEC,Headaches,Nerv,N
4686,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4686,4,Ketosis-prone diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4686,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
4687,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
4687,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4687,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4687,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4688,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4689,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
4689,2,Wheelchair user,Disability issues,Lifestyle issues,SocCi,N
4690,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4691,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
4691,2,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4691,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
4691,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4692,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4692,2,Myopericarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
4692,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4693,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
4693,2,Liver abscess,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
4693,3,Proteus infection,Proteus infections,Bacterial infectious disorders,Infec,N
4694,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
4695,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4695,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4695,3,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4695,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4695,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
4695,6,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
4696,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4696,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4696,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
4696,4,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4696,5,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4696,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4696,7,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4696,8,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4696,9,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4696,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4696,11,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4696,12,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4696,13,Meniere's disease,Inner ear disorders NEC,Inner ear and VIIIth cranial nerve disorders,Ear,N
4696,14,Migraine,Migraine headaches,Headaches,Nerv,N
4696,15,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
4696,16,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4696,17,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4696,18,Peak expiratory flow rate decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
4696,19,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4696,20,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
4696,21,Sleep disorder due to a general medical condition,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4696,22,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4696,23,Sputum abnormal,Respiratory tract and thoracic histopathology procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
4696,24,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
4696,25,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
4697,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
4697,2,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4697,3,Tendon injury,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
4698,1,Pathological fracture,Fractures NEC,Fractures,Musc,N
4699,1,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
4700,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
4701,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4701,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4702,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
4702,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4702,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4702,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4703,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4703,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4703,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
4704,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
4704,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
4704,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4704,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4704,5,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
4704,6,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
4704,7,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4705,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4705,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4705,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
4706,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4706,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4706,3,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4706,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4706,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4706,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4706,7,Gastrointestinal mucosa hyperaemia,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
4706,8,Gastrointestinal mucosa hyperaemia,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
4706,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4706,10,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
4706,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4706,12,Proctitis,Rectal inflammations NEC,Gastrointestinal inflammatory conditions,Gastr,N
4706,13,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4707,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4707,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
4708,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4709,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
4709,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
4710,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
4711,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4712,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
4713,1,Diabetic nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
4713,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
4713,3,Pyelonephritis acute,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4714,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
4714,2,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
4714,3,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
4715,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
4715,2,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4715,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
4715,4,Urine abnormality,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
4716,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
4716,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
4716,3,Headache,Headaches NEC,Headaches,Nerv,N
4716,4,Hemianopia homonymous,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
4716,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4716,6,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
4716,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4717,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
4717,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4717,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4717,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4717,5,Lymphadenitis,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
4717,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4717,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
4717,8,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4717,9,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
4718,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4718,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4718,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4718,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4718,5,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
4718,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4719,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4719,2,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
4719,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4719,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4719,5,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
4719,6,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
4720,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
4720,2,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
4720,3,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
4721,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
4721,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
4721,3,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
4721,4,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
4722,1,Headache,Headaches NEC,Headaches,Nerv,N
4722,2,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
4722,3,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
4722,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4722,5,Proctitis ulcerative,Rectal inflammations NEC,Gastrointestinal inflammatory conditions,Gastr,N
4722,6,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4722,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4722,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4723,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
4724,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
4724,2,Migraine,Migraine headaches,Headaches,Nerv,N
4725,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
4725,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
4725,3,Headache,Headaches NEC,Headaches,Nerv,N
4725,4,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
4725,5,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
4725,6,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
4725,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4726,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4726,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
4726,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
4726,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4726,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4727,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
4727,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
4728,1,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
4729,1,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4730,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4731,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
4731,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4731,3,Sweating fever,Viral infections NEC,Viral infectious disorders,Infec,N
4732,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4732,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4732,3,Migraine,Migraine headaches,Headaches,Nerv,N
4733,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
4733,2,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
4734,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
4734,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
4735,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
4735,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
4736,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
4736,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
4737,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
4737,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
4737,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
4737,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
4738,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
4738,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
4739,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4740,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
4740,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
4740,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
4741,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
4741,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
4741,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
4742,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
4742,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
4742,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
4742,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
4743,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
4743,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
4744,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
4744,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
4745,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
4745,2,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
4745,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,Y
4746,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4747,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4747,2,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4748,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
4749,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4750,1,Dermatomyositis,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
4751,1,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
4751,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
4752,1,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
4752,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
4753,1,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4754,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4755,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
4755,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
4755,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4755,4,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
4755,5,Atonic seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
4755,6,Body temperature fluctuation,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4755,7,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4755,8,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4755,9,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4755,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4755,11,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
4755,12,Generalised onset non-motor seizure,Absence seizures,Seizures (incl subtypes),Nerv,N
4755,13,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
4755,14,Postictal paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
4755,15,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
4755,16,Seizure cluster,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
4755,17,Sudden unexplained death in epilepsy,Death and sudden death,Fatal outcomes,Genrl,Y
4756,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4756,2,Giardiasis,Giardia infections,Protozoal infectious disorders,Infec,N
4756,3,Human T-cell lymphotropic virus type I infection,Retroviral infections,Viral infectious disorders,Infec,N
4756,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
4756,5,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,N
4756,6,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,N
4757,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4757,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4758,1,Back disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
4759,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
4759,2,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
4759,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4759,4,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
4759,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
4760,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4760,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4760,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4760,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4760,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4760,6,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4761,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4762,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
4763,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
4763,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
4763,3,Headache,Headaches NEC,Headaches,Nerv,N
4763,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4764,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
4764,2,Headache,Headaches NEC,Headaches,Nerv,N
4764,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4765,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
4765,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
4765,3,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
4765,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4765,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4765,6,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
4765,7,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4766,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4766,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
4767,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4767,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4767,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
4768,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4769,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4770,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4771,1,Keratopathy,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
4772,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4772,2,Nephrocalcinosis,Renal lithiasis,Urolithiases,Renal,N
4772,3,Renal cyst,Renal neoplasms,Renal disorders (excl nephropathies),Renal,N
4773,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
4773,2,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
4774,1,Osteoporotic fracture,Fractures NEC,Fractures,Musc,N
4775,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4776,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4776,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
4776,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
4777,1,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
4777,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
4777,3,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
4778,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4779,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4780,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
4780,2,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
4781,1,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
4781,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4782,1,Giardiasis,Giardia infections,Protozoal infectious disorders,Infec,N
4782,2,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,N
4783,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4783,2,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,N
4784,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4784,2,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4785,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
4785,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
4786,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
4786,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4786,3,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
4786,4,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4787,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
4787,2,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4788,1,Acanthosis,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
4788,2,Anorectal disorder,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
4788,3,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
4788,4,Macule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4788,5,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
4788,6,Oral hairy leukoplakia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
4788,7,Parakeratosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4788,8,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4788,9,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4788,10,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
4789,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
4789,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
4789,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4789,4,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
4790,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
4790,2,Serratia infection,Serratia infections,Bacterial infectious disorders,Infec,N
4790,3,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4791,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
4791,2,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4792,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
4792,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
4792,3,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
4793,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4793,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4793,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
4793,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4793,5,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,Y
4793,6,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
4793,7,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
4793,8,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
4793,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4793,10,Myalgia,Muscle pains,Muscle disorders,Musc,N
4793,11,Neck mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
4793,12,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4793,13,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
4793,14,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
4793,15,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
4793,16,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4793,17,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4794,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4795,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4795,2,Refusal of treatment by patient,Social issues NEC,Lifestyle issues,SocCi,N
4796,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4796,2,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
4796,3,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
4797,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
4797,2,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
4797,3,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
4797,4,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
4797,5,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
4797,6,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4797,7,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
4797,8,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
4797,9,Myopathy,Myopathies,Muscle disorders,Musc,N
4797,10,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
4798,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4798,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
4799,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4800,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
4801,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4801,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
4801,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4801,4,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
4801,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
4801,6,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
4801,7,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
4801,8,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4801,9,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4801,10,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,N
4802,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,Y
4802,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
4803,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
4803,2,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4803,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4803,4,Inappropriate affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
4804,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4804,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
4804,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4804,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4805,1,Halo vision,Visual disorders NEC,Vision disorders,Eye,N
4805,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4806,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
4806,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4807,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4808,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4808,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4808,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4808,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4808,5,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
4809,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
4809,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4810,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
4810,2,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
4810,3,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
4810,4,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
4810,5,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
4810,6,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4810,7,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
4810,8,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
4810,9,Myopathy,Myopathies,Muscle disorders,Musc,N
4810,10,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
4811,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4811,2,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
4811,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4811,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
4812,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
4813,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4813,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
4813,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
4814,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4814,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4815,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
4815,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
4815,3,Halo vision,Visual disorders NEC,Vision disorders,Eye,N
4815,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4816,1,Hyperaesthesia teeth,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
4817,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
4818,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4818,2,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4818,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4819,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
4819,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4819,3,Headache,Headaches NEC,Headaches,Nerv,N
4819,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
4820,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
4821,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
4821,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
4821,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
4822,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
4823,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4823,2,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
4823,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4823,4,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
4823,5,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4823,6,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
4824,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
4825,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
4826,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4826,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
4826,3,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4826,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4826,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
4826,6,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4826,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4826,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4826,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4826,10,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4826,11,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
4826,12,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
4826,13,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4826,14,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
4827,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4827,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4827,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4828,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
4829,1,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
4830,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4830,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
4830,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4830,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4830,5,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4830,6,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4830,7,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4830,8,Food intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
4830,9,Hyperacusis,Hyperacusia,Hearing disorders,Ear,N
4830,10,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4830,11,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4830,12,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4830,13,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4830,14,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
4830,15,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4830,16,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
4830,17,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4831,1,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4831,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
4832,1,Eye abscess,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
4832,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
4832,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4833,1,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
4834,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4834,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4835,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
4836,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4836,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
4836,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4836,4,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
4837,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
4838,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4839,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4840,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
4841,1,Pleuropericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
4842,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
4843,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4844,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4844,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4844,3,Still's disease,Rheumatoid arthropathies,Joint disorders,Musc,N
4845,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4846,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4847,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4847,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4847,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
4848,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4849,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4850,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
4851,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
4852,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
4852,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4852,3,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4852,4,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
4853,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4853,2,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4854,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4854,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
4855,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
4855,2,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,Y
4856,1,Enterocolitis haemorrhagic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4857,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
4857,2,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
4858,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
4859,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
4860,1,Symptom masked,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4861,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4862,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
4863,1,Cholestasis of pregnancy,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
4863,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4863,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
4864,1,Acute macular neuroretinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
4864,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4864,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4864,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4865,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4865,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4865,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4866,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
4866,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4866,3,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
4866,4,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
4866,5,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,Y
4866,6,Phrenic nerve paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
4867,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4867,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4867,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4868,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4868,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4869,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4869,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4869,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4870,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4870,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4871,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4872,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4872,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4872,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4873,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
4874,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
4874,2,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
4874,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
4874,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4875,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4876,1,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
4876,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4876,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4877,1,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
4878,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4878,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4878,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4878,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4879,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
4879,2,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
4879,3,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
4879,4,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
4879,5,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
4879,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4880,1,Cat scratch disease,Bartonella infections,Bacterial infectious disorders,Infec,N
4880,2,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4881,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4881,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4881,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4881,4,Still's disease,Rheumatoid arthropathies,Joint disorders,Musc,N
4882,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
4882,2,"Hallucination, olfactory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
4882,3,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
4882,4,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
4883,1,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
4884,1,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
4884,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
4884,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
4884,4,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
4885,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4885,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4885,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4886,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4886,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4886,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4886,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
4886,5,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
4887,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
4887,2,"Hallucination, olfactory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
4887,3,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
4887,4,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
4888,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4888,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4889,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4890,1,Fallopian tube cancer,Fallopian tube neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
4890,2,Leiomyosarcoma,Leiomyosarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
4890,3,Uterine leiomyoma,Uterine neoplasms benign,Reproductive neoplasms female benign,Neopl,N
4891,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
4891,2,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
4892,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
4893,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4894,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4894,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
4895,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4896,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4896,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
4896,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4896,4,Weight gain poor,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
4897,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4898,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
4898,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4898,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4898,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4899,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
4900,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
4900,2,Pulmonary sarcoidosis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
4900,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4900,4,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
4900,5,Weight gain poor,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
4901,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4901,2,Osteoporotic fracture,Fractures NEC,Fractures,Musc,N
4902,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4903,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4903,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
4904,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4905,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
4905,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4905,3,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
4905,4,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4906,1,Bone cancer,Bone neoplasms malignant (excl sarcomas),Skeletal neoplasms malignant and unspecified,Neopl,N
4906,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4906,3,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4907,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4908,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
4908,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4909,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4910,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4910,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4911,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
4911,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4911,3,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4911,4,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
4911,5,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4912,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,Y
4912,2,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
4913,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4913,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4913,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4914,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4915,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4915,2,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4916,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
4917,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
4917,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4917,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4918,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
4919,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
4919,2,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
4920,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4920,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
4921,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4921,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
4921,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4922,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
4922,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
4923,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
4924,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4925,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4925,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4925,3,Still's disease,Rheumatoid arthropathies,Joint disorders,Musc,N
4926,1,Aneurysm,Aneurysms and dissections non-site specific,Aneurysms and artery dissections,Vasc,N
4926,2,Peripheral artery occlusion,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
4926,3,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
4926,4,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
4926,5,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
4926,6,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
4927,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4927,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4927,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
4927,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4927,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4928,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4929,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
4929,2,Haematological infection,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4929,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4929,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4930,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
4930,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
4931,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
4931,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
4932,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
4932,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4932,3,Polyomavirus viraemia,Polyomavirus infections,Viral infectious disorders,Infec,N
4933,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
4934,1,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4935,1,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4935,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4935,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
4936,1,Familial haemophagocytic lymphohistiocytosis,Haematological disorders congenital NEC,Blood and lymphatic system disorders congenital,Cong,N
4936,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4936,3,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
4937,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
4937,2,Familial haemophagocytic lymphohistiocytosis,Haematological disorders congenital NEC,Blood and lymphatic system disorders congenital,Cong,N
4937,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4937,4,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4938,1,Gastric operation,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
4939,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
4940,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
4941,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
4942,1,Sleep paralysis,Abnormal sleep-related events,Sleep disturbances (incl subtypes),Nerv,N
4943,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4943,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4943,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4944,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4944,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
4944,3,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4945,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
4946,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4947,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
4947,2,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
4947,3,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
4947,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4947,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
4948,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4949,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4949,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4950,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4951,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4951,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
4951,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4951,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4951,5,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4951,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4951,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
4951,8,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
4951,9,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4951,10,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4952,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4952,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4952,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4953,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4953,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
4954,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
4954,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
4955,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
4955,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
4956,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4956,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
4956,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
4956,4,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
4956,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4956,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4957,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4957,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4958,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
4959,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
4959,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4959,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4959,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4960,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
4961,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
4961,2,Ocular vasculitis,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
4961,3,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
4962,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
4962,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4962,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4962,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4963,1,Migraine,Migraine headaches,Headaches,Nerv,N
4964,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
4965,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
4966,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
4967,1,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
4968,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4969,1,Catastrophic reaction,Stress disorders,Anxiety disorders and symptoms,Psych,N
4969,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4969,3,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
4969,4,Oesophageal rupture,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
4970,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4970,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
4971,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4971,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4971,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4971,4,Hunger,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4971,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
4971,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4972,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
4973,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
4973,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
4973,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
4973,4,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
4973,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4974,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4974,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4974,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4974,4,Myopathy,Myopathies,Muscle disorders,Musc,N
4974,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4975,1,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
4976,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4977,1,Giant cell arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
4977,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4978,1,Cerebellar stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4978,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4978,3,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4979,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
4979,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4980,1,Behcet's syndrome,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
4980,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
4980,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4980,4,Granuloma skin,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
4980,5,Mycobacterium marinum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
4981,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4981,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4981,3,VEXAS syndrome,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
4982,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
4982,2,Granuloma skin,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
4982,3,Mycobacterium marinum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
4983,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4984,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4984,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4985,1,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
4985,2,Wound complication,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
4986,1,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
4987,1,Behcet's syndrome,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
4987,2,Exposure to communicable disease,Exposures to agents or circumstances NEC,"Exposures, chemical injuries and poisoning",Inj&P,N
4987,3,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
4987,4,Mycobacterium marinum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
4987,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4988,1,Granuloma skin,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
4988,2,Mycobacterium marinum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
4988,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4989,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
4989,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4989,3,Vaccination failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4990,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4990,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4990,3,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
4990,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4991,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4991,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4992,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4993,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
4994,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
4995,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
4995,2,Granuloma skin,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
4995,3,Mycobacterium marinum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
4995,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4996,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
4996,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4997,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
4997,2,Mycobacterium marinum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
4998,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
4998,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
4999,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4999,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
4999,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4999,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4999,5,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5000,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
5000,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5001,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
5001,2,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5002,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5002,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5002,3,Nail discolouration,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
5002,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5002,5,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5003,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5003,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
5003,3,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
5003,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
5003,5,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
5003,6,Pulmonary congestion,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5003,7,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5003,8,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
5004,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
5005,1,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
5006,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
5006,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5006,3,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5006,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
5007,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5007,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
5007,3,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
5007,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
5007,5,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
5007,6,Pulmonary congestion,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5007,7,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5007,8,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
5008,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
5008,2,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
5009,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
5009,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5009,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
5009,4,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
5009,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5009,6,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
5009,7,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5009,8,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
5009,9,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5009,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5010,1,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
5011,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
5011,2,Myopathy,Myopathies,Muscle disorders,Musc,N
5011,3,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
5011,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5012,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5012,2,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5013,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
5014,1,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
5015,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5015,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5015,3,VEXAS syndrome,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
5016,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5016,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
5017,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
5017,2,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
5018,1,Autoimmune myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
5018,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
5019,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5019,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
5020,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
5020,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5021,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5021,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
5022,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
5023,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
5023,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5024,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5024,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5024,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5024,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5024,5,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5024,6,Immobile,Disability issues,Lifestyle issues,SocCi,N
5024,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5024,8,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
5024,9,Juvenile idiopathic arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
5024,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5024,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5024,12,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5024,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
5024,14,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5024,15,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5024,16,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5024,17,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
5024,18,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5025,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5025,2,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
5025,3,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5025,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5025,5,Vaccination failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5026,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5027,1,Cholangitis sclerosing,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
5027,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5028,1,Epidural lipomatosis,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
5029,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5029,2,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
5029,3,Eosinophilic oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
5029,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5030,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5030,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
5030,3,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
5030,4,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
5030,5,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
5030,6,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
5030,7,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
5031,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5031,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5031,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
5031,4,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
5031,5,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5031,6,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
5032,1,Allergy to chemicals,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
5032,2,Body temperature fluctuation,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5032,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5032,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5032,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5032,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5032,7,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5032,8,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
5032,9,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5032,10,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
5032,11,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5032,12,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
5032,13,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5033,1,Cerebral atrophy,Structural brain disorders NEC,Structural brain disorders,Nerv,N
5033,2,Hypervigilance,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
5034,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5034,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
5034,3,Panniculitis,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
5034,4,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5035,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5036,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
5037,1,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
5038,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5039,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5039,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5039,3,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
5039,4,Eosinophilic oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
5040,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
5041,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5042,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
5043,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5043,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5043,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5044,1,Musical ear syndrome,Hearing losses,Hearing disorders,Ear,N
5044,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5045,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
5046,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5046,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
5047,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
5047,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
5048,1,Deafness,Hearing losses,Hearing disorders,Ear,N
5048,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5049,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
5050,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
5051,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
5051,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5052,1,Acute motor-sensory axonal neuropathy,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
5053,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5053,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
5053,3,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
5053,4,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
5053,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
5053,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
5053,7,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
5053,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
5054,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5055,1,Panniculitis,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
5055,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5056,1,Behcet's syndrome,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
5056,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
5056,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5056,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5056,5,Granuloma skin,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
5056,6,Mycobacterium marinum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
5056,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5057,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5058,1,Mononeuropathy multiplex,Mononeuropathies,Peripheral neuropathies,Nerv,N
5059,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5059,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
5060,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5060,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
5061,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5061,2,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5061,3,Pneumonia lipoid,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5061,4,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5061,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
5062,1,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
5062,2,Axonal neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
5062,3,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
5062,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5062,5,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5062,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5062,7,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
5063,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5063,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
5063,3,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
5063,4,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
5063,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
5063,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
5063,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5063,8,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
5064,1,Acute motor-sensory axonal neuropathy,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
5065,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
5065,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
5065,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5065,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5065,5,Polymenorrhoea,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
5066,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
5067,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5068,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5068,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5069,1,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
5069,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
5070,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5071,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
5071,2,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
5071,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5071,4,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5072,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
5073,1,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
5073,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
5074,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
5074,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
5075,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5076,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5076,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5077,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
5077,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5077,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5077,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5078,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
5078,2,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
5079,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5079,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5079,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
5079,4,Mucous membrane pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
5080,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5081,1,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
5081,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
5082,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5082,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5082,3,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
5082,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5083,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5083,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
5084,1,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5085,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
5085,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5086,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5086,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
5087,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5088,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5088,2,Skin temperature,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5089,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
5089,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5090,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5090,2,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
5091,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5092,1,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
5093,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5094,1,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
5094,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
5095,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5096,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5096,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5096,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5096,4,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
5096,5,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5096,6,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
5096,7,Breast atrophy,Breast disorders NEC,Breast disorders,Repro,N
5096,8,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
5096,9,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5096,10,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5096,11,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
5096,12,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
5096,13,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5096,14,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
5096,15,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
5096,16,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5096,17,Tension,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5097,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5097,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5098,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5099,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5099,2,Gastrointestinal bacterial overgrowth,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
5099,3,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
5099,4,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
5099,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5100,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5100,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5100,3,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
5100,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5101,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5101,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5101,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
5101,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5102,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
5103,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
5104,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
5105,1,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
5105,2,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
5105,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5106,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
5106,2,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
5106,3,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
5106,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
5106,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5106,6,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
5106,7,Small intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
5106,8,Tuberculosis gastrointestinal,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
5107,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5107,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5107,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
5107,4,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5108,1,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
5108,2,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
5108,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5109,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
5110,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5111,1,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
5112,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5112,2,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
5112,3,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
5112,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5113,1,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
5113,2,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
5113,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5113,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5114,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5114,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5114,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5114,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5114,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
5114,6,Inflammation,Inflammations,General system disorders NEC,Genrl,N
5114,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5115,1,Arthritis reactive,Spondyloarthropathies,Joint disorders,Musc,N
5115,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5115,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5116,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
5116,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5117,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5118,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5119,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5120,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5120,2,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
5121,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
5121,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
5121,3,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
5121,4,Bulbar palsy,Mixed cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
5121,5,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
5121,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5121,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5121,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5121,9,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
5122,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5123,1,Radiculopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
5124,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
5125,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
5126,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
5127,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
5128,1,Acne cystic,Acnes,Skin appendage conditions,Skin,N
5129,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
5130,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
5131,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
5131,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
5131,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5132,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
5133,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
5134,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
5135,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
5136,1,Clonic convulsion,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
5136,2,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
5136,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5136,4,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
5137,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
5137,2,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
5137,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
5138,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
5138,2,Headache,Headaches NEC,Headaches,Nerv,N
5139,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
5140,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
5141,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
5142,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
5143,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
5143,2,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
5143,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
5144,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5144,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
5144,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5144,4,Placental disorder,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
5145,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
5146,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
5147,1,Immune-mediated myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
5147,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5148,1,Blood uric acid abnormal,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
5149,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5149,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5149,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
5149,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
5150,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
5150,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5150,3,Vaccination failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5151,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5151,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
5151,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5151,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5152,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5152,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5153,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5153,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
5154,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5155,1,Henoch-Schonlein purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
5155,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5155,3,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
5156,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
5156,2,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
5156,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
5157,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
5157,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
5158,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5159,1,Hyperaesthesia teeth,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
5160,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
5160,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5160,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5160,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
5160,5,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5161,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5161,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
5161,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5161,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5161,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5161,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
5162,1,Lactation insufficiency,Lactation disorders,Breast disorders,Repro,N
5162,2,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5163,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5163,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5164,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
5164,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5164,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5165,1,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
5166,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5167,1,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
5167,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5168,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
5168,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
5168,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5168,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5168,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5168,6,Inflammation,Inflammations,General system disorders NEC,Genrl,N
5168,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5168,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5168,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5168,10,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
5168,11,Reaction to preservatives,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
5169,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
5170,1,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
5170,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5171,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5172,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
5172,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
5172,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
5173,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5174,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5175,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5175,2,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5175,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
5175,4,Obsessive thoughts,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
5175,5,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
5175,6,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
5176,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5176,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5177,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
5177,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
5177,3,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
5177,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5177,5,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
5177,6,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
5177,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5177,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
5177,9,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
5177,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5177,11,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5177,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5177,13,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
5177,14,Retinal scar,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
5177,15,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
5178,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
5178,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
5178,3,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
5178,4,Brain contusion,Cerebral injuries NEC,Injuries NEC,Inj&P,N
5178,5,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5178,6,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
5178,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5178,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
5178,9,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
5179,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5179,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5180,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
5180,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
5180,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5181,1,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
5181,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5182,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
5182,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
5182,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
5183,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5184,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
5185,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
5186,1,Skin graft infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
5187,1,Skin graft infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
5188,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5188,2,Hyphaema,Eye injuries NEC,Injuries NEC,Inj&P,N
5189,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5190,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5190,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5191,1,Calcinosis,Trophic disorders,Tissue disorders NEC,Genrl,N
5192,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
5192,2,Eye ulcer,Ocular disorders NEC,Eye disorders NEC,Eye,N
5192,3,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
5192,4,Lens disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
5192,5,Lenticular opacities,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
5192,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5193,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
5193,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5194,1,Acquired haemophilia,Coagulation factor deficiencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
5194,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5195,1,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
5195,2,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
5195,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5196,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5197,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5198,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
5199,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5199,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5199,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5200,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5200,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5200,3,Systemic scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
5200,4,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5201,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5202,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5203,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5204,1,Hyperaesthesia teeth,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
5205,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5205,2,Gastric dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
5205,3,Headache,Headaches NEC,Headaches,Nerv,N
5205,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
5205,5,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
5206,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
5206,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
5206,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5206,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
5207,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5207,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
5208,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5208,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
5209,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5209,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5210,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5211,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5212,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5213,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
5214,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5214,2,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5214,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5214,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5214,5,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5214,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5214,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5214,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
5214,9,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
5214,10,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5214,11,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5214,12,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5214,13,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
5215,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
5215,2,Blood immunoglobulin M abnormal,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
5215,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5215,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5216,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5217,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5218,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5218,2,Early satiety,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5218,3,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
5219,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5219,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5219,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5219,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5220,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5220,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
5220,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
5221,1,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
5221,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5222,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5222,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
5222,3,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5223,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
5223,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5224,1,Migraine,Migraine headaches,Headaches,Nerv,N
5225,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
5225,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5226,1,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
5227,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5228,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5228,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5228,3,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
5228,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5229,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5229,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5229,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5229,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
5230,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
5231,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
5231,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5232,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
5233,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5234,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5234,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5234,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5235,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
5236,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5237,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5238,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
5238,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5238,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
5238,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
5239,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5240,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
5241,1,Desmoid tumour,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
5242,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
5243,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5244,1,Urine ketone body,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
5244,2,Urine ketone body,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
5245,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
5245,2,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
5245,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
5245,4,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
5245,5,Human herpesvirus 6 encephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
5245,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5245,7,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
5246,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
5246,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5247,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5248,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5249,1,Gastric cancer,Gastric neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
5250,1,Heart rate,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
5250,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
5250,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
5250,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5251,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5252,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
5252,2,Spinal deformity,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
5252,3,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
5253,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
5254,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5255,1,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5256,1,Acne,Acnes,Skin appendage conditions,Skin,N
5257,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
5257,2,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
5257,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
5258,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
5259,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
5259,2,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5260,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5260,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
5260,3,Spinal deformity,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
5260,4,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
5261,1,Acne,Acnes,Skin appendage conditions,Skin,N
5261,2,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
5261,3,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
5261,4,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
5261,5,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5261,6,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5261,7,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
5261,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5261,9,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5261,10,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5261,11,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
5261,12,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
5261,13,Myalgia,Muscle pains,Muscle disorders,Musc,N
5261,14,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5261,15,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
5261,16,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5262,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5262,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5263,1,Blood glucose,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
5264,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
5265,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
5266,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5266,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
5267,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
5267,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
5267,3,Post-acute COVID-19 syndrome,Coronavirus infections,Viral infectious disorders,Infec,N
5268,1,Intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
5268,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
5268,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5268,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
5268,5,Stoma site reaction,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
5269,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5269,2,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
5269,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5269,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5270,1,Administration site discomfort,Administration site reactions NEC,Administration site reactions,Genrl,N
5271,1,Cerebral aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
5271,2,Fungal test positive,Fungus identification and serology,Microbiology and serology investigations,Inv,N
5272,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5272,2,Giant cell arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,Y
5273,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5274,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5274,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
5275,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
5275,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5275,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
5275,4,Post-acute COVID-19 syndrome,Coronavirus infections,Viral infectious disorders,Infec,N
5275,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
5276,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5277,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5278,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5278,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5279,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5280,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5281,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5281,2,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
5281,3,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
5281,4,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
5281,5,Inflammation,Inflammations,General system disorders NEC,Genrl,N
5281,6,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5281,7,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
5281,8,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
5281,9,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
5281,10,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
5281,11,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
5282,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5283,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
5283,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5283,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
5284,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5285,1,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
5285,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5286,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5286,2,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
5287,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5288,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5289,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5290,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
5290,2,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
5290,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
5291,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
5292,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
5292,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
5293,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
5293,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5294,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
5295,1,Myopathy,Myopathies,Muscle disorders,Musc,N
5295,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
5295,3,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5296,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
5297,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5298,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5298,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5299,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
5300,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
5301,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
5302,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5302,2,Headache,Headaches NEC,Headaches,Nerv,N
5303,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
5304,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
5305,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
5306,1,Headache,Headaches NEC,Headaches,Nerv,N
5307,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
5308,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
5309,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
5310,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
5311,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
5312,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
5313,1,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5314,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5315,1,Diabetic blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
5315,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5316,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
5317,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5317,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5318,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5318,2,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5319,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
5319,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5320,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
5320,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
5320,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5320,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5321,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5321,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5321,3,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5322,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5322,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5323,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5323,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
5324,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5325,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
5325,2,Listeriosis,Listeria infections,Bacterial infectious disorders,Infec,N
5325,3,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
5325,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
5326,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5326,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5327,1,Amoebiasis,Amoebic infections,Protozoal infectious disorders,Infec,N
5327,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5327,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5328,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5328,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5328,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5328,4,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5328,5,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
5329,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5329,2,Pneumatosis intestinalis,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
5330,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5330,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5331,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
5331,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
5331,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5331,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5332,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
5333,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
5334,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5335,1,Cavernous sinus syndrome,Cranial nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
5335,2,Systemic inflammatory response syndrome,Inflammations,General system disorders NEC,Genrl,N
5335,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5336,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5336,2,Epileptic encephalopathy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
5337,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5338,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5338,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5338,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5339,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
5340,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5340,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5340,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5341,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5341,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5341,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
5341,4,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5342,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5342,2,Hyperphosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
5342,3,Volvulus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
5343,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5343,2,Intravascular haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
5343,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5343,4,Warm autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
5344,1,Histoplasmosis disseminated,Histoplasma infections,Fungal infectious disorders,Infec,N
5345,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5346,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
5346,2,Malignant hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
5346,3,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
5347,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
5347,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5347,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5347,4,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5347,5,Scleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
5348,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
5348,2,Listeriosis,Listeria infections,Bacterial infectious disorders,Infec,N
5348,3,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
5348,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
5349,1,Acne,Acnes,Skin appendage conditions,Skin,N
5350,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5350,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
5350,3,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
5351,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5351,2,Listeriosis,Listeria infections,Bacterial infectious disorders,Infec,N
5351,3,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
5351,4,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
5351,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
5351,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5352,1,Antiphospholipid syndrome,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
5353,1,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
5353,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
5354,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5354,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
5354,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5355,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
5355,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
5356,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5357,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5357,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5358,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5359,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5359,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
5359,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
5359,4,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
5359,5,Polychondritis,Cartilage disorders,"Tendon, ligament and cartilage disorders",Musc,N
5359,6,Scleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
5359,7,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
5360,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5361,1,Urine output,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
5362,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5363,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
5364,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5365,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5366,1,Tuberculosis of genitourinary system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
5367,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
5368,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
5368,2,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
5369,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5369,2,Electroencephalogram abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
5370,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5370,2,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5370,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5370,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5370,5,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5370,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5371,1,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
5371,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5372,1,Central serous chorioretinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
5373,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
5374,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
5375,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5375,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
5375,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5375,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5375,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5375,6,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5375,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5376,1,Tendon disorder,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
5377,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5378,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
5379,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
5379,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5380,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5381,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
5382,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
5383,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5383,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5384,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5385,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
5385,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5386,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5387,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5388,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
5389,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
5389,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5389,3,Lipase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
5389,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5389,5,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
5390,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
5390,2,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
5390,3,Sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5390,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
5390,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5391,1,Epstein Barr virus positive mucocutaneous ulcer,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
5392,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5393,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
5393,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5393,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5393,4,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
5394,1,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
5395,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
5395,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5395,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5396,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
5397,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5398,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5399,1,Epstein Barr virus positive mucocutaneous ulcer,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
5400,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
5400,2,Secondary immunodeficiency,Acquired immunodeficiency syndromes,Immunodeficiency syndromes,Immun,N
5400,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5401,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
5401,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5401,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5402,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
5402,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5403,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5404,1,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
5405,1,Amniotic cavity infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
5405,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5405,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
5406,1,Headache,Headaches NEC,Headaches,Nerv,N
5406,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5406,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5407,1,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
5407,2,Female reproductive tract disorder,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
5407,3,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
5407,4,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
5407,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5408,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5408,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5409,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5410,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5410,2,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
5410,3,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5410,4,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
5411,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5411,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
5412,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5412,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5413,1,Amniotic cavity infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
5413,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
5413,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5413,4,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
5414,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5414,2,Haemangioma-thrombocytopenia syndrome,Skin vascular conditions NEC,Skin vascular abnormalities,Skin,N
5415,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
5416,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5416,2,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
5416,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5417,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5417,2,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
5418,1,Chronic graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
5418,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5419,1,Defaecation disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
5420,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5420,2,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5420,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5421,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5421,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5421,3,VEXAS syndrome,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
5422,1,Alternaria infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
5422,2,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
5423,1,Epstein Barr virus positive mucocutaneous ulcer,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
5423,2,Epstein Barr virus positive mucocutaneous ulcer,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
5423,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5424,1,Amniotic cavity infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
5424,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5424,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5424,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
5424,5,Spontaneous rupture of membranes,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
5425,1,Alternaria infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
5425,2,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
5425,3,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
5426,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5427,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5427,2,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5428,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5429,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5430,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
5431,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
5431,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5431,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5431,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5431,5,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5431,6,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
5432,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
5433,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5433,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5434,1,Alternaria infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
5434,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
5435,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
5436,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5436,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
5437,1,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5437,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5437,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5437,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
5438,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5439,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5439,2,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
5440,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
5441,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
5441,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5441,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
5442,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
5443,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5444,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5445,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5445,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5445,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5445,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5446,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5446,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5447,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5447,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
5447,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
5447,4,Polychromasia,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
5447,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5447,6,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5447,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5448,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
5449,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
5449,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5449,3,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5450,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5450,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5450,3,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5451,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
5452,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5452,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5452,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5453,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
5454,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5454,2,Orofacial granulomatosis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
5454,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5455,1,Acne,Acnes,Skin appendage conditions,Skin,N
5455,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5455,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5456,1,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
5457,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5457,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
5458,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
5459,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5459,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
5459,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5460,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
5460,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
5461,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5461,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5462,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5463,1,Pseudolymphoma,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
5464,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
5464,2,Eye operation,Eye therapeutic procedures NEC,Eye therapeutic procedures,Surg,N
5464,3,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
5464,4,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5464,5,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
5464,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5464,7,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
5464,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5464,9,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
5464,10,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5464,11,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
5464,12,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5464,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5464,14,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5465,1,Pancreatic disorder,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
5466,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5466,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
5466,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5467,1,Headache,Headaches NEC,Headaches,Nerv,N
5467,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5467,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5467,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5468,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5469,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
5469,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5469,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5470,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5470,2,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
5470,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5470,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5470,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5470,6,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5471,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
5472,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5473,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
5474,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5474,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5474,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5475,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
5475,2,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5476,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
5476,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
5477,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5477,2,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
5477,3,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
5477,4,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5477,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5477,6,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5477,7,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5477,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
5477,9,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
5478,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5478,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
5479,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5479,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5479,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5480,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
5480,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5480,3,Human herpesvirus 6 encephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
5480,4,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
5481,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
5482,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
5482,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5482,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5483,1,Central serous chorioretinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
5484,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5485,1,Chronic spontaneous urticaria,Urticarias,Angioedema and urticaria,Skin,N
5485,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5485,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5485,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5485,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5486,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
5487,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5488,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5489,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
5490,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5490,2,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5490,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5491,1,Headache,Headaches NEC,Headaches,Nerv,N
5491,2,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5491,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5492,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5492,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5492,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5493,1,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
5494,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
5494,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
5495,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
5496,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5496,2,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
5496,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
5497,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5497,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5498,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5498,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
5499,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
5499,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5500,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5500,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5501,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5502,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
5503,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
5503,2,Delayed graft function,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
5503,3,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
5503,4,Morganella infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
5503,5,Pyelonephritis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
5504,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
5504,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5504,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5505,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5505,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5505,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5505,4,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
5506,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5507,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5507,2,Duodenal perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
5508,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5508,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5509,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5510,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5510,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5511,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
5512,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5512,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5512,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5513,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5513,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5513,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5514,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
5514,2,Pyelonephritis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
5515,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5515,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5515,3,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
5515,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
5515,5,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
5515,6,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5515,7,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5516,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
5516,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5517,1,Intraductal proliferative breast lesion,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
5517,2,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
5518,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
5519,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
5519,2,Pyelonephritis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
5520,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5520,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
5520,3,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
5521,1,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5522,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
5523,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5524,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
5524,2,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
5524,3,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
5524,4,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
5524,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
5524,6,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
5525,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5526,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
5526,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
5527,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
5528,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5528,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
5528,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
5528,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
5528,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
5528,6,Pasteurella infection,Pasteurella infections,Bacterial infectious disorders,Infec,N
5528,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
5529,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
5529,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
5529,3,Perineal necrosis,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
5529,4,Rectal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
5529,5,Rectal perforation,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
5530,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5530,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5530,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5531,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
5532,1,Sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5533,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
5533,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5534,1,Heart rate,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
5535,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
5535,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5536,1,Genital haemorrhage,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
5537,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5538,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
5539,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
5539,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
5539,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5539,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
5540,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5541,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5541,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5541,3,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5542,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
5543,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
5543,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
5544,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
5545,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5545,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
5546,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
5546,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5547,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5548,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5548,2,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
5548,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5549,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5550,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5551,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
5551,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
5551,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5552,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
5552,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
5552,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5553,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5554,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5554,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
5555,1,Acute cardiac event,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5555,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
5556,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5556,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5557,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5558,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5559,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5560,1,Chronic myelomonocytic leukaemia,Myelodysplastic syndromes,Leukaemias,Neopl,N
5561,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5561,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5561,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5561,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5562,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5563,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
5563,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
5564,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5565,1,Atrial enlargement,Myocardial disorders NEC,Myocardial disorders,Card,N
5565,2,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
5565,3,Autonomic nervous system imbalance,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
5565,4,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
5565,5,Dilatation atrial,Myocardial disorders NEC,Myocardial disorders,Card,N
5565,6,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
5565,7,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
5565,8,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
5566,1,Adenoviral encephalitis,Adenoviral infections,Viral infectious disorders,Infec,N
5566,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
5566,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
5566,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5566,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5566,6,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
5566,7,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
5567,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5567,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5568,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
5568,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5569,1,Migraine,Migraine headaches,Headaches,Nerv,N
5570,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5570,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
5571,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5571,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5572,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5572,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5573,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5573,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5574,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5574,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5575,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5576,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5577,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
5578,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5579,1,Trichophytic granuloma,Tinea infections,Fungal infectious disorders,Infec,N
5580,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5580,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5581,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5581,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5581,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5582,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5582,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5583,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5583,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5584,1,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
5584,2,Overweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
5585,1,Overweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
5586,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
5586,2,Blood insulin increased,"Gastrointestinal, pancreatic and APUD hormone analyses",Endocrine investigations (incl sex hormones),Inv,N
5586,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5587,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
5588,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5589,1,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
5590,1,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
5591,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5592,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
5593,1,Overweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
5594,1,Atrial enlargement,Myocardial disorders NEC,Myocardial disorders,Card,N
5594,2,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
5594,3,Autonomic nervous system imbalance,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
5594,4,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
5594,5,Dilatation atrial,Myocardial disorders NEC,Myocardial disorders,Card,N
5594,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5594,7,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
5594,8,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
5594,9,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
5595,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5596,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
5596,2,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
5596,3,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
5596,4,Male genital tract fistula,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
5596,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5596,6,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
5596,7,Testicular abscess,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
5596,8,Urinary fistula,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
5597,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5598,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5599,1,Herpes zoster reactivation,Herpes viral infections,Viral infectious disorders,Infec,N
5600,1,Varicella zoster pneumonia,Herpes viral infections,Viral infectious disorders,Infec,Y
5601,1,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
5601,2,Overweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
5602,1,Dental discomfort,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
5603,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5603,2,Dyschromatopsia,Colour blindness (incl acquired),Vision disorders,Eye,N
5603,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
5604,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
5605,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
5605,2,Listeriosis,Listeria infections,Bacterial infectious disorders,Infec,N
5605,3,Opportunistic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5605,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
5606,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
5607,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
5607,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5607,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
5607,4,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
5608,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
5609,1,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5610,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5611,1,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
5612,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
5612,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5612,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5612,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5612,5,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
5612,6,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
5613,1,Antisynthetase syndrome,Muscle infections and inflammations,Muscle disorders,Musc,N
5613,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
5613,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
5614,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
5615,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
5616,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5616,2,Erythrodermic psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5616,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5616,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5616,5,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5616,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
5617,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
5617,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
5618,1,Epstein-Barr virus associated lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
5619,1,Basal ganglia haematoma,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
5619,2,Collagen disorder,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
5619,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
5619,4,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
5620,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
5620,2,Epstein-Barr virus associated lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
5621,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
5621,2,Epstein-Barr virus associated lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
5622,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
5622,2,Retinal vasculitis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
5623,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5623,2,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
5623,3,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
5624,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
5625,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
5625,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5626,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
5627,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5628,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5628,2,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5629,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
5630,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
5630,2,Epstein-Barr virus associated lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
5631,1,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5631,2,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5632,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
5633,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
5633,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
5634,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
5634,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5635,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5635,2,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5636,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
5636,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
5636,3,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
5637,1,Epstein-Barr virus associated lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
5637,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
5637,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5637,4,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
5638,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5638,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
5639,1,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
5639,2,Disseminated trichosporonosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
5639,3,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
5639,4,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
5639,5,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
5640,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
5640,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
5641,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5641,2,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
5641,3,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
5642,1,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
5643,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5643,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
5644,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5644,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5645,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5646,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5646,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5647,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
5648,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
5649,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
5650,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5650,2,Unevaluable investigation,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
5651,1,Diabetic complication,Diabetic complications NEC,Diabetic complications,Metab,N
5652,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
5653,1,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
5653,2,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5654,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
5654,2,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5654,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5654,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
5655,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5656,1,Acne,Acnes,Skin appendage conditions,Skin,N
5656,2,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5656,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5656,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5657,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
5657,2,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
5658,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5659,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5659,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5659,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5660,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
5660,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5661,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5661,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5662,1,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
5662,2,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5663,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
5663,2,Mycobacterium haemophilum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
5663,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
5664,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5664,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
5664,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
5665,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
5665,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5666,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
5667,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
5668,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5669,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5669,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
5670,1,Migraine,Migraine headaches,Headaches,Nerv,N
5671,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5672,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
5673,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
5673,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
5674,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5674,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
5675,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5675,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
5675,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
5676,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
5676,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
5677,1,Product deposit,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5678,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5679,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
5680,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
5681,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
5681,2,Mycobacterium marinum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
5682,1,Acne,Acnes,Skin appendage conditions,Skin,N
5682,2,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
5682,3,C-reactive protein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
5682,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5682,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5682,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5682,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5682,8,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
5682,9,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
5682,10,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5683,1,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
5683,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
5684,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5684,2,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
5685,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5685,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5685,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
5686,1,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
5687,1,Acrochordon,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
5687,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5687,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5687,4,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5687,5,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
5688,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5688,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
5688,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
5688,4,Delirium,Deliria,Deliria (incl confusion),Psych,N
5688,5,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5688,6,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
5688,7,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
5688,8,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5689,1,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
5690,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
5691,1,Headache,Headaches NEC,Headaches,Nerv,N
5691,2,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
5691,3,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
5692,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5693,1,Acne,Acnes,Skin appendage conditions,Skin,N
5693,2,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
5693,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5693,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5693,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5694,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
5695,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5695,2,Bradyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
5695,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5695,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5695,5,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
5695,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5695,7,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5695,8,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5695,9,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
5695,10,Headache,Headaches NEC,Headaches,Nerv,N
5695,11,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5695,12,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5695,13,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5696,1,Acne,Acnes,Skin appendage conditions,Skin,N
5696,2,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
5696,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5696,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5696,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5696,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5697,1,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
5698,1,Acne,Acnes,Skin appendage conditions,Skin,N
5698,2,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
5698,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5698,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5698,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
5698,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5699,1,Beta haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
5699,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
5699,3,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
5699,4,Polyomavirus-associated nephropathy,Polyomavirus infections,Viral infectious disorders,Infec,N
5699,5,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5700,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5700,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
5701,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
5702,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
5703,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
5704,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5704,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5704,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5704,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5705,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
5705,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
5706,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
5706,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
5706,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5707,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5708,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5708,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5708,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5708,4,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5708,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5708,6,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
5708,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5708,8,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
5708,9,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5708,10,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
5708,11,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
5708,12,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5708,13,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
5709,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5709,2,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
5710,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5710,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5711,1,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
5712,1,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
5713,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5714,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5715,1,Suicidal behaviour,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5715,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5716,1,Bowel movement irregularity,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
5716,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
5717,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
5717,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5718,1,Alpha haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
5718,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
5718,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
5718,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
5718,5,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
5719,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
5720,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5720,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5720,3,Headache,Headaches NEC,Headaches,Nerv,N
5720,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5720,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5721,1,Delayed graft function,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
5721,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5721,3,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
5721,4,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
5721,5,Pyelonephritis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
5722,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
5722,2,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5722,3,Donor specific antibody present,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
5722,4,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
5722,5,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
5723,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
5723,2,Deafness,Hearing losses,Hearing disorders,Ear,N
5723,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5723,4,Erythrodermic psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5723,5,Guttate psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5723,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5723,7,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5723,8,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5723,9,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5723,10,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5724,1,Addison's disease,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
5725,1,Muscle strength abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5726,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
5727,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5728,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5728,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
5729,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
5729,2,Encephalitis cytomegalovirus,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
5730,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5730,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
5731,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5731,2,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
5731,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5732,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
5732,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
5732,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5733,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5734,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
5734,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5735,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
5736,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5737,1,Perioral dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5738,1,Atrial thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5738,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
5738,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5738,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5739,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5739,2,Costochondritis,Cartilage disorders,"Tendon, ligament and cartilage disorders",Musc,N
5739,3,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5739,4,Painful respiration,Respiratory signs and symptoms NEC,Respiratory tract signs and symptoms,Resp,N
5739,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
5740,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5741,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5742,1,Menstruation delayed,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
5743,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5744,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
5745,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5746,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
5746,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5747,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5747,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5747,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5748,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5749,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
5749,2,Feeding tube user,Dietary and nutritional issues,Lifestyle issues,SocCi,N
5750,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5751,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
5751,2,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
5752,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5752,2,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
5752,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
5753,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5753,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5753,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5753,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
5754,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
5754,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
5754,3,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
5755,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5755,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5755,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
5755,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
5755,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5756,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5756,2,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
5756,3,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
5757,1,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
5758,1,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
5759,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
5759,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5760,1,Cystoid macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
5760,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5761,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
5761,2,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
5761,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5761,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5761,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5762,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
5763,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
5764,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5765,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5766,1,Ocular hypertension,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
5766,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5767,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5768,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5769,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
5769,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5769,3,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
5769,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
5769,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5770,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5770,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5771,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
5772,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
5773,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5774,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
5775,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
5776,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5777,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
5778,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5778,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5779,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
5779,2,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
5779,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5779,4,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5779,5,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
5780,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5780,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5781,1,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
5782,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5783,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
5783,2,Glucose tolerance impaired,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5784,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5784,2,Headache,Headaches NEC,Headaches,Nerv,N
5784,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5784,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5784,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
5784,6,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5785,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
5786,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
5787,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
5788,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
5788,2,Glucose tolerance impaired,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5789,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5789,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
5789,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5789,4,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5789,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5790,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
5791,1,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5791,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
5792,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5792,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
5793,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
5794,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5795,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5796,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5796,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5796,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5797,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5797,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
5797,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
5797,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5798,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
5799,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
5799,2,Granuloma,Inflammations,General system disorders NEC,Genrl,N
5799,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5800,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
5801,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5802,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5803,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5804,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5805,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
5806,1,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5807,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5807,2,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
5807,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
5807,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
5807,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5807,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5807,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5807,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5807,9,Pharyngeal erythema,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
5808,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
5809,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
5810,1,Headache,Headaches NEC,Headaches,Nerv,N
5810,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5810,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
5811,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5812,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
5812,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5812,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5813,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5814,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5814,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5815,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5816,1,Malacoplakia gastrointestinal,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
5817,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5817,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5818,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5819,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5820,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5820,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5821,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5821,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
5822,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
5823,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
5824,1,Central nervous system immune reconstitution inflammatory response,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
5824,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
5824,3,Eye infection toxoplasmal,Toxoplasma infections,Protozoal infectious disorders,Infec,N
5824,4,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
5825,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
5825,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5825,3,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
5826,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
5826,2,Malacoplakia gastrointestinal,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
5827,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5828,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
5828,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5828,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5828,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5828,5,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5828,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5828,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5828,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5828,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5828,10,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
5828,11,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
5828,12,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
5828,13,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5828,14,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5828,15,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
5828,16,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5828,17,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5828,18,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
5829,1,Atypical femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
5830,1,Menstruation delayed,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
5831,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
5831,2,Myopathy,Myopathies,Muscle disorders,Musc,N
5831,3,Myopathy,Myopathies,Muscle disorders,Musc,N
5832,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5832,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
5833,1,Osteoporotic fracture,Fractures NEC,Fractures,Musc,N
5833,2,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
5833,3,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
5834,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
5835,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5835,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5835,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
5835,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5836,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
5837,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5838,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
5839,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5840,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5840,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
5841,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
5842,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
5843,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
5843,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
5844,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5844,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
5844,3,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
5845,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5845,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
5845,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
5845,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5846,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5846,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
5846,3,Scleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
5847,1,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
5848,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5848,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
5848,3,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
5848,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5848,5,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
5849,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5849,2,Drug-disease interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5849,3,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
5850,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5851,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
5852,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
5853,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5854,1,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
5854,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
5854,3,Pulmonary tumour thrombotic microangiopathy,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
5854,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
5854,5,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
5855,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5856,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,Y
5857,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
5857,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5858,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
5859,1,Bezoar,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
5859,2,Bladder obstruction,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
5859,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
5859,4,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
5859,5,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
5860,1,Bezoar,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
5860,2,Bladder obstruction,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
5860,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
5860,4,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
5860,5,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
5861,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
5862,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5863,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5864,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5865,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5866,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5866,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5866,3,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
5866,4,Mycobacterium marinum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
5867,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
5867,2,Infection reactivation,Infections NEC,Infections - pathogen unspecified,Infec,N
5867,3,Mycobacterium test positive,Mycobacteria identification and serology,Microbiology and serology investigations,Inv,N
5868,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5869,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5870,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
5871,1,Central serous chorioretinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
5872,1,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
5872,2,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
5872,3,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
5873,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5873,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5874,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
5874,2,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
5874,3,Parvovirus B19 infection,Parvoviral infections,Viral infectious disorders,Infec,N
5875,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
5876,1,Acne,Acnes,Skin appendage conditions,Skin,N
5876,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
5876,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5876,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5876,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5876,6,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5876,7,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
5876,8,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5876,9,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5876,10,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
5876,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
5876,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
5876,13,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
5877,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
5877,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
5878,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
5878,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
5879,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5879,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5879,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
5879,4,Listeriosis,Listeria infections,Bacterial infectious disorders,Infec,N
5879,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5880,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5880,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5881,1,Oesophageal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
5881,2,Oesophageal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5882,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
5882,2,Myelodysplastic syndrome with single lineage dysplasia,Myelodysplastic syndromes,Leukaemias,Neopl,N
5882,3,Parvovirus B19 infection,Parvoviral infections,Viral infectious disorders,Infec,N
5883,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5883,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5883,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5883,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5883,5,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
5883,6,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
5883,7,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5883,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5883,9,Inflammation,Inflammations,General system disorders NEC,Genrl,N
5883,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5883,11,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5883,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5883,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5884,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
5884,2,Erosive duodenitis,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
5884,3,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
5884,4,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
5884,5,Parvovirus B19 infection,Parvoviral infections,Viral infectious disorders,Infec,N
5884,6,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5884,7,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
5885,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
5885,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5885,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5886,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
5886,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
5886,3,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
5886,4,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5886,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
5886,6,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5886,7,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
5886,8,Drug monitoring procedure not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5886,9,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
5886,10,Homicidal ideation,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
5886,11,Neuropsychological symptoms,Mental disorders due to a general medical condition NEC,Psychiatric disorders NEC,Psych,N
5886,12,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
5886,13,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5886,14,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
5887,1,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
5888,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5888,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5888,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5888,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5888,5,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5888,6,Headache,Headaches NEC,Headaches,Nerv,N
5888,7,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5888,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5888,9,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
5889,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5889,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
5889,3,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
5890,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5890,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
5890,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
5891,1,Corneal scar,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
5891,2,Herpes ophthalmic,Herpes viral infections,Viral infectious disorders,Infec,N
5891,3,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
5891,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5892,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
5892,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
5892,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
5892,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5892,5,Renal graft infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
5892,6,Vitamin D increased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
5893,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5893,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
5894,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5894,2,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5894,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5894,4,Intrusive thoughts,Thinking disturbances,Disturbances in thinking and perception,Psych,N
5894,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5895,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5895,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
5895,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
5896,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5896,2,Superinfection,Infections NEC,Infections - pathogen unspecified,Infec,N
5897,1,Vascular occlusion,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
5898,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
5899,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5900,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
5900,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
5900,3,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
5900,4,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
5901,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5901,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
5901,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
5902,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5902,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5903,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5904,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
5905,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
5905,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
5906,1,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
5907,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
5908,1,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5908,2,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5908,3,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5909,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
5909,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5910,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5910,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
5911,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
5911,2,Granuloma,Inflammations,General system disorders NEC,Genrl,N
5912,1,Addison's disease,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
5912,2,Decreased interest,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5912,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5912,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5912,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5912,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5913,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5913,2,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
5913,3,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
5914,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5915,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
5915,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5915,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5915,4,Neurodermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5915,5,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
5915,6,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
5916,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5917,1,Blood cholesterol abnormal,Cholesterol analyses,Lipid analyses,Inv,N
5917,2,High density lipoprotein abnormal,Cholesterol analyses,Lipid analyses,Inv,N
5917,3,Low density lipoprotein abnormal,Cholesterol analyses,Lipid analyses,Inv,N
5918,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5919,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5920,1,Nasal polyps,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
5921,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5922,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5922,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5922,3,Nail deformation,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
5922,4,Onychomadesis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
5922,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5922,6,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5922,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5922,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
5922,9,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5922,10,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5922,11,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
5923,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5924,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
5925,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
5925,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5925,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
5925,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
5926,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
5927,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
5928,1,C-reactive protein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
5928,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
5928,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
5928,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
5928,5,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5928,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
5929,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5930,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
5931,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
5931,2,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
5932,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
5932,2,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
5932,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5932,4,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5932,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5932,6,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
5932,7,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
5932,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5932,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5932,10,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
5932,11,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
5933,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
5933,2,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
5933,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
5933,4,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
5934,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
5934,2,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
5934,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
5934,4,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
5935,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5936,1,Acne,Acnes,Skin appendage conditions,Skin,N
5936,2,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
5936,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5937,1,C-reactive protein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
5937,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
5937,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
5937,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
5937,5,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5937,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
5937,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5938,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5938,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5938,3,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
5939,1,Acne,Acnes,Skin appendage conditions,Skin,N
5939,2,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
5939,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5939,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5940,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
5940,2,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
5940,3,Enterococcal bacteraemia,Enterococcal infections,Bacterial infectious disorders,Infec,N
5940,4,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
5940,5,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,Y
5940,6,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
5940,7,Systemic candida,Candida infections,Fungal infectious disorders,Infec,N
5941,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
5941,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
5941,3,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
5941,4,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5941,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5941,6,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
5941,7,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5941,8,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
5941,9,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
5941,10,Headache,Headaches NEC,Headaches,Nerv,N
5941,11,Inappropriate affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
5941,12,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5941,13,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
5941,14,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
5941,15,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5941,16,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
5941,17,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5942,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5942,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5942,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5942,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
5943,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5943,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5944,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
5944,2,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
5944,3,Enterobacter bacteraemia,Enterobacter infections,Bacterial infectious disorders,Infec,N
5944,4,Enterococcal bacteraemia,Enterococcal infections,Bacterial infectious disorders,Infec,N
5944,5,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
5944,6,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
5944,7,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,Y
5944,8,Systemic candida,Candida infections,Fungal infectious disorders,Infec,N
5945,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
5945,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5945,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5945,4,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
5946,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5947,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5947,2,Product closure removal difficult,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5947,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5948,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5948,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
5948,3,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
5948,4,Fungaemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5948,5,Glomerulonephritis minimal lesion,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
5948,6,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
5948,7,Immunoglobulin G4 related disease,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
5948,8,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
5948,9,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
5948,10,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5948,11,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5949,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5949,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5950,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5950,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
